{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.06040"}, {"@name": "filename", "#text": "10537_arquivo2779_1.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "UNIVERSIDADE FEDERAL DE PERNAMBUCO \n\nCENTRO DE CI\u00caNCIAS BIOL\u00d3GICAS \n\nPROGRAMA DE P\u00d3S-GRADUA\u00c7\u00c3O EM CI\u00caNCIAS BIOL\u00d3GICAS \n\nN\u00cdVEL DOUTORADO \n\n \n  \n \n\n  \n \n\n \n\n \n\nPurifica\u00e7\u00e3o, caracteriza\u00e7\u00e3o estrutural e funcional da lectina do \n\nveneno de Bothrops leucurus: Modula\u00e7\u00e3o de eventos \n\ncitot\u00f3xicos ap\u00f3s a irradia\u00e7\u00e3o gamma. \n \n \n \n \n \n \n \n \n  \n\nERIKA DOS SANTOS NUNES \n\n \n\n \n\n \n\n \n\nRECIFE \n\n2011 \n\n\n\nERIKA DOS SANTOS NUNES \n\n \n\n \n\n \n\n \n\nPurifica\u00e7\u00e3o, caracteriza\u00e7\u00e3o estrutural e funcional da lectina do \n\nveneno de Bothrops leucurus: Modula\u00e7\u00e3o de eventos \n\ncitot\u00f3xicos ap\u00f3s a irradia\u00e7\u00e3o gamma. \n \n\n \n\n \n\n \n\n                                                                         Tese apresentada ao Programa de P\u00f3s-Gradua\u00e7\u00e3o em \nCi\u00eancias Biol\u00f3gicas da Universidade Federal de \nPernambuco como pr\u00e9-requisito para a obten\u00e7\u00e3o do \nt\u00edtulo em Doutor em Ci\u00eancias Biol\u00f3gicas. \n\n \n\n \n\nOrientadora: Profa. Dra. Maria Tereza dos Santos Correia \n\nCo-orientadora: Profa. Dra. M\u00edriam Camargo Guarnieri \n\n \n\nBanca examinadora: \n\nProfa. Dra. Maria Tereza dos Santos Correia (Presidente/UFPE) \n\nProfa. Dra. Luana Cassandra Breitenbach Barroso Coelho (UFPE) \n\nProfa. Dra. Vera L\u00facia de Menezes Lima (UFPE) \n\nProfa. Dra. M\u00e1rcia Vanusa da Silva (UFPE) \n\nProfa. Dra. Jeanne Cla\u00edne de Albuquerque Modesto (UFPE/CAV) \n\n \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n\n\n\n \n \n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n                                                                 \n\n \n\n\u201c\u00c9 gra\u00e7a divina come\u00e7ar bem. Gra\u00e7a \n\nmaior persistir na caminhada certa. Mas \n\ngra\u00e7a das gra\u00e7as \u00e9 n\u00e3o desistir nunca.\u201d \n\n                                                                                                   \n\n                                                                                                    Dom H\u00e9lder C\u00e2mara \n\n\n\nAGRADECIMENTOS \n\n \n\nA Deus por guiar meus passos todos os dias de minha vida. \n\nA meus pais por me apoiarem em todos os momentos da minha exist\u00eancia.  \n\nA meu esposo Roberto, por sua paci\u00eancia, dedica\u00e7\u00e3o, por suas palavras de incentivo e \n\nprincipalmente por seu amor.  \n\nAs minhas irm\u00e3s e cunhados que me apoiaram e torceram por mim em todas as etapas desse \n\ntrabalho. \n\nAs profa. Dra Tereza Correia e a profa. Dra. Miriam Guarnieri, pela amizade, aten\u00e7\u00e3o e por \n\nacreditar no meu potencial para executar esse trabalho.  \n\nA profa. Dra. Teresinha Gon\u00e7alves e a Jaciana Aguiar pela amizade e colabora\u00e7\u00e3o nesse trabalho. \n\nA profa. Dra. Maria Madalena e Andr\u00e9 Mariano do Departamento de Veterin\u00e1ria pela amizade e \n\ncolabora\u00e7\u00e3o na an\u00e1lise de Microscopia de fluoresc\u00eancia.    \n\nA profa. Dra. Maria Luiza V. Oliva e a profa. Dra. Rosemeire A. Silva-Lucca pela colabora\u00e7\u00e3o \n\nnesse trabalho. \n\nA todos que integram o Laborat\u00f3rio de Glicoprote\u00ednas, pela paci\u00eancia, amizade e por me receberem \n\nde bra\u00e7os abertos....... bem abertos. \n\nA meu \u201cfilho\u201d Fernando, a Lidiany, Giselly e Mary, pela paci\u00eancia, amizade e colabora\u00e7\u00e3o...... \n\n\u201cvoc\u00eas moram no meu cora\u00e7\u00e3o\u201d.  \n\nA Thiago e Francis pela ajuda nesse trabalho, amizade e aten\u00e7\u00e3o...... \u201ceita dupla arretada de boa\u201d. \n\nAos meus colegas de Doutorado, em especial a minha amiga Dil\u00eania, por sua amizade e incentivo \n\nsempre presentes. \n\nA todos os meus amigos e parentes que mesmo distantes torceram por mim. \n\nA Universidade do Estado da Bahia (UNEB) pelo afastamento tempor\u00e1rio concedido para a \n\nrealiza\u00e7\u00e3o desse trabalho. \n\n                                                                                                                                      Muito obrigada! \n\n \n\n\n\nRESUMO \n\n \n\nLectinas s\u00e3o prote\u00ednas ou glicoprote\u00ednas de origem n\u00e3o imune cuja liga\u00e7\u00e3o revers\u00edvel e espec\u00edfica a \ncarboidratos resulta em aglutina\u00e7\u00e3o celular. Bothrops leucurus, serpente da Fam\u00edlia Viperidae, \nrepresenta um s\u00e9rio problema m\u00e9dico para a regi\u00e3o Nordeste do Brasil. Uma lectina ligante de \ngalactos\u00eddeo (BlL) foi purificada do veneno da serpente Bothrops leucurus atrav\u00e9s da combina\u00e7\u00e3o \nde cromatografia de afinidade e gel filtra\u00e7\u00e3o. BlL aglutinou eritr\u00f3citos de coelho e humano, com \nprefer\u00eancia para eritr\u00f3citos de coelho, sendo especificamente inibida por galactose, rafinose e \nlactose, bem como por glicoproteinas. BlL \u00e9 uma prote\u00edna \u00e1cida, com massa molecular de 30 kDa e \ncomposta de duas subunidades de 15 kDa, exibiu depend\u00eancia de c\u00e1tions divalentes, foi \nprincipalmente ativa em pH 4.0 a 7.0 e termoest\u00e1vel at\u00e9 70\u00b0C. O espectro de emiss\u00e3o de \nfluoresc\u00eancia mostrou res\u00edduos de tript\u00f3fano completamente encobertos na sua estrutura. Dicro\u00edsmo \nCircular de BlL foi t\u00edpico de uma prote\u00edna toda ? estrutural.  BlL mostrou ser efetivo contra \nbact\u00e9rias gram-positivas (Staphylococcus aureus, Enterococcus faecalis e Bacillus subtilis). A \natividade antitumoral de BlL foi avaliada em rela\u00e7\u00e3o ao seu potencial citot\u00f3xico em linhagem \ntumoral (K562, Hep-2 e NCI-H292) e quanto \u00e0 sua capacidade hemol\u00edtica. BlL apresentou uma \nsignificante atividade citot\u00f3xica em todas as linhagens tumorais testadas e n\u00e3o exibiu atividade \nhemol\u00edtica na m\u00e1xima concentra\u00e7\u00e3o testada (2000 \u00b5 g/mL). Al\u00e9m disso, foi realizada em c\u00e9lulas \nK562, a an\u00e1lise da externaliza\u00e7\u00e3o da fosfatidilserina e potencial de membrana mitocondrial, \nutilizando microsc\u00f3pio de fluoresc\u00eancia. Tratamento com BlL induziu externaliza\u00e7\u00e3o da \nfosfatidilserina e despolariza\u00e7\u00e3o mitocondrial, indicando morte celular por apoptose. Ap\u00f3s \nirradia\u00e7\u00e3o gamma, BlL apresentou mudan\u00e7as estruturais e teve sua atividade hemaglutinante \nsignificante alterada. SDS-PAGE indicou que a irradia\u00e7\u00e3o causou fragmenta\u00e7\u00e3o e com posterior \nagrega\u00e7\u00e3o da lectina. A an\u00e1lise em cromatografia de fase reversa revelou fragmenta\u00e7\u00e3o estrutural. A \natividade citot\u00f3xica de BlL em linhagens tumorais (K562, Hep-2 e NCI-H292) foi abolida ap\u00f3s \nirradia\u00e7\u00e3o, indicando que a irradia\u00e7\u00e3o de BlL se mostrou uma eficiente estrat\u00e9gia para inativar sua \natividade citot\u00f3xica. Esses achados demonstram que o veneno de B.leucurus contem uma lectina \nligante de galactos\u00eddeo com potencial promissor para aplica\u00e7\u00e3o terap\u00eautica e biotecnol\u00f3gica.     \n\n \n\nPalavras-chave: lectina, Bothrops leucurus, apoptose, irradia\u00e7\u00e3o gamma, veneno de serpente.   \n\n \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nABSTRACT \n\n \n\nLectins are proteins or glycoproteins of nonimmune origin which specific and reversible binding to \ncarbohydrates resultins in cell clumps. Bothrops leucurus, Family Viperidae snake, represents a \nserious medical problem for the Northeast region of Brazil. A galactoside-binding lectin (BlL) was \npurified from the venom of Bothrops leucurus through a combination of affinity chromatography \nand gel filtration. BlL agglutinate rabbit erythrocytes and human, with a preference for rabbit \nerythrocytes and is specifically inhibited by galactose, raffinose and lactose, as well as \nglycoproteins. BlL is an acid protein with a molecular mass of 30 kDa and composed of two \nsubunits of 15 kDa, exhibited dependence on divalent cations, was especially active at pH 4.0 to 7.0 \nand heat stable up to 70\u00b0C. The emission spectra of tryptophan fluorescence showed residue \ncompletely buried in its structure. Circular Dichroism BlL was typical of an entire protein ? \nstructure. BlL was show to be effective against gram-positive bacteria (Staphylococcus aureus, \nEnterococcus faecalis e Bacillus subtilis). Antitumor activity of BlL was assessed in relation to \ntheir cytotoxic potential in type of tumor (K562, Hep-2 e NCI-H292) and the its hemolytic capacity. \nBlL showed a significant cytotoxic activity in all tumor cell lines tested and showed no hemolytic \nactivity at maximum concentration tested (2000 \u00b5 g/mL). Furthermore, it was held in K562 cells, \nanalysis of externalization of phosphatidylserine and mitochondrial membrane potential using \nfluorescence microscope. BlL treatment induced phosphatidylserine externalization and \nmitochondrial depolarization, indicating cell death by apoptosis. After gamma irradiation, BlL \nshowed structural changes and its hemagglutinating activity was significantly altered. SDS-PAGE \nindicated that irradiation caused fragmentation and subsequent aggregation of the lectin. The \nanalysis in reverse-phase chromatography revealed structural fragmentation. Cytotoxic activity in \ntumor cell lines BlL (K562, Hep-2 e NCI-H292) was abolished after irradiation, indicating that the \nirradiation of BlL proved an efficient strategy for inactivating their cytotoxic activity. These \nfindings demonstrate that the venom contains a B. leucurus galactoside-binding lectin with \npromising potential for therapeutic and biotechnological application. \n\n \n\nKeywords: lectin, Bothrops leucurus, apoptosis, gamma irradiation, snake venom.   \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nLISTA DE FIGURAS DA REVIS\u00c3O BIBLIOGR\u00c1FICA \n\n \n\nFigura 1: Representa\u00e7\u00e3o esquem\u00e1tica de lectinas tipo-C (CTLs) e prote\u00ednas relacionadas               \n\nas lectinas tipo-C (CLRPs) de venenos de serpentes ou snaclecs. \n\n08 \n\nFigura 2: M\u00e9todos cromatogr\u00e1ficos para purifica\u00e7\u00e3o de prote\u00ednas. 10 \n\nFigura 3: Caracter\u00edsticas das c\u00e9lulas tumorais. 13 \n\nFigura 4: Vias intr\u00ednseca e extr\u00ednseca da apoptose. 15 \n\nFigura 5: Serpente Bothrops leucurus. 20 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nLISTA DE FIGURAS DOS ARTIGOS \n\n \n\nARTIGO I \n\n \n\nFig.1. (A) Purification of BlL by affinity chromatography of B. leucurus venom (30 mg \n\nof protein) on a guar gel column. Elution with CTBS buffer (-?-) followed by 200 mM D-\n\ngalactose (-?-; arrow). Specific hemagglutinating activity (SHA, -?-). (B) Purification of \n\nBlL by chromatography in Superdex 75 column coupled to an \u00c4KTA purifier system. (C) \n\nSDS-PAGE of BlL. (MW) molecular weight markers; BlL under non-reducing (lane 1) or \n\nreducing conditions (lane 2); electrophoresis under native conditions for acidic proteins \n\n(lane 3). (D) Reverse phase HPLC on a C4 column. (E) BlL chain separation after \n\ndesalting on a C4 column. The column was equilibrated with 0.1% TFA (solvent A) and \n\neluted using 90% acetonitrile/10% H2O/0.1% TFA (solvent B) in a non-linear gradient, \n\nwhere B = 0% at t = 5 min, 45% at t = 10 min, 50% at t = 30 min and 100% at t = 35 min. \n\n(F) Hemagglutinating activity (HA) of EDTA-treated BlL after addition of Ca2+ in \n\ndifferent concentrations. \n\n \n\n53 \n\nFig.2. (A) Intrinsic fluorescence emission of BlL excited at 280 nm (---) and 295 nm (\u2014). \n\n(B) CD spectrum of BIL in 50 mM phosphate buffer, pH 7.2, at 25\u00b0C. Measurements are \n\nthe average of eight scans using a solution containing 0.25 mg of protein/mL. CD \n\nspectrum deconvolution using CDPro software calculated 1% ?-helix, 44% ?-sheet, 24% \n\n?-turn, 31% unordered structures and an RMS of 2%. \n\n \n\n57 \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nARTIGO II \n\n \n\nFig.1. Effect of BlL in K562 cell population determined by fluorescence microscopy \n\nusing Annexin V\u2013FITC Kit, after 48 h incubation. The negative control (NC) was the \n\nvehicle used (DMSO). Etoposide was used as positive control (E). *p &lt;0.01 in \n\ncomparison to control by ANOVA followed by Newman Keulls test. Data are presented \n\nas mean \u00b1 S.D. from three independent experiments. \n\n74 \n\n \n\nFig.2. Effect of BlL in K562 cell population determined by fluorescence microscopy \n\nusing JC-1, after 48 h incubation. The negative control (NC) was the vehicle used \n\n(DMSO). Etoposide was used as positive control (E). *p &lt;0.01 in comparison to control \n\nby ANOVA followed by Newman Keulls test. Data are presented as mean \u00b1 S.D. from \n\nthree independent experiments. \n\n \n\n74 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nARTIGO III \n\n \n\nFig.1. Effect of ?-radiation on lectin activity and molecular weight. (a) The percentage of \n\nremaining specific hemagglutination activity, %SHAREM is represented after irradiation. \n\nError in the determination of %SHAREM for the different doses was approximately \u00b1 1%, \n\nwhich is less than the size of the symbols. * Significant difference (p &lt;0.05) compared to \n\nnon-irradiated lectin. (b) SDS-PAGE from irradiated BlL. SDS-PAGE was performed in \n\na discontinuous system with 15% separating and 5% stacking gels. (MW) Molecular \n\nweight; (C) non-irradiated control; (1) 1 kGy and (2) 2 kGy. (c) Reverse phase \n\nchromatography on an HPLC system: (?) control and irradiated lectins at (?) 1 kGy and \n\n(?) 2 kGy. (d) Light scattering was measured at 90\u00b0 for the aggregation assays. \n\n90 \n\nFig.2. BlL intrinsic fluorescence. (a) Mass center; Lectin excitation (280 nm) and \n\nemission (295\u2013450 nm). (b) Mass center tryptophan; Lectin excitation (295 nm) and \n\nemission (305-450 nm).  \n\n91 \n\nFig.3. BlL bis-ANS fluorescence. Mass center; Lectin excitation (360 nm) and emission \n\n(400\u2013600 nm).   \n\n92 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nLISTA DE TABELAS DOS ARTIGOS \n\n \n\nARTIGO I \n\n \n\nTable 1. Summary of B. leucurus lectin (BlL) purification. 52 \n\nTable 2. Inhibition of hemagglutinating activity of BlL by carbohydrates and \nglycoproteins. \n\n55 \n\nTable 3. Minimum inhibitory (MIC) and minimum bactericidal concentrations (MBC) of \nBlL. \n\n58 \n\n \n\nARTIGO II \n\n \n\nTable 1. Cytotoxic activity of BlL against tumor cell lines. 70 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\nLISTA DE ABREVIATURAS \n\n \n\nAH   Atividade Hemaglutinante \n\nAPAF-1 Fator Ativador de Apoptose-1 \n\nADP Adenosina difosfato \n\nBlL                       Lectina de Bothrops Leucurus \n\nBis-ANS   4.4'-Bis 1-anilinonaphthaleno 8-sulfonato \n\nBJcuL Lectina de Bothrops jararacussu \n\nBmLec Lectina de Bothrops moojeni \n\nCD Dicro\u00edsmo Circular \n\nCfLEC-2 Lectina de Chlamys farreri \n\nCFU Unidades Formadoras de Col\u00f4nia \n\nCI50 Concentra\u00e7\u00e3o Inibit\u00f3ria M\u00e9dia 50% \n\nCLEC-2 Receptor transmembrana tipo II C-tipo lectina-like \n\nCM Carboximetil \n\nCMB Concentra\u00e7\u00e3o M\u00ednima Bactericida \n\nCMI Concentra\u00e7\u00e3o M\u00ednima Inibit\u00f3ria \n\nConA Concanavalina A \n\nCRD Dom\u00ednio de Reconhecimento de Carboidratos \n\nCRLPs Prote\u00ednas Relacionadas Lectinas tipo-C \n\nCTLs Lectinas tipo-C  \n\nCTBS Tamp\u00e3o Tris Base Salina \n\nDEAE Dietilaminoetil \n\nDMEM Meio Dulbecco\u2019s Modificado Eagle\u2019s \n\nDMSO Dimetilsulf\u00f3xido \n\nDTT Dithiolthreitol \n\nEDTA \u00c1cido etilenodiaminotetrac\u00e9tico \n\n\n\nFBS Soro Fetal Bovino \n\nFITC Isotiocianato de Fluoresce\u00edna \n\nFPLC Cromatografia L\u00edquida de R\u00e1pida Resolu\u00e7\u00e3o \n\nGPIb Glicoprote\u00edna Ib \n\nHPLC-RP Cromatografia L\u00edquida de Alta Resolu\u00e7\u00e3o em Fase Reversa \n\nIgG2 Imunoglobulina G subclasse 2 \n\nMML Lectina de Musca domestica \n\nMMP Permeabilidade da Membrana Mitocondrial \n\nMTT Brometo de (3-(4, 5-dimetiltiazol-2-il)-2, 5-difeniltetraz\u00f3lio) \n\nPCL Lectina de Polygonatum cyrtonema  \n\nPAGE Eletroforese em gel de poliacrilamida \n\nPI Iodeto de prop\u00eddeo \n\nPOL lectina de Polygonatum odoratum \n\nSDS-PAGE Eletroforese em gel de poliacrilamida com dodecilsulfato de s\u00f3dio \n\nSHA Atividade Hemaglutinante Espec\u00edfica \n\nSnaclecs Lectina Tipo-C de Veneno de Serpente \n\nTh1 Linf\u00f3cito T auxiliar \n\nThT Thioflavina \n\n \n\n \n\n                    \n\n                           \n\n \n\n                     \n\n \n\n \n\n \n\n \n\n\n\nSUM\u00c1RIO \n\n \n\nRESUMO  \n\nABSTRACT  \n\nLista de Figuras  \n\nLista de Tabelas  \n\n1 INTRODU\u00c7\u00c3O 01 \n\n2 OBJETIVOS 03 \n\n2.1 Objetivo Geral 03 \n\n2.2 Objetivos Espec\u00edficos 03 \n\n3 REVIS\u00c3O BIBLIOGR\u00c1FICA 04 \n\n3.1 Lectinas 04 \n\n3.2 Lectinas de venenos de serpentes 05 \n\n3.3 Purifica\u00e7\u00e3o e Caracteriza\u00e7\u00e3o de lectinas 09 \n\n3.4 C\u00e2ncer 11 \n\n3.5 Morte celular (apoptose) 13 \n\n3.6 Atividade antitumoral 15 \n\n3.7 Atividade antibacteriana 17 \n\n3.8 Radia\u00e7\u00e3o 18 \n\n3.9 Serpente Bothrops leucurus 20 \n\n4 REFER\u00caNCIAS BIBLIOGR\u00c1FICAS 22 \n\n5 ARTIGO CIENT\u00cdFICO I \n\nPurification of a lectin with antibacterial activity from Bothrops leucurus snake venom \n\n44 \n\n6 ARTIGO CIENT\u00cdFICO II  \n\n\n\nCytotoxic effect and apoptosis induction by Bothrops leucurus venom lectin on tumor cell \n\nlines \n\n67 \n\n7 ARTIGO CIENT\u00cdFICO III \n\nGamma irradiation abolish in vitro cytotoxicity of lectin of Bothrops leucurus snake \nvenom \n\n \n\n82 \n\n8 CONCLUS\u00d5ES 98 \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n1 INTRODU\u00c7\u00c3O \n\n \n\nO Interesse em lectinas tem se intensificado com a constata\u00e7\u00e3o que estas s\u00e3o extremamente \n\nvaliosas para a investiga\u00e7\u00e3o de a\u00e7\u00facares na superf\u00edcie celular, na intera\u00e7\u00e3o de c\u00e9lulas com o seu \n\nmeio e tamb\u00e9m em uma variedade de processos patol\u00f3gicos (SHARON, 2007). Lectinas s\u00e3o \n\nprote\u00ednas ou glicoproteinas de origem n\u00e3o imunol\u00f3gica, ubiquamente distribu\u00eddas na natureza, as \n\nquais reconhecem e ligam-se reversivelmente a carboidratos de maneira n\u00e3o-catal\u00edtica (LAM et al., \n\n2010).  \n\nA habilidade de ligar-se seletivamente a glicoconjugados faz dessas prote\u00ednas not\u00e1veis \n\nferramentas para pesquisa experimental e cl\u00ednica. Em microbiologia, as lectinas t\u00eam assumido um \n\nimportante papel no estudo de glicoconjugados e superf\u00edcie de c\u00e9lulas microbianas. Evid\u00eancias \n\nsuportam sua intera\u00e7\u00e3o com bact\u00e9rias gram-negativas e gram-positivas, detectando sutis diferen\u00e7as \n\nna estrutura de carboidratos complexos (LUO et al., 2007), onde lectinas podem atuar interferindo \n\ncom o seu crescimento e desempenhando um papel em sistemas de defesa (SUN et al., 2008). Com \n\no resultado da alta preval\u00eancia de bact\u00e9rias multi-resistentes, a pesquisa por novos prot\u00f3tipos \n\nantimicrobianos s\u00e3o continuamente necess\u00e1rios, uma vez que pode permitir uma otimiza\u00e7\u00e3o no \n\ntratamento de infec\u00e7\u00f5es bacterianas relacionadas com cepas resistentes aos antibi\u00f3ticos \n\nconvencionais (WORLD HEALTH ORGANIZATION, 2007). \n\nNa Cancerologia Experimental, altera\u00e7\u00f5es na glicosila\u00e7\u00e3o durante a transforma\u00e7\u00e3o maligna, \n\ndesempenham um importante papel no comportamento metast\u00e1tico das c\u00e9lulas tumorais e essas \n\nmodifica\u00e7\u00f5es podem ser detectadas por lectinas (DAMODARAN et al., 2008; ARAB et al., 2010). \n\nIntera\u00e7\u00e3o lectina-carbohidrato causa aglutina\u00e7\u00e3o das c\u00e9lulas tumorais, citotoxicidade, indu\u00e7\u00e3o da \n\napoptose e inibi\u00e7\u00e3o do crescimento tumoral, criando uma variedade de possibilidades para a \n\nprodu\u00e7\u00e3o de medicamentos anticancer (De MEJ\u00cdA &amp; PRISECARU, 2005; NAKAHARA et al., \n\n2005). A identifica\u00e7\u00e3o de novos compostos citot\u00f3xicos que melhorem ou restaurem a capacidade \n\ndas c\u00e9lulas malignas em sofrer apoptose pode ser crucial para terapias mais eficazes contra o c\u00e2ncer \n\n(REYES-ZURITA et al., 2009)  \n\nA descoberta tamb\u00e9m incentiva os pesquisadores a buscarem mol\u00e9culas similares em \n\nvenenos de serpentes, uma vez que esses s\u00e3o uma fonte rica em componentes bioativos, como \n\nenzimas, prote\u00ednas e pept\u00eddeos com importantes propriedades farmacol\u00f3gicas, que podem levar a \n\nprodu\u00e7\u00e3o de novos agentes com valor terap\u00eautico (KOH et al., 2006). \n\n\n\n2 \n\n \n\nVenenos de serpentes s\u00e3o empregados como imun\u00f3genos para produ\u00e7\u00e3o de soro antiof\u00eddico \n\ne v\u00e1rios esfor\u00e7os tem sido realizados para diminuir sua toxicidade, visando minimizar os danos \n\ncausados aos animais imunizados, prolongando o seu tempo de vida (GALLACI et al., 2000). \n\nRadia\u00e7\u00e3o ionizante vem sendo empregada com sucesso para atenuar venenos de serpentes e suas \n\ntoxinas isoladas, diminuindo ou abolindo suas atividades biol\u00f3gicas e t\u00f3xicas, sem alterar sua \n\nimunogenicidade, mostrando-se uma potente ferramenta para modificar e destoxicar biomol\u00e9culas. \n\n(FERREIRA JUNIOR et al., 2005; BAPTISTA et al., 2009; CAPRONI et al., 2009). \n\nCom base nessas considera\u00e7\u00f5es, o estudo das propriedades e fun\u00e7\u00f5es da lectina de Bothrops \n\nleucurus contribui para o entendimento da intera\u00e7\u00e3o prote\u00edna-carboidrato, como tamb\u00e9m para \n\naplica\u00e7\u00f5es m\u00e9dicas e biol\u00f3gicas.  \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n3 \n\n \n\n2 OBJETIVOS \n\n \n\n2.1 Objetivo Geral  \n\n \n\nPurificar, caracterizar estrutural e funcionalmente a lectina do veneno de Bothrops leucurus: \n\nDestoxica\u00e7\u00e3o do efeito citot\u00f3xico ap\u00f3s a irradia\u00e7\u00e3o gamma. \n\n \n\n2.2 Objetivos Espec\u00edficos \n\n \n\n? Purificar e caracterizar a lectina do veneno da serpente Bothrops Leucurus (BlL); \n\n? Avaliar a atividade antibacteriana da lectina em bact\u00e9rias patog\u00eanicas humanas; \n\n? Determinar a citotoxicidade da lectina em linhagens tumorais humanas (Hep-2, K562 e NCI-\n\nH292) in vitro; \n\n? Examinar a atividade hemol\u00edtica da lectina em eritr\u00f3citos de camundongos; \n\n? Avaliar o mecanismo de a\u00e7\u00e3o envolvida na atividade citot\u00f3xica da lectina em c\u00e9lulas K562 \n\nin vitro; \n\n? Determinar o efeito da radia\u00e7\u00e3o gamma na estrutura da lectina purificada; \n\n? Avaliar a citotoxicidade da lectina purificada ap\u00f3s irradia\u00e7\u00e3o gamma em c\u00e9lulas tumorais \n\nHep-2, K562 e NCI-H292.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n4 \n\n \n\n3 REVIS\u00c3O BIBLIOGR\u00c1FICA \n\n \n\n3.1 Lectinas \n\n  \n\nO termo \u201clectina\u201d (originado do latim lectus, que significa escolhido, selecionado) foi \n\nprimeiro empregado por BOYD &amp; SHAPLEIGH em 1954, para designar um grupo de prote\u00ednas que \n\napresentava a caracter\u00edstica comum de seletividade na intera\u00e7\u00e3o com carboidratos. Em 1980, \n\nGOLDSTEIN et al. (1980) definiram as lectinas como prote\u00ednas ou glicoprote\u00ednas de origem n\u00e3o \n\nimunol\u00f3gica, que apresentavam dois ou mais s\u00edtios de liga\u00e7\u00e3o a carboidratos, atrav\u00e9s dos quais \n\ninteragem com carboidratos, aglutinando c\u00e9lulas vegetais e/ou animais e precipitando \n\npolissacar\u00eddeos, glicoprote\u00ednas e glicolip\u00eddeos de forma irrevers\u00edvel. O termo aglutinina \u00e9 utilizado \n\ncomo sin\u00f4nimo para lectina, porque se refere \u00e0 habilidade de aglutinar eritr\u00f3citos ou outras c\u00e9lulas \n\n(PEUMANS &amp; VAN DAMME, 1995).  \n\nDe acordo com a nova defini\u00e7\u00e3o, s\u00e3o consideradas lectinas prote\u00ednas ou glicoprote\u00ednas de \n\norigem n\u00e3o imune que possuem pelo menos um s\u00edtio-n\u00e3o catal\u00edtico, o qual se liga revers\u00edvelmente a \n\nmono ou oligossacar\u00eddeos espec\u00edfico (PEUMANS &amp; VAN DAMME, 1995, 1998; PEUMANS et \n\nal., 2001). Cada lectina liga-se a um carboidrato espec\u00edfico ou grupo de carboidratos em \n\noligossacar\u00eddeos ou glicoprote\u00ednas, atrav\u00e9s dos seus s\u00edtios de liga\u00e7\u00e3o que tendem a se localizar na \n\nsuperf\u00edcie da mol\u00e9cula prot\u00e9ica e a seletividade da liga\u00e7\u00e3o s\u00e3o obtidas atrav\u00e9s de pontes de \n\nhidrog\u00eanio, intera\u00e7\u00f5es hidrof\u00f3bicas e de van der Waals (COMINETTI et al., 2002; SHARON &amp; \n\nLIS, 2002). \n\nAs lectinas apresentam ampla variedade estrutural, sendo comum entre elas a presen\u00e7a de, \n\nao menos, um s\u00edtio espec\u00edfico de liga\u00e7\u00e3o a carboidrato, denominado \u201cDom\u00ednio de Reconhecimento \n\nde Carboidrato\u201d (CRD), o qual se liga a carboidratos ou glicoconjugados em solu\u00e7\u00e3o ou que estejam \n\nconectadas ao envolt\u00f3rio celular (WEIS &amp; DRICKAMER, 1996).    \n\nA presen\u00e7a de lectinas pode ser detectada pelo ensaio de hemaglutina\u00e7\u00e3o em eritr\u00f3citos \n\nhumanos ou de outras esp\u00e9cies animais. Nesse ensaio \u00e9 realizada uma dilui\u00e7\u00e3o serial e em seguida, \n\nincuba\u00e7\u00e3o com os eritr\u00f3citos, onde a atividade hemaglutinante \u00e9 detectada pela forma\u00e7\u00e3o de uma \n\nmalha decorrente da intera\u00e7\u00e3o entre a lectina e os carboidratos localizados na superf\u00edcie dos \n\neritr\u00f3citos. A capacidade de aglutina\u00e7\u00e3o por lectinas pode ser intensificada quando os eritr\u00f3citos s\u00e3o \n\nsubmetidos a tratamentos com enzimas ou com solu\u00e7\u00f5es qu\u00edmicas (COELHO &amp; SILVA, 2000). \n\n\n\n5 \n\n \n\nPara assegurar que o agente aglutinante \u00e9 uma lectina, s\u00e3o realizados ensaios subseq\u00fcentes de \n\ninibi\u00e7\u00e3o da atividade hemaglutinante (AH) com diferentes carboidratos (KAWAGISHI et al., 2001; \n\nJAYATI et al., 2005). \n\nAs lectinas t\u00eam ampla distribui\u00e7\u00e3o na natureza, sendo encontradas em microorganismos \n\n(SINGH et al., 2010), plantas (YAN et al., 2010; YAO et al., 2010) e animais (BATTISON &amp; \n\nSUMMERFIELD, 2009; CHEN et al., 2010). O reino animal tem demonstrado ser um rico \n\nmanancial para obten\u00e7\u00e3o de lectinas, servindo como fonte para o isolamento e caracteriza\u00e7\u00e3o dessas \n\nmacromol\u00e9culas. A primeira atividade de lectina animal, provavelmente, foi observada no veneno \n\nde serpentes, o qual foi capaz de promover a aglutina\u00e7\u00e3o em eritr\u00f3citos humanos (KILPATRICK, \n\n2002).   \n\nDiferentes fun\u00e7\u00f5es t\u00eam sido atribu\u00eddas as lectinas de animais, incluindo reconhecimento de \n\npat\u00f3genos (DUTTA et al, 2005; XU et al., 2010), inibi\u00e7\u00e3o da agrega\u00e7\u00e3o plaquet\u00e1ria (SARRAY et \n\nal., 2004), atividade antiproliferativa sobre c\u00e9lulas tumorais (CAO et al., 2010) e indutores da \n\napoptose (ZHAO et al., 2010).  \n\nAs lectinas animais podem ser classificadas com base na estrutura molecular em cinco \n\nprincipais categorias: tipo-C, tipo-S (galectinas), tipo-I (siglecs), tipo-P (receptor de manose-6P) e \n\ntipo-N (SHARON &amp; LIS, 2004). De acordo com a seq\u00fc\u00eancia do CRD, lectinas animais tipo-C \n\npodem ser classificadas dentro de 17 grupos (I ao XVII) (ZELENSKY &amp; GREADY, 2005), estando \n\nas lectinas de venenos de serpentes inclu\u00eddas no grupo VII (OGAWA et al., 2005).   \n\n   \n\n3.2 Lectinas de venenos de serpentes \n\n \n\nEnvenenamentos of\u00eddicos representam um problema m\u00e9dico-social de consider\u00e1vel \n\nmagnitude, uma vez que cerca de 2.5 milh\u00f5es de pessoas s\u00e3o picadas por serpentes anualmente, \n\nsendo mais de 100.000 casos fatais. Contudo, venenos de serpentes constituem em uma fonte \n\nbiol\u00f3gica natural que cont\u00e9m diversos componentes farmacologicamente ativos, os quais, com o \n\nadvento da biotecnologia podem ser isolados e delineados suas propriedades terap\u00eauticas (KOH et \n\nal., 2006; ANGULO &amp; LOMONTE, 2009). \n\n\n\n6 \n\n \n\nVenenos de serpentes possuem uma variedade de prote\u00ednas, tais como serinoproteases, \n\nfosfolipases, desintegrinas (LIMA et al., 2005), toxinas three-finger (3FTxs) (PAHARI et al., 2007), \n\nmetaloproteases e lectinas tipo-C (DOLEY &amp; KINI, 2009).  \n\n Lectinas de serpentes tem sido encontrada em diversas serpentes da fam\u00edlia Viperidade, \n\nElapidae and Crotalidae (GUIMAR\u00c3ES-GOMES et al., 2004; LIN et al., 2007; SILVA JR. et al., \n\n2008; WANG, 2008). Essas exibem alta homologia na seq\u00fc\u00eancia prim\u00e1ria, com alguns invariantes \n\nres\u00edduos de amino\u00e1cidos, incluindo um padr\u00e3o conservado de liga\u00e7\u00f5es dissulfeto. Sua \n\nespecificidade de liga\u00e7\u00e3o \u00e9 mais freq\u00fcentemente atribu\u00edda \u00e0 galactose, mas tamb\u00e9m a manose \n\n(SHARON et al., 2003).  \n\nDe acordo com sua estrutura e fun\u00e7\u00f5es biol\u00f3gicas, essas prote\u00ednas podem ser classificadas \n\nem dois subgrupos: lectinas tipo-C verdadeiras (CTLs), as quais contem um dom\u00ednio de \n\nreconhecimento de carboidratos (CRD) que se liga a a\u00e7\u00facar e aglutina eritr\u00f3citos; e prote\u00ednas \n\nrelacionadas com lectinas tipo-C (CRLPs), com CRDs incompleto e, portanto, apresentando outras \n\natividades biol\u00f3gicas contra os fatores de coagula\u00e7\u00e3o e plaquetas, afetando a hemostasia \n\n(DRICKAMER, 1999; WEI et al., 2002; MORITA et al., 2004). Em recente nomenclatura, esse \n\ngrupo foi renomeado para snaclecs (lectinas tipo-C de venenos de serpentes) (CLEMETSON et al., \n\n2009).  \n\nA primeira lectina isolada e parcialmente caracterizada de serpente foi obtida do veneno de \n\nBothrops atrox. Essa prote\u00edna foi denominada de trombolectina e apresentou as seguintes \n\ncaracter\u00edsticas bioqu\u00edmicas e biol\u00f3gicas: prote\u00edna homodim\u00e9rica, ligante de ?-galactos\u00eddeo, n\u00e3o \n\nglicosilada e dependente de \u00edons c\u00e1lcio para exercer sua atividade de hemaglutina\u00e7\u00e3o (GARTNER \n\net al., 1980; GARTNER &amp; OGILVIE, 1984).  \n\nCTLs consistem em uma fam\u00edlia de prote\u00ednas estruturalmente hom\u00f3logas, as quais s\u00e3o \n\ngeralmente homod\u00edmeros ?? ligados por ponte dissulfeto com dois polipept\u00eddeos hom\u00f3logos de \n\naproximadamente 14 kDa, apresentando atividade de aglutina\u00e7\u00e3o de eritr\u00f3citos e liga\u00e7\u00e3o a \n\ncarboidratos, principalmente galactose (Figura 1b) na presen\u00e7a de \u00edons Ca2+ (LU et al., 2005; \n\nOGAWA et al., 2005). Esses homod\u00edmeros t\u00eam sido reportados em v\u00e1rias serpentes, tais como \n\nBothrops jararaca (OZEKI et al., 1994), Lachesis muta stenophyrs (ARAGON-ORTIZ et al., \n\n1996), Trimeresurus stejnegeri (XU et al., 1999), Crotalus ruber (HAMAKO et al., 2007) e \n\nBungarus multicinctus (LIN et al., 2007). Em adi\u00e7\u00e3o, CTLs podem ser constitu\u00eddas por \n\nhomoolig\u00f4meros (HIRABAYASHI et al., 1991; WANG, 2008).     \n\n\n\n7 \n\n \n\n V\u00e1rias dessas prote\u00ednas t\u00eam sido parcialmente ou completamente seq\u00fcenciadas (KOMORI et \n\nal., 1999; NIKAI et al., 2000; CARVALHO et al., 2002; HAMAKO et al., 2007) e, em alguns casos \n\nseus genes clonados (GUIMAR\u00c3ES-GOMES et al., 2004; KASSAB et al., 2004; LIN et al., 2007; \n\nJEBALI et al., 2009). Estudos de cristalografia e dicro\u00edsmo circular est\u00e3o revelando particularidades \n\nna estrutura das lectinas de serpentes. WALKER et al. (2004) isolaram uma lectina de Crotalus \n\natrox (RSL) e observaram uma organiza\u00e7\u00e3o intrigantemente oligom\u00e9rica de acordo com os dados \n\ncristalogr\u00e1ficos, por exemplo, uma estrutura decam\u00e9rica formada por cinco d\u00edmeros. Espectros de \n\ndicro\u00edsmo circular da lectina de Bothrops jararacussu (BJcuL), mostraram 32,2% de estrutura ? e \n\n18.8% de estrutura ?, estando de acordo com a maioria das lectinas de venenos de serpentes, as \n\nquais pertencem a classe ?+? (SILVA JR. et al., 2008). Contudo, a lectina isolada de Lachesis muta \n\napresentou 78% ? de estrutura e 1% ? como caracter\u00edstica de sua estrutura secund\u00e1ria (ARAGON-\n\nORTIZ et al., 1989).  \n\n Diversos efeitos biol\u00f3gicos das CTLs de venenos de serpentes t\u00eam sido relatados, incluindo \n\natividade mitog\u00eanica sobre linf\u00f3citos (MASTRO et al., 1986), libera\u00e7\u00e3o de c\u00e1lcio do ret\u00edculo \n\nsarcoplasm\u00e1tico (OHKURA et al., 1996), inibi\u00e7\u00e3o da prolifera\u00e7\u00e3o de v\u00e1rias linhagens tumorais \n\n(PEREIRA-BITTENCOURT et al., 1999), aglutina\u00e7\u00e3o de eritr\u00f3citos (KASSAB et al., 2001), \n\ncitotoxicidade para alguns tumores e c\u00e9lulas endoteliais (CARVALHO et al., 2001), efeitos renais \n\n(HAVT et al., 2005; BRAGA et al., 2006), aumento a ader\u00eancia de leuc\u00f3citos sobre c\u00e9lulas \n\nendoteliais de v\u00eanulas (EL\u00cdFIO-ESPOSITO et al., 2007), inibi\u00e7\u00e3o viral in vitro (ISLAS et al., 2007) \n\ne a\u00e7\u00e3o inibit\u00f3ria sobre pat\u00f3genos de plantas (R\u00c1DIS-BAPTISTA et al., 2006; BARBOSA et al., \n\n2010).   \n\n Em contraste com CTLs, snaclecs n\u00e3o apresentam o cl\u00e1ssico loop de liga\u00e7\u00e3o a a\u00e7\u00facar/c\u00e1lcio \n\ne possuem a habilidade de interagir com fatores de coagula\u00e7\u00e3o e receptores de membranas nas \n\nplaquetas (XU et al., 2004; LU et al., 2005; CLEMETSON, 2010). Geralmente, apresentam uma \n\nestrutura b\u00e1sica de heterod\u00edmeros (??) ligadas covalentemente por pontes dissulfeto ou olig\u00f4meros \n\nde heterod\u00edmeros (Figura 1c, d) (MORITA, 2004, 2005; CHEN et al., 2010).  \n\n\n\n8 \n\n \n\n \n\nFigura 1: Representa\u00e7\u00e3o esquem\u00e1tica de lectinas tipo-C (CTLs) e prote\u00ednas relacionadas as lectinas \n\ntipo-C (CLRPs) de venenos de serpentes ou snaclecs (Fonte: DOYLE &amp; KINI, 2009). \n\n Snaclecs apresentam uma variedade de atividades biol\u00f3gicas, como anticoagulantes e \n\nagonistas ou antagonistas da agrega\u00e7\u00e3o plaquet\u00e1ria (CLEMETSON, 2010). Por exemplo, \n\njerdonuxina purificada de Trimeresurus jerdonii induziu agrega\u00e7\u00e3o plaquet\u00e1ria, provavelmente, \n\natrav\u00e9s da liga\u00e7\u00e3o ao receptor GPIb (CHEN et al., 2011). Agretina, isolada do veneno de \n\nCalloselasma rhodostoma, estimula agrega\u00e7\u00e3o plaquet\u00e1ria atrav\u00e9s de um novo receptor de \n\nplaquetas, denominado CLEC-2 (SUZUKI-INOUE et al., 2006). Por outro lado, flavocetina-A se \n\nliga a GPIb e fortemente inibe a agrega\u00e7\u00e3o plaquet\u00e1ria dependente do fator de von Willebrand \n\n(FUKUDA et al., 2000). Muitos membros dessa fam\u00edlia interagem com os fatores de coagula\u00e7\u00e3o \n\nIX/X ou ?-trombina e formam complexos bloqueando as subseq\u00fcentes rea\u00e7\u00f5es da cascata de \n\ncoagula\u00e7\u00e3o, exibindo atividade anticoagulante (KOO et al., 2002; MONTEIRO &amp; ZINGALI, 2002; \n\nZANG et al., 2003). \n\nApesar das diversas atividades descritas para as lectinas de serpentes, o papel destas no \n\nenvenenamento n\u00e3o est\u00e1 claramente definido. Entretanto, se sup\u00f5em que esses componentes tenham \n\numa fun\u00e7\u00e3o de defesa assim como nos invertebrados, por\u00e9m de uma maneira mais ofensiva. Tem \n\nsido proposto que CTLs juntamente com as snaclecs, que inibem trombina e fatores de coagula\u00e7\u00e3o \n\n(CASTRO et al., 1999), provavelmente, ajudam a causar a desordem hematol\u00f3gica particularmente \n\nevidente nos acidentes com as serpentes do g\u00eanero Bothrops. Al\u00e9m disso, a atividade de \n\nhemaglutina\u00e7\u00e3o (HAVT et al., 2005), bem como a indu\u00e7\u00e3o de edema em camundongos e o aumento \n\nda permeabilidade vascular (LOMONTE et al., 1990; PANUNTO et al., 2006) induzidos por essas \n\nprote\u00ednas, podem contribuir para os severos efeitos locais observados ap\u00f3s o envenenamento pelas \n\nserpentes desse g\u00eanero, incluindo Bothrops leucurus.  \n\n\n\n9 \n\n \n\n  3.3 Purifica\u00e7\u00e3o e Caracteriza\u00e7\u00e3o de lectinas  \n\n \n\nA utiliza\u00e7\u00e3o de t\u00e9cnicas cromatogr\u00e1ficas purifica as lectinas de acordo com a massa \n\nmolecular, carga e afinidade espec\u00edfica de liga\u00e7\u00e3o a carboidratos. Na cromatografia de troca i\u00f4nica a \n\nprote\u00edna \u00e9 separada em fun\u00e7\u00e3o de sua carga ao se ligar a um suporte com carga contr\u00e1ria a sua. A \n\ncoluna \u00e9 lavada com solu\u00e7\u00e3o tamp\u00e3o e as prote\u00ednas com nenhuma ou pouca intera\u00e7\u00e3o com o \n\ntrocador de \u00edons s\u00e3o exclu\u00eddas. As prote\u00ednas adsorvidas na matriz podem ser elu\u00eddas pelo aumento \n\nda for\u00e7a i\u00f4nica ou altera\u00e7\u00e3o do valor de pH do meio (DATTA et al., 2001). Como exemplo tem a \n\ndietilaminoetil (DEAE) celulose (LI et al., 2008), um trocador ani\u00f4nico, e a carboximetil (CM) \n\ncelulose um trocador cati\u00f4nico. \n\nA cromatografia de filtra\u00e7\u00e3o em gel ou exclus\u00e3o molecular (ROJO et al., 2003; POHLEVEN \n\net al., 2009) separa as prote\u00ednas de acordo com o tamanho molecular (Figura 2B), onde as prote\u00ednas \n\nmaiores migram em maior velocidade que as menores devido a sua exclus\u00e3o dos poros do gel. Este \n\ntipo de cromatografia \u00e9 usado tanto para obter prepara\u00e7\u00f5es prot\u00e9icas homog\u00eaneas (FREIRE et al., \n\n2002) como para defini\u00e7\u00e3o de massa molecular da prote\u00edna (KAWAGISHI et al., 2001). A \n\ncromatografia de afinidade (Figura 2C), t\u00e9cnica mais comumente utilizada, baseia-se na habilidade \n\ndas lectinas se ligarem especificamente a suportes polissacar\u00eddeos atrav\u00e9s dos seus s\u00edtios \n\nespec\u00edficos. A prote\u00edna desejada pode ser obtida com alto grau de pureza (YE &amp; NG, 2002), \n\nalterando-se as condi\u00e7\u00f5es de pH (S\u00c1 et al., 2008), for\u00e7a i\u00f4nica (FREIRE et al., 2002) ou pela \n\nelui\u00e7\u00e3o com uma solu\u00e7\u00e3o contendo um competidor (OLIVEIRA et al., 2002). As matrizes de \n\nafinidade podem ser selecionadas de acordo com a especificidade da lectina a carboidratos. Gel de \n\nguar \u00e9 uma dessas matrizes composta de um polissacar\u00eddeo com cadeias de manose substitu\u00eddas por \n\nres\u00edduos de galactose ? 1-6, sendo uma matriz vers\u00e1til para isolamentos de lectinas ligantes de D-\n\ngalactopiranosil e N-acetil-galactosaminil (COELHO &amp; SILVA, 2000). \n\n    \n\n\n\n10 \n\n \n\n \n\nFigura 2: M\u00e9todos cromatogr\u00e1ficos para purifica\u00e7\u00e3o de prote\u00ednas. (Fonte: STRYER et al., 2004) \n\n \n\nM\u00e9todos eletrofor\u00e9ticos s\u00e3o utilizados para caracterizar estruturalmente as lectinas, bem \n\ncomo para estabelecer o grau de pureza das mesmas. A eletroforese em gel de poliacrilamida \n\n(PAGE) pode ser realizada usando um gel contendo dodecilsulfato de s\u00f3dio (SDS) ou ?-\n\nmercaptoetanol (condi\u00e7\u00f5es redutoras), que sob condi\u00e7\u00f5es redutoras revela o grau de pureza, a \n\ncomposi\u00e7\u00e3o, a massa molecular de subunidades (REYNOSO-CAMACHO et al., 2003; PAIVA et \n\nal., 2006) e atrav\u00e9s de colora\u00e7\u00e3o espec\u00edfica, a natureza glicoprot\u00e9ica (COELHO &amp; SILVA, 2000; \n\nFENG et al., 2006).  \n\n Cromatografia l\u00edquida de r\u00e1pida resolu\u00e7\u00e3o (FPLC) e cromatografia l\u00edquida de alta resolu\u00e7\u00e3o \n\nem fase reversa (HPLC-RP) t\u00eam sido amplamente utilizadas com um processo final de purifica\u00e7\u00e3o \n\nmais refinada de lectinas, ap\u00f3s a utiliza\u00e7\u00e3o de outros m\u00e9todos cromatogr\u00e1ficos (WONG &amp; NG, \n\n2003; JIANG et al., 2009). FPLC e HPLC podem estabelecer a homogeneidade de lectinas, como \n\ntamb\u00e9m separar subunidades prot\u00e9icas, assim determinar se essas biomol\u00e9culas s\u00e3o monom\u00e9ricas \n\nou n\u00e3o (KAWSAR et al., 2008; SILVA et al., 2009).      \n\n Lectinas podem ser caracterizadas atrav\u00e9s da avalia\u00e7\u00e3o da AH em diferentes temperaturas, \n\nbem como a inibi\u00e7\u00e3o da AH por carboidratos e/ou glicoconjugados e o efeito de \u00edons na atividade \n\nhemaglutinante. Em rela\u00e7\u00e3o ao pH, a verifica\u00e7\u00e3o da faixa de estabilidade pode ser realizada \n\nsubmetendo-se a lectina a tamp\u00f5es em diferentes valores de pH (MANSOUR &amp; ABDUL-SALAM., \n\n2009). Quanto ao efeito da temperatura algumas lectinas permanecem est\u00e1veis at\u00e9 80\u00b0C e a partir de \n\n\n\n11 \n\n \n\nent\u00e3o, com a eleva\u00e7\u00e3o da temperatura, a AH diminui at\u00e9 ser abolida, como no caso da lectina de \n\nAplysia kurodai (KAWSAR et al., 2009). Contudo, lectina ativa ap\u00f3s aquecimento a 100\u00b0C tamb\u00e9m \n\nfoi isolada (SANTOS et al., 2009).  \n\n Muitas lectinas necessitam de \u00edons met\u00e1licos bivalentes para exibir sua atividade. Ficou \n\ndemonstrado que a lectina de Macrotyloma axillare necessita de Ca2+ e Mn2+ para capturar o \n\ncarboidrato pelo qual tem afinidade (SANTANA et al., 2008). Por outro lado, a lectina da folha de \n\nPhthirusa pyrifolia n\u00e3o teve sua AH abolida quando tratada com EDTA e, portanto, a AH \u00e9 \n\nindependente de \u00edons met\u00e1licos, tais como Ca2+, Mg2+ and Mn2+ (COSTA et al., 2010).  \n\n Muitos outros m\u00e9todos tamb\u00e9m s\u00e3o ferramentas relevantes para a caracteriza\u00e7\u00e3o das \n\nlectinas, tais como a determina\u00e7\u00e3o da seq\u00fc\u00eancia de amino\u00e1cidos, cristaliza\u00e7\u00e3o, estudos de \n\nfluoresc\u00eancia e dicro\u00edsmo circular (FUJII et al., 2011; DING et al., 2010; VAZ et al., 2010; \n\nVAREJ\u00c3O, 2010).  \n\n \n\n3.4 C\u00e2ncer \n\n \n\nOs primeiros relatos da ocorr\u00eancia de c\u00e2ncer foram encontrados nos papiros do Egito e data \n\nde aproximadamente 1.600 a.C., os quais s\u00e3o referentes \u00e0 descri\u00e7\u00e3o de oito casos de tumores ou \n\n\u00falceras de mama que foram tratados por cauteriza\u00e7\u00e3o. A palavra c\u00e2ncer, no grego, significa \n\ncaranguejo e est\u00e1 associada a uma analogia entre o crescimento infiltrante do c\u00e2ncer e a forma como \n\nesse crust\u00e1ceo se prende ao solo usando suas patas (AMERICAN CANCER SOCIETY, 2009).  \n\nO c\u00e2ncer constitui-se em um importante problema de sa\u00fade p\u00fablica em pa\u00edses desenvolvidos \n\ne em desenvolvimento, sendo respons\u00e1vel por mais de seis milh\u00f5es de \u00f3bitos a cada ano, \n\nrepresentando cerca de 12% de todas as causas de morte no mundo. Embora as maiores taxas de \n\nincid\u00eancia de c\u00e2ncer sejam encontradas em pa\u00edses desenvolvidos, dos dez milh\u00f5es de casos novos \n\nanuais de c\u00e2ncer, cinco milh\u00f5es e meio s\u00e3o diagnosticados nos pa\u00edses em desenvolvimento \n\n(WORLD HEALTH ORGANIZATION, 2002). \n\nNo Brasil, as estimativas para o ano de 2010, v\u00e1lidas para o ano de 2011, apontam para a \n\nocorr\u00eancia de 489.270 casos novos de c\u00e2ncer, sendo 236.240 (sexo masculino) e 235.030 para o \n\nsexo feminino. Os tipos mais incidentes, \u00e0 exce\u00e7\u00e3o do c\u00e2ncer de pele do tipo n\u00e3o-melanoma, ser\u00e3o \n\nos c\u00e2nceres de pr\u00f3stata e de pulm\u00e3o no sexo masculino e os c\u00e2nceres de mama e do colo do \u00fatero no \n\n\n\n12 \n\n \n\nsexo feminino, acompanhando o mesmo perfil observado na Am\u00e9rica Latina (INSTITUTO \n\nNACIONAL DO C\u00c2NCER, 2010). \n\nC\u00e2ncer pode ser causado por dieta incorreta, predisposi\u00e7\u00e3o gen\u00e9tica e fatores ambientais. \n\nCerca de 35% dos c\u00e2nceres no mundo s\u00e3o causados por uma dieta incorreta, e no caso do c\u00e2ncer de \n\nc\u00f3lon, esse fator pode responder por 80% dos casos. Quando adiciona \u00e1lcool e cigarros na dieta, a \n\npercentagem pode aumentar para 60%. A predisposi\u00e7\u00e3o gen\u00e9tica \u00e9 respons\u00e1vel por 20% dos casos \n\nde c\u00e2ncer. Ent\u00e3o, a grande maioria dos casos de c\u00e2ncer est\u00e1 associada com a carcinog\u00eanese \n\nambiental (REDDY et al., 2003).    \n\nO processo de carcinog\u00eanese inclui tr\u00eas est\u00e1gios: inicia\u00e7\u00e3o, promo\u00e7\u00e3o e progress\u00e3o tumoral. \n\nNo primeiro est\u00e1gio as c\u00e9lulas sofrem o efeito de uma agente carcin\u00f3geno, levando a forma\u00e7\u00e3o de \n\numa c\u00e9lula geneticamente transformada. O segundo est\u00e1gio da carcinog\u00eanese envolve a a\u00e7\u00e3o de \n\nsubst\u00e2ncias classificadas como oncopromotores, que induzem a express\u00e3o de genes envolvidos no \n\ncrescimento celular. A c\u00e9lula iniciada \u00e9 transformada em c\u00e9lula maligna de forma lenta e gradual. O \n\nterceiro e \u00faltimo est\u00e1gio, o de progress\u00e3o, caracteriza-se pela multiplica\u00e7\u00e3o descontrolada das \n\nc\u00e9lulas mutadas, onde come\u00e7am a surgir as primeiras manifesta\u00e7\u00f5es cl\u00ednicas da doen\u00e7a (ALMEIDA \n\net al., 2005).     \n\nAs muta\u00e7\u00f5es envolvem amplifica\u00e7\u00e3o e/ou supra-express\u00e3o de oncogenes aliada \u00e0 dele\u00e7\u00e3o \n\ne/ou silenciamento de genes supressores de tumor (HAHN &amp; WEINBERG 2002). Segundo LUO et \n\nal. (2009), as muta\u00e7\u00f5es no c\u00e2ncer promovem a reativa\u00e7\u00e3o ou modifica\u00e7\u00e3o de programas celulares \n\nque regulam mecanismos relacionados \u00e0 embriog\u00eanese e a homeostasia, tais como prolifera\u00e7\u00e3o, \n\ndiferencia\u00e7\u00e3o, migra\u00e7\u00e3o e apoptose. \n\nAs c\u00e9lulas tumorais apresentam auto-sufici\u00eancia para os sinais de crescimento e resist\u00eancia \n\naos sinais antiproliferativos, evas\u00e3o de morte celular programada (apoptose), potencial de \n\nreplica\u00e7\u00e3o ilimitado, angiog\u00eanese, invas\u00e3o tecidual e met\u00e1stase (HANAHAN &amp; WEINGERG, \n\n2000). Recentes trabalhos (Figura 3) t\u00eam mostrado a adi\u00e7\u00e3o de outras caracter\u00edsticas, tais como: \n\nescape do sistema imune (KROEMER &amp; POUYSSEGUR, 2008) e fen\u00f3tipos de estresse, incluindo \n\nmetab\u00f3lico, mit\u00f3tico, proteot\u00f3xico, oxidativo e de dano ao DNA (LUO et al., 2009). \n\n   \n\n \n\n \n\n\n\n13 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 3: Caracter\u00edsticas das c\u00e9lulas tumorais. (Fonte: LUO et al., 2009) \n\n \n\nAtualmente, o tratamento do c\u00e2ncer \u00e9 considerado como um dos problemas mais \n\ndesafiadores da medicina (CHABNER &amp; JR., 2005). A partir do momento que a neoplasia prim\u00e1ria \n\nmetastatiza o progn\u00f3stico se torna ruim, sendo a quimioterapia antineopl\u00e1sica a principal forma de \n\ntratamento nesse est\u00e1gio. A vantagem desse tratamento \u00e9 o de atingir igualmente as met\u00e1stases \n\ndisseminadas pelo corpo. Contudo, esses medicamentos apresentam diversos efeitos colaterais, pois \n\nsua grande maioria possui baixo \u00edndice terap\u00eautico, ou seja, dose terap\u00eautica muito pr\u00f3xima da dose \n\nt\u00f3xica. Dessa forma, torna-se fundamental estimular as pesquisas, as quais medicamentos \n\nantineopl\u00e1sicos mais eficazes e seguros sejam descobertos (FUKUMASU et al., 2008).  \n\n \n\n3.5 Morte celular (Apoptose) \n\n \n\nO equil\u00edbrio entre a morte celular e prolifera\u00e7\u00e3o celular regula e controla o n\u00famero de \n\nc\u00e9lulas no organismo. A cascata de eventos, bioqu\u00edmicos e fisiol\u00f3gicos, que leva a mudan\u00e7a na \n\ns\u00edntese de macromol\u00e9culas, na homeostase e volume celular, bem como na perda da viabilidade \n\ncelular est\u00e3o relacionadas \u00e0s altera\u00e7\u00f5es morfol\u00f3gicas caracter\u00edsticas de cada tipo de morte celular \n\n(TINARI et al., 2008).   \n\nApoptose \u00e9 considerado um mecanismo vital em diversos processos, tais como homeostase \n\ndos tecidos, apropriado funcionamento do sistema imune e desenvolvimento embrion\u00e1rio (BRAS et \n\nal., 2005: ELMORE, 2007). Por outro lado, a desregula\u00e7\u00e3o da apoptose pode afetar o balan\u00e7o entre \n\nInvas\u00e3o tecidual e \nmet\u00e1stase\n\nAngiog\u00eanese\nsustentada\n\nInibi\u00e7\u00e3o de \nvigil\u00e2ncia imune\n\nEstresse \nmetab\u00f3lico\n\nEstresse \nProteot\u00f3xico\n\nEstresse \nmit\u00f3tico\n\nEstresse \noxidativo\n\nDanos no DNA\n\nPotencial \nreplicativo\nilimitado\n\nInsens\u00edvel a sinais de \nanti-crescimento\n\nAuto-suficiente em \nsinais de crescimento\n\nEvas\u00e3o da \napoptose\n\nHip\u00f3xia Senesc\u00eancia\n\nAneuploidia\n\nBaixo\n\npH\n\nSobrevida e \nprolifera\u00e7\u00e3o em novos \n\nambientes\n\nInvas\u00e3o tecidual e \nmet\u00e1stase\n\nAngiog\u00eanese\nsustentada\n\nInibi\u00e7\u00e3o de \nvigil\u00e2ncia imune\n\nEstresse \nmetab\u00f3lico\n\nEstresse \nProteot\u00f3xico\n\nEstresse \nmit\u00f3tico\n\nEstresse \noxidativo\n\nDanos no DNA\n\nPotencial \nreplicativo\nilimitado\n\nInsens\u00edvel a sinais de \nanti-crescimento\n\nAuto-suficiente em \nsinais de crescimento\n\nEvas\u00e3o da \napoptose\n\nHip\u00f3xia Senesc\u00eancia\n\nAneuploidia\n\nBaixo\n\npH\n\nSobrevida e \nprolifera\u00e7\u00e3o em novos \n\nambientes\n\n\n\n14 \n\n \n\nprolifera\u00e7\u00e3o celular e morte celular, resultando no aparecimento de v\u00e1rias doen\u00e7as humanas, \n\nincluindo o c\u00e2ncer (ZORNING et al., 2001; DANIAL &amp; KORSMEYER, 2004). \n\nO termo apoptose foi introduzido por KERR et al (1972), para definir um conjunto de \n\ncaracter\u00edsticas morfol\u00f3gicas e bioqu\u00edmicas, como redu\u00e7\u00e3o de volume nuclear e celular, condensa\u00e7\u00e3o \n\nda cromatina (OTT et al., 2007), fragmenta\u00e7\u00e3o do n\u00facleo, forma\u00e7\u00e3o de prolongamentos da \n\nmembrana plasm\u00e1tica (blebbs), fragmenta\u00e7\u00e3o celular (corpos apopt\u00f3ticos) (KIECHLE &amp; ZHANG, \n\n2002; KROEMER et al., 2005), exposi\u00e7\u00e3o da fosfatidilserina (ZIEGLER &amp; GROSCRURTH, 2004) \n\ne mudan\u00e7as na permeabilidade de membrana mitocondrial com perda do potencial de membrana \n\n(RICCI &amp; ZONG, 2006). \n\nEm condi\u00e7\u00f5es normais, os fosfolip\u00eddios s\u00e3o assimetricamente distribu\u00eddos, com o \n\nfosfolip\u00eddio fosfatidilserina normalmente confinada na face citoplasm\u00e1tica da membrana plasm\u00e1tica \n\npor um mecanismo de transporte ativo. Essa assim\u00e9trica distribui\u00e7\u00e3o pode ser perturbada \n\nprincipalmente durante o processo de apoptose, na qual serve como um sinal prim\u00e1rio para remo\u00e7\u00e3o \n\nfagoc\u00edtica de c\u00e9lulas apopt\u00f3ticas (BALASUBRAMANIAN &amp; SCHROIT, 2003). A externaliza\u00e7\u00e3o \n\nda fosfatidilserina corresponde a um evento quase universal da apoptose, que ocorre poucas horas \n\nap\u00f3s o est\u00edmulo apopt\u00f3tico, e apresenta um alvo muito abundante (milh\u00f5es de s\u00edtios por c\u00e9lula), \n\nsendo facilmente acess\u00edvel na face externa da membrana (BOERSMA et al., 2005; \n\nBLANKENBERG, 2008).  \n\nEssa altera\u00e7\u00e3o da membrana plasm\u00e1tica levou KOOPMAN et al (1994) e outros a delinear \n\num ensaio de detec\u00e7\u00e3o da fosfatidilserina por colora\u00e7\u00e3o com isotiocianato fluoresce\u00edna (FITC)-\n\nconjugado com Anexina V, uma prote\u00edna com forte afinidade natural para fosfatidilserina \n\n(MARTIM et al. 1995; OZGEN et al., 2000; BRUMATI et al., 2008). Por ser capaz de distinguir \n\nentre c\u00e9lulas apopt\u00f3ticas e necr\u00f3ticas, as quais t\u00eam comprometida a integridade da membrana, \n\niodeto de prop\u00eddeo (IP) foi adicionado. Por esse ensaio, c\u00e9lulas vi\u00e1veis, apopt\u00f3ticas e necr\u00f3ticas \n\npodem ser discriminadas por microscopia de fluoresc\u00eancia ou cit\u00f4metro de fluxo (VERMES et al., \n\n1995; BOERSMA et al., 2005; GROSSE et al., 2009). \n\nApoptose pode ser induzida por uma via extr\u00ednseca, envolvendo receptores de morte \n\npresentes na superf\u00edcie celular, ou por via intr\u00ednseca induzida por est\u00edmulos extracelular que \n\ntransmite um sinal para a mitoc\u00f4ndria (Figure 4) (BRENNER &amp; KROEMER, 2000; KUO et al., \n\n2010). A via extr\u00ednseca \u00e9 caracterizada por intera\u00e7\u00e3o de um ligante com receptores de morte, que \n\ndesencadeia a forma\u00e7\u00e3o de um complexo multim\u00e9rico, seguido por recrutamento e ativa\u00e7\u00e3o da \n\ncaspase-8 (LAVRIK et al., 2005).  \n\n\n\n15 \n\n \n\nA via intr\u00ednseca envolve altera\u00e7\u00e3o no potencial de membrana mitocondrial, levando a \n\npermeabiliza\u00e7\u00e3o da membrana mitocondrial (MMP), e seguida por libera\u00e7\u00e3o do citocromo C \n\n(CHIPUK et al., 2006; KROEMER et al., 2007). O citocromo C citos\u00f3lico liga-se a prote\u00edna APAF-\n\n1 (\u201cFator 1 ativador da apoptose\u201d), desencadeando a forma\u00e7\u00e3o de um complexo prot\u00e9ico chamado \n\nde apoptosomo, o qual permite o recrutamento e ativa\u00e7\u00e3o da caspase-9 (BAO &amp; SHI, 2007). MMP \n\n\u00e9 regulada por membros da fam\u00edlia Bcl-2 e Bax, que inibe ou promove a permeabiliza\u00e7\u00e3o da \n\nmembrana mitocondrial, respectivamente (REED, 2006). Ambas as vias, convergem para a caspase-\n\n3 executora, cuja atividade produz as caracter\u00edsticas morfol\u00f3gicas da apoptose (PORTER &amp; \n\nJANICKE, 1999). Ent\u00e3o, MMP e principalmente, a perda do potencial de membrana mitocondrial \n\nmarca o ponto de n\u00e3o retorno do processo de morte celular (KROEMER, 2003). Por causa deste \n\npapel central na cascata da apoptose, a avalia\u00e7\u00e3o do potencial de membrana mitocondrial fornece \n\numa importante direcionamento para o mecanismo de morte celular (GOTTLIEB &amp; GRANVILLE, \n\n2002), bem como a caracteriza\u00e7\u00e3o de novos agente indutores da apoptose (BUENZ et al., 2007).       \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigura 4. Vias intr\u00ednseca e extr\u00ednseca da apoptose (Fonte: ANDERSEN et al., 2005) \n\n \n\n \n\n3.6 Atividade antitumoral  \n\n \n\nDiversas prote\u00ednas produzidas em c\u00e9lulas de mam\u00edferos ocorrem como glicoprote\u00ednas e \n\nrecentes avan\u00e7os na glicobiologia t\u00eam revelado que suas cadeias de a\u00e7\u00facar desempenham pap\u00e9is \n\nimportantes no reconhecimento celular, sendo essenciais para manuten\u00e7\u00e3o da ordem social no \n\nEst\u00edmulo apopt\u00f3tico\n\n(quimioterapia,  UV)\nIntr\u00ednseco\n\nMitoc\u00f4ndria\n\nMorte Celular\n\nExtr\u00ednseco\n\nLigante\n\nReceptor\n\nEst\u00edmulo apopt\u00f3tico\n\n(quimioterapia,  UV)\nIntr\u00ednseco\n\nMitoc\u00f4ndria\n\nMorte Celular\n\nExtr\u00ednseco\n\nLigante\n\nReceptor\n\n\n\n16 \n\n \n\ncomportamento das c\u00e9lulas que constituem organismos multicelulares (KOBATA &amp; AMANO, \n\n2005).  \n\nGlicosila\u00e7\u00e3o \u00e9 uma modifica\u00e7\u00e3o p\u00f3s-translational comum em prote\u00ednas celulares, ocorrendo \n\ndurante o desenvolvimento normal das c\u00e9lulas (LEHLE et al., 2006; CAMPBELL et al., 2007). \n\nEntretanto, a bioss\u00edntese das cadeias de oligossacar\u00eddeos presentes nas glicoprote\u00ednas se encontra \n\nfreq\u00fcentemente alterada na diferencia\u00e7\u00e3o e transforma\u00e7\u00e3o maligna. Algumas dessas mudan\u00e7as \n\npodem ser reconhecidas por prote\u00ednas ligantes de carboidratos, as lectinas (GAJ et al., 2009). \n\nNos \u00faltimos anos lectinas t\u00eam recebido aten\u00e7\u00e3o especial devido as suas importantes \n\natividades biol\u00f3gicas explor\u00e1veis, como citoaglutina\u00e7\u00e3o, sonda histoqu\u00edmica, atividade mitog\u00eanica, \n\ncitotoxicidade, a\u00e7\u00e3o antiproliferativa e indutora da apoptose (SOBRAL, 2010; LAM &amp; NG, 2010; \n\nYAN et al., 2010; ZHANG et al., 2010). \n\nO campo da pesquisa terap\u00eautica vem se desenvolvendo no sentido de testar novas formas \n\nde tratamento, bem como novas subst\u00e2ncias potencialmente eficazes contra as neoplasias (SAAD-\n\nHOSNE et al., 2004). Nesse contexto, estudos experimentais utilizando lectinas de serpentes e \n\nc\u00e9lulas tumorais t\u00eam revelado resultados promissores, indicando sua potencial atividade antitumoral \n\natrav\u00e9s da preven\u00e7\u00e3o e/ou tratamento do c\u00e2ncer. Lectina de Bothrops jararacussu (PEREIRA-\n\nBITTENCOURT et al, 1999) demonstrou uma potente atividade inibit\u00f3ria para linhagens celulares \n\nde c\u00e2ncer humano (renal e pancre\u00e1tico). Em outro estudo, CARVALHO et al. (2001) sugeriram que \n\nessa lectina pode servir como uma interessante ferramenta para combater a progress\u00e3o do c\u00e2ncer, \n\npor inibir o crescimento de linhagens celulares humanas de c\u00e2ncer de mama metast\u00e1tico (MDA-\n\nMB-435) e carcinoma de ov\u00e1rio (OVCAR-5).  \n\nRecentes trabalhos mostram um efeito inibit\u00f3rio de lectinas de serpentes sobre diversas \n\nfun\u00e7\u00f5es mediadas por integrinas em c\u00e9lulas tumorais. Lebectina, uma lectina tipo-C isolada do \n\nveneno de Macrovipera lebetina, apresenta not\u00e1vel atividade anti-integrina, sendo h\u00e1bil para \n\nprevenir ades\u00e3o, migra\u00e7\u00e3o, invas\u00e3o e prolifera\u00e7\u00e3o de c\u00e9lulas tumorais in vitro (SARRAY, et al., \n\n2004).  \n\nLebecetina, uma segunda lectina tipo-C purificada desse mesmo veneno, tamb\u00e9m exerce o \n\nmesmo efeito de lebectina sobre c\u00e9lulas tumorais, e ambas, provavelmente, atuam via intera\u00e7\u00e3o com \n\na integrina ?5?1 (SARRAY et al., 2001, 2007). De acordo com SARRAY et al. (2009) lebectina foi \n\ncapaz de controlar a ades\u00e3o c\u00e9lula-c\u00e9lula mediada por N-caderina, e em conjunto com seu efeito \n\n\n\n17 \n\n \n\ninibit\u00f3rio sobre a integrina ?5?1, pode contribuir para o bloqueio da migra\u00e7\u00e3o de c\u00e9lulas tumorais \n\npreviamente observado.  \n\n \n\n3.7. Atividade antibacteriana \n\n \n\n A hist\u00f3ria da humanidade pode ser considerada, do ponto de vista m\u00e9dico, como uma luta \n\ncontra microorganismos que causam infec\u00e7\u00f5es e doen\u00e7as. Embora, no in\u00edcio do s\u00e9culo XX, doen\u00e7as \n\ninfecciosas se apresentassem como a principal causa de morte no mundo, a introdu\u00e7\u00e3o dos \n\nantibi\u00f3ticos como a sulfa e penicilina em uso cl\u00ednico em 1930 e 1940, respectivamente, teve um \n\nnot\u00e1vel impacto sobre o tratamento de infec\u00e7\u00f5es, diminuindo drasticamente a mortalidade \n\n(COHEN, 2000; BUYNAK, 2004). \n\n No entanto, a euforia no potencial controle das doen\u00e7as infecciosas teve vida curta, pois \n\nquase t\u00e3o rapidamente como drogas antibacterianas foram implantadas, bact\u00e9rias responderam por \n\nmanifestar v\u00e1rias formas de resist\u00eancia (TENOVER et al., 2006; SPELLBERG et al., 2008). \n\nEmbora tenham surgido in\u00fameras classes de antibi\u00f3ticos, observa-se atualmente que existe pelo \n\nmenos uma cepa resistente a esses f\u00e1rmacos, seja em comunidade ou em hospitais (FLUIT &amp; \n\nSCHMITZ, 2004; MATLOW &amp; MORRIS, 2009), acarretando um s\u00e9rio problema para a sa\u00fade \n\np\u00fablica em todo o mundo (LEVI &amp; MARSHALL, 2004; RAGHUNATH, 2008). Permanece, \n\nportanto, a necessidade de novos antimicrobianos ou prot\u00f3tipos antibacterianos, que possam ser \n\nempregados no delineamento de antibi\u00f3ticos contra bact\u00e9rias multidroga-resistentes. \n\nPept\u00eddeos e prote\u00ednas t\u00eam sido avaliados como antibi\u00f3ticos para o controle de bact\u00e9rias \n\npatog\u00eanicas (NAIR et al., 2007; WANG et al., 2008). Lectinas tem assumido um importante papel \n\nem intera\u00e7\u00f5es com pat\u00f3genos, atrav\u00e9s do reconhecimento espec\u00edfico de glicoconjugados presentes \n\nna superf\u00edcie das c\u00e9lulas bacterianas (TATENO et al., 2002), como peptidioglicanos, \u00e1cido teic\u00f3ico, \n\nlipopolisacar\u00eddeos e glicolip\u00eddeos (SCHAFFER &amp; MESSNER, 2005; CLOUD-HANSEN et al., \n\n2006), resultando em atividade antibacteriana (MOURA et al., 2006). Al\u00e9m disso, lectinas podem \n\nativar prote\u00ednas ou enzimas associadas ao processo de elimina\u00e7\u00e3o de microorganismos patog\u00eanicos \n\n(WANG et al., 2008). Em animais, s\u00e3o ferramentas not\u00e1veis para agregar e opsonizar pat\u00f3genos \n\n(FUJITA, 2002).  \n\nDevido a essa habilidade, diversas lectinas de animais v\u00eam sendo avaliadas quanto ao seu \n\npotencial antibacteriano. Lectina do anel\u00eddeo Perineresis nuntia foi capaz de inibir o crescimento de \n\n\n\n18 \n\n \n\nBacillus megeterium e Bacillus subtilis e foi sugerido que a prote\u00edna est\u00e1 envolvida na defesa imune \n\ndo hospedeiro (KAWSAR et al., 2010). CfLEC-2, uma lectina de Chlamys farreri, apresentou \n\natividade agregante quando testada frente a bact\u00e9ria Staphylococcus haemolyticus, atuando como \n\nmecanismo de defesa (ZHENG et al., 2008). A lectina de Holothuria scabra apresentou potente \n\natividade antimicrobiana contras \u00e0s bact\u00e9rias gram-negativas e gram-positivas, indicando seu efeito \n\nantibacteriano de amplo espectro (GOWDA et al., 2008). \n\nEm venenos de serpentes, lectinas tipo-C com a\u00e7\u00e3o antibacteriana tamb\u00e9m tem sido \n\npurificadas em recentes estudos. Crotacetina, isolada de Crotalus durissus terrificus, inibiu \n\nsignificativamente o crescimento de dois pat\u00f3genos de plantas: X. axonopodis pv. passiflorae e C. \n\nmichiganensis michiganensis, bact\u00e9rias gram-negativa e gram-positiva, respectivamente (R\u00c1DIS-\n\nBAPTISTA et al., 2006). Uma lectina tipo-C BmLec, isolada de Bothrops moojeni, exibiu potente \n\nefeito antibacteriano contra Xanthomonas axonopodis pv. (bact\u00e9ria gram-negativa), causando \n\nvacuoliza\u00e7\u00e3o do citoplasma e ruptura da membrana celular (BARBOSA et al., 2010). \n\nA relev\u00e2ncia biol\u00f3gica dessa atividade, induzida por prote\u00ednas, no envenenamento por \n\nserpentes n\u00e3o est\u00e1 clara, no entanto, alguns autores sugerem que possa contribuir para a baixa \n\nfreq\u00fc\u00eancia de infec\u00e7\u00f5es bacterianas no local da picada (TALAN et al., 1991; TRABI et al., 2001; \n\nSAMPAIO et al., 2010) ou como mecanismo de defesa contra microorganismos presentes na sua \n\npresa durante a alimenta\u00e7\u00e3o (SHIVIK, 2006).   \n\n \n\n3.8. Radia\u00e7\u00e3o  \n\n \n\n Radia\u00e7\u00e3o ionizante consiste de ondas eletromagn\u00e9ticas resultantes de transi\u00e7\u00f5es nucleares, \n\nque se propagam com alta velocidade, possuindo energia suficiente para quebrar liga\u00e7\u00f5es qu\u00edmicas, \n\nbem como a capacidade de promover a ioniza\u00e7\u00e3o e excita\u00e7\u00e3o nos meios com elevado poder de \n\npenetra\u00e7\u00e3o (BREWER, 2004, 2009). Radia\u00e7\u00e3o gamma ou raio gamma (?) \u00e9 um tipo de radia\u00e7\u00e3o \n\neletromagn\u00e9tica produzida por elementos radioativos, em um processo subat\u00f4mico como a \n\naniquila\u00e7\u00e3o de um par p\u00f3sitron-el\u00e9tron. Possui comprimento de onda de alguns picometros e por \n\ncausa das altas energias, constituem um tipo de radia\u00e7\u00e3o capaz de penetrar mais profundamente na \n\nmat\u00e9ria. Devido \u00e0 sua elevada energia irradia\u00e7\u00e3o gamma emite el\u00e9tron e gera radicais a partir da \n\nquebra do is\u00f3topo cobalto 60, ao quais afetam a estrutura das prote\u00ednas intactas, seguido por um \n\nataque ao res\u00edduo radio-sens\u00edvel ou liga\u00e7\u00f5es (SEO et al., 2007).  \n\n\n\n19 \n\n \n\nIrradia\u00e7\u00e3o causa danos ou inativam prote\u00ednas atrav\u00e9s de dois diferentes mecanismos \n\n(KEMPNER, 2001). Primeiro, pode provocar quebra de liga\u00e7\u00f5es covalentes em mol\u00e9culas de \n\nprote\u00ednas alvo, como resultado direto de um f\u00f3ton de energia. Segundo, atua indiretamente via \n\nradi\u00f3lise da \u00e1gua, produzindo radicais livres e esp\u00e9cies reativas de oxig\u00eanio (ROS), respons\u00e1vel \n\npela maioria dos danos na prote\u00edna (ZBIKOWSKA, 2006). \n\n A exposi\u00e7\u00e3o de prote\u00ednas a radia\u00e7\u00e3o produz altera\u00e7\u00f5es em sua estrutura qu\u00edmica e f\u00edsica por \n\nfragmenta\u00e7\u00e3o, \u201c cross-linking \u201d, agrega\u00e7\u00e3o, desnatura\u00e7\u00e3o, forma\u00e7\u00e3o de novos grupos reativos, e \n\noxida\u00e7\u00e3o por radicais oxig\u00eanios que s\u00e3o gerados na radi\u00f3lise da \u00e1gua, resultando em distor\u00e7\u00f5es na \n\nestrutura secund\u00e1ria e terci\u00e1ria, levando a diminui\u00e7\u00e3o ou perda da fun\u00e7\u00e3o biol\u00f3gica da prote\u00edna \n\n(SHACTER, 2000; MOON &amp; SONG, 2001).  \n\n Os radicais hidroxila e anion super\u00f3xido que s\u00e3o gerados por radia\u00e7\u00e3o podem modificar as \n\npropriedades moleculares das prote\u00ednas, que resultam em altera\u00e7\u00f5es de prote\u00ednas por liga\u00e7\u00f5es \n\ncruzadas covalentes em prote\u00ednas formadas ap\u00f3s a irradia\u00e7\u00e3o (SHAWRANG et al., 2008). O efeito \n\nda irradia\u00e7\u00e3o sobre a conforma\u00e7\u00e3o das prote\u00ednas depende de v\u00e1rios fatores, como concentra\u00e7\u00e3o da \n\nprote\u00edna, a presen\u00e7a de oxig\u00eanio e da sua estrutura quatern\u00e1ria (LEE et al., 2003; GABER, 2005). \n\nRadia\u00e7\u00e3o gamma vem sendo empregada como agente atenuante de venenos of\u00eddicos e \n\ntoxinas isoladas, resultando em um produto de baixa ou nenhuma toxicidade, preservando, por\u00e9m, \n\nsuas propriedades imunol\u00f3gicas. Crotamina, uma toxina de Crotalus durissus terrificus, irradiada \n\nna dose de 2.0 kGy foi duas vezes menos t\u00f3xica para camundongos que a crotamina nativa (BONI-\n\nMITAKE et al., 2001). SOUZA et al. (2002) demonstraram que o veneno irradiado de Bothrops \n\njararacussu, o qual apresenta miotoxinas em sua composi\u00e7\u00e3o, n\u00e3o exibiu efeitos miot\u00f3xicos nas \n\nprepara\u00e7\u00f5es musculares in vitro, quando comparado com o veneno nativo. Em outro estudo, \n\nCASARE et al. (2006) observaram que Crotoxina quando submetida \u00e0 radia\u00e7\u00e3o, em diferentes \n\ndoses, apresentou diminui\u00e7\u00e3o significativa na mortalidade de camundongos. O tratamento de \n\nBothropstoxina-1 com radia\u00e7\u00e3o na dose de 2.0 kGy promoveu modifica\u00e7\u00f5es estruturais na toxina, \n\nno entanto, manteve muita das propriedades antig\u00eanicas da prote\u00edna nativa. Esses autores \n\nverificaram tamb\u00e9m que a toxina irradiada induziu altos t\u00edtulos de IgG2, sugerindo que c\u00e9lulas Th1 \n\nest\u00e3o envolvidas na resposta imune (CAPRONI et al., 2009).  \n\nEm recente estudo, irradia\u00e7\u00e3o gamma foi utilizada como um tratamento alternativo para \n\nabolir alergenicidade de lectinas em alimentos. VAZ et al. (2010) observaram que a irradia\u00e7\u00e3o da \n\nlectina isolada da entrecasca de Sebastiana jacobinenses (SejaBL), em altas doses (acima de 1kGy), \n\n\n\n20 \n\n \n\ninduziu uma significante perda da atividade hemaglutinante e causou altera\u00e7\u00f5es estruturais na \n\nprote\u00edna, incluindo fragmenta\u00e7\u00e3o e agrega\u00e7\u00e3o ap\u00f3s irradia\u00e7\u00e3o.       \n\n \n\n3.9. Serpente Bothrops leucurus \n\n \n\n No Brasil, serpentes do g\u00eanero Bothrops s\u00e3o respons\u00e1veis por 90% de todos os acidentes \n\nof\u00eddicos nos quais a serpente \u00e9 identificada. Bothrops leucurus (jararaca-do-rabo-branco) \u00e9 uma \n\nserpente que apresenta uma ampla distribui\u00e7\u00e3o na costa brasileira, do estado do Maranh\u00e3o at\u00e9 o \n\nEsp\u00edrito Santo (LIRA-DA-SILVA, 2009). Na Bahia, essa esp\u00e9cie \u00e9 a principal causadora de \n\nenvenenamentos por picadas de serpentes em humanos (LIRA-DA-SILVA &amp; NUNES, 1993; MISE \n\net al., 2007), representando um s\u00e9rio problema m\u00e9dico para a regi\u00e3o Nordeste do Brasil (Figura 5). \n\n \n\n \n\nFigura 5. Serpente Bothrops leucurus (Fonte: LIRA-DA-SILVA et al. 2009) \n\n \n\nEm um estudo sobre atividades biol\u00f3gicas de venenos de serpente da Am\u00e9rica do Sul, \n\nSANCHES et al. (1992) demonstraram que a letalidade, como tamb\u00e9m as atividades \n\nedematog\u00eanica, coagulante, hemorr\u00e1gica e necrosante de B. leucurus foram semelhantes \u00e0s de \n\nv\u00e1rias outras esp\u00e9cies botr\u00f3picas, incluindo B. jararaca.  Em adi\u00e7\u00e3o, B. leucurus exibiu a\u00e7\u00e3o \n\nneuromuscular e miot\u00f3xica em prepara\u00e7\u00f5es de nervo-m\u00fasculo de aves (PRIANTI JR et al., 2003). \n\nComponentes implicados em uma variedade de efeitos t\u00f3xicos locais, assim como em \n\nprofundas perturba\u00e7\u00f5es no sistema hemost\u00e1tico das v\u00edtimas foram isolados do veneno de B. \n\n\n\n21 \n\n \n\nleucurus. BELLO et al. (2006) purificou uma proteinase fibrinol\u00edtica, denominada leuc-a, a qual \n\nexibiu efeito inibit\u00f3rio sobre agrega\u00e7\u00e3o plaquet\u00e1ria induzida por ADP. Uma L-amino oxidase, \n\npurificada desse veneno, inibiu agrega\u00e7\u00e3o plaquet\u00e1ria estimulada por col\u00e1geno, contribuindo para o \n\nsangramento t\u00edpico de pessoas picadas por essa serpente (SILVA et al., 2007). HIGUCHI et al. \n\n(2007) demonstrou a presen\u00e7a duas fosfolipases no veneno de B. leucurus, e observou que essas \n\ninibiram significantemente a coagula\u00e7\u00e3o e foram h\u00e1beis em estimular o crescimento tumoral. Outras \n\ntoxinas tamb\u00e9m foram isoladas, incluindo uma enzima trombina-like (MAGALH\u00c3ES et al., 2007), \n\numa P-III metaloproteinase hemorr\u00e1gica (SANCHEZ et al., 2007), uma metaloproteinase n\u00e3o \n\nhemorr\u00e1gica, com atividade edematog\u00eanica e trombol\u00edtica (GREMSKI et al., 2007). Recentemente, \n\nfoi purificado uma metaloproteinase fibrinogenol\u00edtica n\u00e3o hemorr\u00e1gica (BleucMP), com habilidade \n\npara diminuir significantemente o n\u00edvel de fibrinog\u00eanio plasm\u00e1tico provocado por incoagulabilidade \n\nsangu\u00ednea (Gomes et al., 2010). \n\n   \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n22 \n\n \n\n4 REFER\u00caNCIAS BIBLIOGR\u00c1FICAS \n\n \n\nALMEIDA, V.L.; LEIT\u00c3O, A.; REINA, L.C.B.; MONTANARI, C.A.; DONNICI, C.L. (2005) \n\nCancer and cell cicle-specific and cell cicle nonspecific anticancer DNA-interactive agents. \n\nQuimica Nova, 28(1): 118-129. \n\nAMERICAN CANCER SOCIETY (ACS). The history of cancer. Dispon\u00edvel em: \n\n<http://www.cancer.org/>. Acesso em: 30 out. 2010. \n\nANDERSEN, M.H.; BECKER, J.C.; STRATEN, P.T. (2005) Regulators of apoptosis: suitable \n\ntargets for immune therapy of cancer. Nature Reviews Drug Discovery, 4:399-409. \n\nANGULO, Y.; LOMONTE, B. (2009) Biochemistry and toxicology of toxins purified from the \n\nvenom of the snake Bothrops asper. Toxicon, 54(7): 949-957. \n\nARAB, M.R.; SALARI, S.; KARIMI, M.; MODIFIDPOUR, H. (2010) Lectin histochemical study \n\nof cell surface glycoconjugate in gastric carcinoma using Helix pomatia agglutinin. Acta \n\nMedica Iranica, 48(4): 209-213. \n\nARAGON-ORTIZ, F.; BRENES, J.R.B.; GUBENSEK, F. (1989) Characterization of a lectin-like \n\nprotein isolated from Lachesis muta snake venom. Revista de Biologia Tropical, 37:70-83. \n\nARAGON-ORTIZ, F.; MENTELE, R.; AUERSWALD, E.A. (1996) Amino acid sequence of a \n\nlectin-like protein form Lachesis muta stenophyrs venom. Toxicon, 34:763-769. \n\nBALASUBRAMANIAN, K.; SCHROIT, A.J. (2003) Aminophospholipid asymmetry: a matter of \n\nlife and death. Annual Reviews Physiology, 65:701-734. \n\nBAO, Q.; SHI, Y. (2007) Apoptosomo: a platform for the activation of initiator caspases. Cell \n\nDeath Differentiation, 14(1): 56-65. \n\nBAPTISTA, J.A.; VIEIRA, D.P.; GALISTEO-J\u00daNIOR, A.J.; CAPRONI, P.; CASARE, M.; \n\nANDRADE-J\u00daNIOR, H.F.; SPENCER, P.J.; NASCIMENTO, N. (2009) Immunological \n\nproperties of 60Co gamma-rays irradiated bothropstoxin-I. Journal of Radioanalytical and \n\nNuclear Chemistry, 279(3): 817-821. \n\nBARBOSA, P.S.F.; MARTINS, A.M.C.; TOYAMA, M.H.; JOAZEIRO, P.P.; LOS, B.; \n\nFONTELES, M.C.; MONTEIRO, H.S.A. (2010) Purification and biological effects of a C-type \n\n\n\n23 \n\n \n\nlectin isolated from Bothrops moojeni. Journal of Venomous Animals and Toxins including \n\nTropical Diseases, 16(3): 493-504. \n\nBATTISON, A.L.; SUMMERFIELD, R.L. (2009) Isolation and partial characterization of four \n\nnovel plasma lectins from the American lobster Homarus americanus. Developmental &amp; \n\nComparative Immunology, 33:198-204. \n\nBELLO, C.A.; HERMOGENES, A.L.N.; MAGALHAES, A.; VEIGA, S.S.; GREMSKI, L.H.; \n\nRICHARDSON, M.; SANCHEZ, E.F. (2006) Isolation and biochemical characterization of a \n\nfibrinolytic proteinase from Bothrops leucurus (white-tailed-jararaca) snake venom. \n\nBiochemie, 88:189-200. \n\nBLANKENBERG, F.G. (2008) In vivo detection of apoptosis. Journal Nuclear Medicine, 49(2): \n\n81S-91S. \n\nBOERSMA, H.H.; KIETSELAER, B.L.J.H.; STOLK, L.M.L.; BENNAGHMOUCH, A.; \n\nHOFSTRA, L.; NARULA, J.; HEIDENDAL, G.A.K.; REUTELINGSPERGER, C.P.M. (2005) \n\nPast, present, and future of annexin A5: from protein discovery to clinical applications. \n\nJournal Nuclear of Medicine, 46:2035-2050. \n\nBONI-MITAKE, M.; COSTA, H.; SPENCER, P.J.; VASSILIEFF, V.S.; ROGERO, J.R. (2001) \n\nEffects of 60Co gamma radiation on crotamine. Brazilian Journal of Medical and Biological \n\nResearch, 34(12): 4531-4538. \n\nBOYD, W.C.; SHAPLEIGH, E. (1954) Specific precipitating activity of plant agglutinins (Lectins). \n\nScience, 119(3091): 419. \n\nBRAGA, M.D.M.; MARTINS, A.M.C.; AMORA, D.N.; MENEZES, D.B.; TOYAMA, M.H.; \n\nTOYAMA, D.O.; MARANGONI, S.; BARBOSA, P.S.F.; ALVES, R.S.; FONTELES, M.C.; \n\nMONTEIRO, H.S.A. (2006) Purification and biological effects of C-type lectin isolated from \n\nBothrops insularis venom. Toxicon, 47:859-867.    \n\nBRAS, M.; QUEENAN, B.; SUSIN, S.A. (2005) Programmed cell death via mitochondria: \n\ndifferent modes of dying. Biochemistry, 70(2): 231-239. \n\nBRENNER, C.; KROEMER, G. (2000) Apoptosis: mitochondria-the death signal integrators. \n\nScience, 289(5482): 1150-1151. \n\nBREWER, M.S. (2004) Irradiation effects on meat color-a review. Meat Science, 68:1-17. \n\n\n\n24 \n\n \n\nBREWER, M.S. (2009) Irradiation effects on meat flavor: a review. Meat Science, 81:1-14. \n\nBRUMATTI, G.; SHERIDAN, C.; MARTIN, S. (2008) Expression and purification of recombinant \n\nannexin V for the detection of membrane alterations on apoptotic cells. Methods, 44:235-240. \n\nBUENZ, E.J.; LIMBURG, P.J.; HOWE, C.L. (2007) A high-throughput 3-parameter flow \n\ncytometry-based cell death assay. International Society for Analytical Cytology, 71:170-173.  \n\nBUYNAK, J.D. (2004) The discovery and development of modified penicillin- and cephalosporin-\n\nderived beta-lactamase inhibitors. Current Medicinal Chemistry, 11:1951-1964. \n\nCAMPBELL, C.T.; SAMPATHKUMAR, S.G.; YAREMA, K.J. (2007) Metabolic oligosaccharide \n\nengineering perspectives, applications, and future directions. Molecular Biosystems, 3: 187-\n\n194   \n\nCAO, X.; SUN, Y.; WANG, C.; ZENG, B. (2010) Purification and characterization of a new \n\ngalactose-specific lectin the housefly, Musca domestica and its antiproliferative effect on \n\nhuman K562 and tumor cells. Journal of Insect Science, 79:1-12. \n\nCAPRONI, P.; BAPTISTA, J.A.; ALMEIDA, T.L.; PASSOS, L.A.C.; NASCIMENTO, N. (2009) \n\nStudy of irradiated bothropstoxin-1 with 60Co gamma rays: immune system behavior. Journal \n\nof Venomous Animals and Toxins include Tropical Diseases, 15(2): 216-225. \n\nCARVALHO, D.D.; MARANGONI, S.; NOVELLO, J.C. (2002) Primary structure characterization \n\nof Bothrops jararacussu snake venom lectin. Journal of Protein Chemistry, 21:43-50. \n\nCARVALHO, D.D.; SCHMITMEIER, S.; NOVELLO, J.C.; MARKLAND, F.S. (2001) Effect of \n\nBJcuL (a lectin from the venom of the snake Bothrops jararacussu) on adhesion and growth of \n\ntumor and endothelial cells. Toxicon, 39:1471-1476 \n\nCASARE, M.S.; SPENCER, P.; CAMPOS, L.A.; NASCIMENTO, N. (2006) Study of gamma-\n\nradiation effects on crotamine and crotoxin. Journal of Radioanalytical and Nuclear \n\nChemistry, 269(3): 571-577. \n\nCASTRO, H.C.; FERNANDES, M.; ZINGALI, R.B. (1999) Identification of bothrojaracin-like \n\nproteins in sanke venoms from Bothrops species and Lachesis muta. Toxicon, 37(10): 1403-\n\n1416. \n\n\n\n25 \n\n \n\nCHABNER, B.A.; JR., R.T.G. (2005) Timeline: chemotherapy and the war on cancer. Nature \n\nReviews Cancer, 5(65): 65-72.  \n\nCHEN, Y.S.; HUANG, C.H.; CHIOU, S.H. (2010) Characterization and molecular cloning of one \n\nnovel C-type lectin from the venom of Taiwan habu (Trimeresurus mucroquasmatus). \n\nToxicon, 55(4): 762-772. \n\nCHEN, Z.M.; WU, J.B.; ZHANG, Y.; YU, G.Y.; LEE, W.H.; LU, Q.M. (2011) Jerdonuxin, a novel \n\nsnaclec (snake C-type lectin) with platelet aggregation activity from Trimeresurus jerdonii \n\nvenom. Toxicon, 57(1): 109-116.    \n\nCHIPUK, J.E.; BOUCHIER-HAYES, L.; GREEN, D.R. (2006) Mitochondrial outer membrane \n\npermeabilization during apoptosis: the innocent bystander scenario. Cell Death &amp; \n\nDifferentiation, 13(8): 1396-1402. \n\nCLEMETSON, K.J. (2010) Snaclecs (snake C-type lectins) that inhibit or active platelets by \n\nbinding to receptors. Toxicon, 56(7): 1236-1246. \n\nCLEMETSON, K.J.; MORITA, T.; MANJUNATHA KINI, R. (2009) Scientific and \n\nstandardization committee communications: classification and nomenclature of snake venom \n\nC-type lectins and related proteins. Journal Thrombosis and Haemostasis, 7:360.  \n\nCLOUD-HANSEN, K.A.; PETERSON,S.B.; STABB, E.V.; GOLDMAN, W.E.; MACFALL-\n\nNGAI, M.J.; HANDELSMAN, J. (2006) Breaching the great wall: peptidoglican and microbial \n\ninteractions. Nature, 4:710-716. \n\nCOELHO, L.C.B.B.; SILVA, M.B.R. (2000) Simple method to purify milligram quantities pf the \n\ngalactose-specific lectin from the leaves of Bauhinia monandra. Phytochemical Analysis, \n\n11:295-300. \n\nCOHEN, M. (2000) Changing patterns of infectious disease. Nature, 406:762-767.  \n\nCOMINETTI, M.R.; MARQUES, M.R.F.; LORENZINI, D.M.; LOFGREN, S.E.; DAFFRE, S.; \n\nBARRACCO, M.A. (2002) Characterization and partial purification of a lectin from the \n\nhemolymph of the white shrimp Litopenaeus schmitti. Developmental &amp; Comparative \n\nImmunology, 26:715-721. \n\n\n\n26 \n\n \n\nCOSTA, R.M.P.B.; VAZ, A.F.M.; OLIVA, M.L.V.; COELHO, L.L.B.B.; CORREIA, M.T.S.; \n\nCARNEIRO-DA-CUNHA, M.G. (2010) A new mistletoe Phthirusa pyrifolia leaf lectin with \n\nantimicrobial properties. Process Biochemistry, 45:526-533. \n\nDAMODARAN, D.; JEYAKANI, J.; CHAUHAN, A.; KUMAR, N.; CHANDRA, N.R.; \n\nSUROLIA, A. (2008) CancerLectin DB: a database of lectins relevant to cancer. Glycoconjugate, \n\n25:191-198. \n\nDANIAL, N.N.; KORSMEYER, S.J. (2004) Cell death: critical control points. Cell, 116:205-219.  \n\nDATTA, K.; USHA, R.; DUTTA, S.K.; SINGH, M.A. (2001) A comparative study of the winged \n\nbean protease inhibitors and their interaction proteases. Plant Physiology and Biochemistry, \n\n39:949-959. \n\nDE MEJ\u00cdA, E.G.; PRISECARU, V.I. (2005) Lectins as bioactive plant proteins: a potential cancer \n\ntreatment. Critical Reviews in Food Science and Nutrition, 45:425-445. \n\nDING, J.; BAO, J.; ZHU, D.; ZHANG, Y.; WANG, D.C. (2010) Crystal structures of a novel anti-\n\nHIV mannose-binding lectin from Polygonatum cyrtonema Hua with unique ligand-binding \n\nproperty and super-structure. Journal of Structural Biology, 171(3): 309-317. \n\nDOYLE, R.; KINI, R.M. (2009) Protein complexes in snake venom. Cellular and Molecular Life \n\nSciences, 66:2851-2871. \n\nDRICKAMER, K. (1999) C-type lectin-like domains. Current Opinion in Structural Biology, \n\n9(5): 585-590. \n\nDUTTA, S.; SINHA, B.; BHATTACHARYA, B.; VHATTERJEE, B.; MAZUMDER, S. (2005) \n\nCharacterization of a galactose binding serum lectin from the Indian catfish, Clarias batrachus: \n\npossible involvement of fish lectins in differential recognition of pathogens. Comparative \n\nBiochemistry and Physiology Part C, 141(1): 76-84. \n\nEL\u00cdFIO-ESPOSITO, S.L.; HESS, P.L.; MORENO, A.N.; LOPES-FERREIRA, M.; RICART, \n\nC.A.O.; SOUZA, M.V.; HASSELMAN-ZIELINSKI, F.; BECKER, J.A.; PEREIRA, L.F. \n\n(2007) A C-type lection from Bothrops jararacussu venom can adhere to extracellular matrix \n\nproteins and induce the rolling of leukocytes. Journal of Venomous Animals and Toxins \n\nincluding Tropical Diseases, 13(4): 782-799. \n\n\n\n27 \n\n \n\nELMORE, S. (2007) Apoptosis: a review of programmed cell death. Toxicologic Pathology, 35(4): \n\n495-516. \n\nFENG, K.; LIU, Q.H.; NG, T.B.; LIU, H.; LI, J.Q.; CHEN, G.; SHENG, H.Y.; XIE, Z.L.; WANG, \n\nH.X. (2006) Isolation and characterization of a novel lectin from the mushroom Armillaria \n\nluteo-virens. Biochememical and Biophysical Research Communications, 345:1573-1578. \n\nFERREIRA JUNIOR, R.S.; NASCIMENTO, N.; MARTINEZ, J.C.; ALVES, J.B.; MEIRA, D.A.; \n\nBARRAVIERA, B. (2005) Immunological assessment of mice hyperimmunized with native \n\nand cobalt-60-irradiated Bothrops venoms. Journal of Venomous and Toxins including \n\nTropical Diseases, 11(4): 447-464. \n\nFLUII, A.C.; SCHMITZ, F.J. (2004) Resistance integrons, super integrons. Clinical Microbiology \n\nand Infection, 10:272-288. \n\nFREIRE, M.G.; GOMES, V.M.; CORSINI, R.E.; MACHADO, O.L.T.; DE SIMONE, S.G.; \n\nNOVELLO, J.C.; MARANGONI, S.; MACEDO, M.L.R. (2002) Isolation and partial \n\ncharacterization of a novel lectin from Talisia esculenta seeds that interferes with fungal \n\ngrowth. Plant Physiology Biochemistry, 40:61-68.  \n\nFUJII, Y.; KAWSAR, S.M.A.; MATSUMOTO, R.; DOGASKI, C.; HOSONO, M.; NITTA, K.; \n\nHAMAKO, J. (2011) A D-galactose-binding lectin purified from coronate moon turban, Turbo \n\n(Lunella) coreensis, with a unique amino acid sequence and the ability to recognize lacto-series \n\nglycosphingolipids. Comparative Biochemistry and Physiology Part B, 158:30-37. \n\nFUJITA, T. (2002) Evolution of the lectin-complement pathway and its role in innate immunity. \n\nNature, 2:347-353.      \n\nFUKUDA, K.; MIZUNO, H.; ATODA, H.; MORITA, T. (2000) Crystal structure of Flavocetin-A, \n\na platelet glycoprotein Ib-binding protein, reveals a novel cyclic tetramer of C-type lectin-like \n\nheterodimers. Biochemistry, 39: 1915-1923.  \n\nFUKUMASU, H.; LATORRE, A.O.; BRACCI, N.; G\u00d3RNIAK, S.L.; DAGLI, M.L.Z. (2008) \n\nFitoter\u00e1picos e potenciais intera\u00e7\u00f5es medicamentosas na terapia do c\u00e2ncer. Revista Brasileira \n\nde Toxicologia, 21(2): 49-59. \n\nGABER, M.H. (2005) Effect of ?-irradiation on the molecular properties of bovine serum albumin. \n\nJournal of Bioscience and Bioengineering, 100(2): 203-206. \n\n\n\n28 \n\n \n\nGAJ, Z.; KRZESLAK, A.; POMORSKI, L.; LIPINSKA, A. (2009) Intracelular glycoproteins \n\nbinding galectin-1 in thyroid lesions. Tumori, 95: 352-356. \n\nGALLACI, M.; NASCIMENTO, N.; ROGERO, J.R.; VASSILIEFF, V.S. (2000) Influence of \n\ntemperature upon effects of crotoxin and gamma-irradiated crotoxin at rat neuromuscular \n\ntransmission. Toxicology Letters, 114:77-80. \n\nGARTNER, T.K.; STOCKER, K.; WILLIAMS, K.C. (1980) Thrombolectin: a lectin isolated from \n\nBothrops atrox venom. FEBS Letters, 117: 13-16. \n\nGARTNER, T.K.; OGILVIE, L. (1984) Isolation and characterization of three Ca2+ dependent ?-\n\ngalactoside-specific lectin from snake venom. Biochemical Journal, 224:301-307. \n\nGOLDSTEIN, I.J.; HUGHES, R.C.; MONSIGNY, M.; OSAWA, T.; SHARON, N. (1980) What \n\nshould be called a lectin?. Nature,  285:66. \n\nGOMES, M.S.; de QUEIROZ, M.R.; MAMEDE, C.C.; MENDES, M.M.; HAMAGUCHI, A.; \n\nHOMSI-BRANDEBURGO, M.I.; SOUSA, M.V.; AQUINO, E.N.; CASTRO, M.S.; de \n\nOLIVEIRA, F.; RODRIGUES, V.M. (2010) Purification and functional characterization of a \n\nnew metalloproteinase (BleucMP) from Bothrops leucurus snake venom. Comparative \n\nBiochemistry and Physiology Part C Toxicology Pharmacology. In press. \n\nGOTTLIEB, R.A.; GRANVILLE, D.J. (2002) Analyzing mitochondrial changes during apoptosis. \n\nMethods, 26:341-347. \n\nGOWDA, N.M.; GOSWAMI, U.; KHAN, M.I. (2008) T-antigens binding lectin with antibacterial \n\nactivity from marine invertebrate, sea cucumber (Holothuria scabra): possible involvement in \n\ndifferential recognition of bacteria. Journal of Invertebrate Pathology, 99:141-145. \n\nGREMSKI, L.H.; CHAIM, O.M.; PALUDO, K.S.; SADE, Y.B.; OTUKI, M.F.; RICHARDSON, \n\nM.; GREMSKI, W.; SANCHEZ, E.F.; VEIGA, S.S. (2007) Cytotoxic, thrombolytic and \n\nedematogenic activities of leucurolysin-a, a metalloproteinase from Bothrops leucurus snake \n\nvenom. Toxicon, 50:120-134. \n\nGROSSE, J.; GRIMM, D.; WESTPHAL, K.; ULBRICH, C.; MOOSBAUER, J.; POHL, F.; \n\nKOELBL, O.; INFANGER, M.; EILLES, C.; SCHOENBERGER, J. (2009) Radiolabeled \n\nannexin V for imaging apoptosis in radiated human follicular thyroid carcinomas \u2013 is an \n\nindividualized protocol necessary? Nuclear Medicine and Biology, 36:89-98.  \n\n\n\n29 \n\n \n\nGUIMAR\u00c3ES-GOMES, V.; OLIVEIRA-CARVALHO, A.L.; JUNQUEIRA-AZEVEDO, I.L.M.; \n\nDUTRA, D.L.S.; PUJOL-LUZ, M.; CASTRO, H.C.; HO, P.L.; ZINGALI, R.B. (2004) \n\nCloning, characterization and structural analysis of a C-type lectin from Bothrops insularis \n\n(BiL) venom. Archives of Biochemistry and Biophysics, 432:1-11. \n\nHAHN, W.C.; WEINBERG, R.A. (2002) Modelling the molecular circuitry of cancer. Nature \n\nReviews Cancer, 2(5): 331-341. \n\nHAMAKO, J.; SUZUKI, Y.; HAYASHI, N.; KIMURA, M.; OZEKI, Y.; HASHIMOTO, K.; \n\nMATSUI, T. (2007) Amino acid sequence and characterization of C-type lectin purified from \n\nthe snake venom of Crotalus ruber. Comparative Biochemistry and Physiology Part B, \n\n146:299-306.  \n\nHANAHAN, D.; WEINGERG, R.A. (2000) The hallmarks of cancer. Cell, 100:57-70.   \n\nHAVT, A.; TOYAMA, M.H.; NASCIMENTO, N.R.F.; TOYAMA, D.O.; NOBRE, A.C.L.; \n\nMARTINS, A.M.C.M.; BARBOSA, P.S.F.; NOVELLO, J.C.; BOSCHERO, A.C.; \n\nCARNEIRO, E.M.; FONTELES, M.C.; MONTEIRO, H.S.A. (2005) A new C-type animal \n\nlectin isolated from Bothrops pirajai is responsible for the snake venom major effects in the \n\nisolated kidney. The International Journal of Biochemistry &amp; Cell Biology, 37:130-141.   \n\nHIGUCHI, D.A.; BARBOSA, C.M.V.; BINCOLLETO, C.; CHAGAS, J.R.; MAGALH\u00c3ES, A.; \n\nRICHARDSON, M.; SANCHEZ, E.F.; PESQUERO, J.B.; ARAUJO, R.C.; PESQUERO, J.L. \n\n(2007) Purification and characterization of two phospholipases A2 from Bothrops leucurus \n\n(white-tailed-jararaca) snake venom. Biochimie, 89:319-328.  \n\nHIRABAYASHI, J.; KUSUNOKI, T.; KASAI, K. (1991) Complete primary structure of a \n\ngalactose-specific lectin from de venom of the rattlesnake Crotalus atrox homologies with Ca2+ \n\n-dependent-type lectins. The Journal of Biological Chemistry, 266:2320-2326. \n\nINSTITUTO NACIONAL DO C\u00c2NCER (INCA). Estimativa 2010: Incid\u00eancia de c\u00e2ncer no \n\nBrasil. Rio de Janeiro. 2009. p.23-24. Dispon\u00edvel em: \n\n<http:www.inca.gov.br/estimativa/2010/vers\u00e3ofinal.pdf>. Acesso em: 13 Out. 2010. \n\nISLAS, A.A.; TRUJILLO, A.H.S.; VILLAF\u00c1N, O.P.; ROMERO, B.L.B.; BAUMGARTEN, E.H.; \n\nGUTI\u00c9RREZ, V.R.T.; SETI\u00c9N, A.A. (2007) Interference of a hemagglutinant fraction of \n\ncrotalic venom in the adsortion of parainfluenza-3 (PI-3) virus. Veterinaria M\u00e9xico, \n\n38(2):165-175. \n\n\n\n30 \n\n \n\nJAYATI, B.; ARUN, K.G.; BISHNU, P.C. (2005) Purification and molecular characterization of a \n\nsialic acid specific lectin from the phytopathogenic fungus Macrophomina phaseolina. \n\nCarbohydrate Research, 340:1973-1982. \n\nJEBALI, J; BAZAA, A.; SARRAY, S.; BENHAJ, K.; KARBOUL, A.; EL AYEB, M.; \n\nMARRAKCHI, N.; GARGOURI, A. (2009) C-type lectin protein isoforms of Macrovipera \n\nlebetina: cDNA cloning and genetic diversity. Toxicon, 53(2): 228-237.   \n\nJIANG, L.; PENG, L.; ZHANG, Y.; CHEN, J.; ZHANG, D.; LIANG, S. (2009) Expression, \n\npurification and characterization of a group of a lectin-like peptides from the spider \n\nOrnithoctomus huwena. Peptides, 30(4): 669-674. \n\nKASSAB, B.H.; CARVALHO, D.D.; OLIVEIRA, M.A.; BAPTISTA, G.R.; PEREIRA, G.A.G.; \n\nNOVELLO, J.C. (2004) Cloning, expression, and structural analysis of recombinant BJcuL, a \n\nC-type lectin from the Bothrops jararacussu snake venom. Protein Expression and \n\npurification, 35:344-352.  \n\nKASSAB, B.H.; CARVALHO, D.D.; MARANGONI, S.; NOVELLO, J.C. (2001) Characterization \n\nof a hemagglutinating glycoprotein isolated from Bothrops moojeni snake venom. Protein and \n\nPeptide Letters, 8(1): 13-20. \n\nKAWAGISHI, H.; TAKAGI, J.; TAIRA, T.; MURATA, T.; USUI, T. (2001) Purification and \n\ncharacterization of a lectin from the mushroom Mycoleptodonoides aitchisonii. \n\nPhytochemistry, 56:53-58. \n\nKAWSAR, S.M.; MATSUMOTO, R.; FUJII, Y.; YASUMITSU, H.; DOGASAKI, C.; HOSONO, \n\nM.; NITTA, K.; HAMAKO, J.; MATSUI, T.; KOJIMA, N., OZEKI, Y. (2009) Purification and \n\nbiochemical characterization of a D-galactose binding lectin from japanese sea hare (Aplysia \n\nkurodai) eggs. Biochemistry, 74(7): 709-716. \n\nKAWSAR, S.M.; FUJII, Y.; MATSUMOTO, R.; ICHIKAWA, T.; TATENO, H.; \n\nHIRABAYASHI, J.; YASUMITSU, H.; DOGASAKI, C.; HOSONO, M.; NITTA, K.; \n\nHAMAKO, J.; MATSUI, T.; OZEKI, Y. (2008) Isolation, purification, characterization and \n\nglycan-binding profile of a D-galactoside specific lectin from the marine sponge Halichondria \n\nokadai. Comparative Biochemistry and Physiology Part B, 150:349-357. \n\nKAWSAR, S.M.A.; MAMUN, S.M.A.; RAHMAN, S.; YASUMITSU, H.; OZEKI, Y. (2010) \n\nBiological effects of a carbohydrate-binding protein from an Annelid, Perinereis nuntia against \n\n\n\n31 \n\n \n\nhuman and phytopathogenic microorganisms. International Journal of Biological and Life \n\nSciences, 6:44-50.  \n\nKEMPNER, E.S. (2001) Effects of high-energy electrons and gamma rays directly on protein \n\nmolecules. Journal of Pharmaceutical Sciences, 90:1637-1646. \n\nKERR, J.F.R.; WYLLIE, A.H.; CURRIE, A.R. (1972) Apoptosis: A basic biological phenomenon \n\nwith wide-ranging implications in tissue kinetics. British Journal of Cancer, 26:239-257. \n\nKIECHLE, F.L.; ZHANG, X. (2002) Apoptosis: biochemical aspects and clinical implications. \n\nClinica Chimica Acta, 326:27-45. \n\nKILPATRICK, D.C. (2002) Animal lectins: a historical introduction and overview. Biochimica et \n\nBiophysica Acta, 1572:187-197. \n\nKOBATA, A.; AMANO, J. (2005) Altered glycosilation of proteins produced by malignant celss, \n\nand application for the diagnosis and immunotherapy of tumours. Immunology and Cell \n\nBiology, 83: 429-439. \n\nKOH, D.C.; ARMUGAN, A.; JEYASEELAN, K. (2006) Snake venom components and their \n\napplications in biomedicine. Cellular and Molecular Life Science, 63(24): 3030-3041. \n\nKOMORI, Y.; NIKAI, T.; TOHKAI, T.; SUGIHARA, H. (1999) Primary structure and biological \n\nactivity of snake venom lectin (APL) from Agkistrodon p. piscivorus (Eastern cottonmouth). \n\nToxicon, 37:1053-1064. \n\nKOO, B.H.; SOHN, Y.D.; HWANG, K.C.; KIM, D.S.; CHUNG, K.H. (2002) Characterization and \n\ncDNA cloning of halyxin, a heterogeneous three-chain anticoagulant protein from the venom of \n\nAgkistrodon halys brevicaudus. Toxicon, 40:947-957. \n\nKOOPMAN, G.; REUTELINGSPERGER, C.P.; KUIJTEN, G.A.; KEEHNER, R.M.; PALS, S.T.; \n\nVAN OERS, M.H. (1994) Annexin V for flow cytometric detection of phosphatidylserine \n\nexpression on B cells undergoing apoptosis. Blood, 84:1415-1420.  \n\nKROEMER, G. (2003) Mitochondrial control of apoptosis: an introduction. Biochemical \n\nBiophysical and Research Communication, 304:433-435.  \n\nKROEMER, G.; GALLUZZI, L.; BRENNER, C. (2007) Mitochondrial membrane permeabilization \n\nin cell death. Physiology Reviews, 87:99-163 \n\n\n\n32 \n\n \n\nKROEMER, G.; EL-DEIRY, W.S.; GOLSTEIN, P.; PETER, M.E.; VAUX, D.; \n\nVANDENABEELE, P.; ZHIVOTOVSKY, B.; BLAGOSKLONNY, M.V.; MALORNI, W.; \n\nKNIGHT, R.A.; PIACENTINI, M.; NAGATAS, S.; MELINO, G. (2005) Classification of cell \n\ndeath: recommendations of the Nomenclature Committee on Cell Death. Cell Death &amp; \n\nDifferentiation, 2:1463-1467. \n\nKROEMER, G.; POUYSSEGUR, J. (2008) Tumor cell metabolism: cancer\u00b4s Achilles\u00b4hell. Cancer \n\nCell, 13:472-482.    \n\nKUO, W.T.; HO, Y.J.; KUO, S.M.; LIN, F.H.; TSAI, F.J.; CHEN, Y.S.; DONG, G.C.; YAO, C.H. \n\n(2010) Induction of the mitochondria apoptosis pathway by phytohemagglutinin \n\nerythroagglutinating in human lung cancer cells. Annals of Surgical Oncology. In press.  \n\nLAM, S.K.; NG, T.B. (2010) Lectins: production and practical applications. Applied Microbiology \n\nand Biotechnology, 89:45-55. \n\nLAVRIK, I.; GOLKS, A.; KRAMMER, P.H. (2005) Death receptor signaling. Journal of Cell \n\nScience, 118(2): 265-267. \n\nLEE, S.; LEE, S.; SONG, K.B. (2003) Effect of gamma-irradiation on the physicochemical \n\nproperties of porcine and bovine blood plasma proteins. Food Chemistry, 82:521-526. \n\nLEHLE, L.; STRAH, S.; TANNER, W. (2006) Protein glycosylation, conserved from yeast to man: \n\na model organism helps elucidate congenital human diseases. Angewandte Chemie \n\nInternational Edition, 45:6802-6818. \n\nLEVI, S.B.; MARSHAL, B. (2004) Antibacterial resistance worldwide: causes, chalenges and \n\nresponses. Nature Medicine, 10:122-129.  \n\nLI, Y.; LIU, Q.H.; WANG, H.X.; NG, T.B. (2008) A novel lectin with potent antitumor, mitogenic \n\nand HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus \n\ncitrinopileatus. Biochimica et Biophysica Acta, 1780:51-57  \n\nLIMA, D.C.; ABREU, P.A.; FREITAS, C.C.; SANTOS, D.O.; BORGES, R.O.; SANTOS, T.C.; \n\nCABRAL, L.M.; RODRIGUES, C.R.; CASTRO, H.C. (2005) Snake venom: any clue for \n\nantibiotics and CAM?. Evidence-based Complementary and Alternative Medicine, 2(1): 39-\n\n47.  \n\n\n\n33 \n\n \n\nLIN, L.P.; LIN, Q.; WANG, Y.Q. (2007) Cloning, expression and characterization of two C-type \n\nlectins from the venom gland of Bungarus multicinctus. Toxicon, 50:411-419. \n\nLIRA-DA-SILVA, R.M.; NUNES, B.T. (1993) Ophidic accidents by Bothrops leucurus Wagler, \n\n1824 in Bahia, Brazil. Toxicon, 31:143-144. \n\nLIRA-DA-SILVA, R.M. (2009) Bothrops leucurus Wagler, 1824 (Serpentes; Viperidae): natural \n\nhistory, venom and envenomation. Gazeta M\u00e9dica da Bahia, 79(1): 56-65. \n\nLOMONTE, B.; ROJAS, G.; GUTI\u00c9RREZ, J.M.; RAM\u00cdREZ, G. (1990) Isolation of a galactose-\n\nbinding lectin from the venom of the snake Bothrops godmani (Godmann\u00b4s pit viper). Toxicon, \n\n28:75-81 \n\nLU, Q.; NAVDAEV, A.; CLEMETSON, J.M.; CLEMETSON, K.J. (2005) Snake venom C-type \n\nlectins interacting with platelet receptors. Structure-function relationships and effects on \n\nhaemostasis. Toxicon, 45:1089-1098. \n\nLUO, Y.; XU, X.; LIU, X.; LI, J.; SUN, Y.; LIU, Z.; LIU, J.; VAN DAMME, E.; BALZARI, J.; \n\nBAO, J. (2007) A novel mannose-binding tuber lectin from Typhonium divaricatum (L.) Decne \n\n(family Araceae) with antiviral activity against HSV-II and antiproliferative effect on human \n\ncancer cell lines. Journal of Biochemistry and Molecular Biology, 40(3): 358-367. \n\nLUO, J.; SOLIMINI, N.L.; ELLEDGE, S.J. (2009) Principles of cancer therapy: Oncogene and \n\nnon-oncogene addiction. Cell, 136(5): 823-837. \n\nMAGALH\u00c3ES, A.; MAGALH\u00c3ES, H.P.B.; RICHARDSON, M.; GONTIJO, S.; FERREIRA, \n\nR.N.; ALMEIDA, A.P.; SANCHEZ, E.F. (2007) Purification and properties of a coagulant \n\nthrombin-like enzyme from the venom of Bothrops leucurus. Comparative Biochemistry and \n\nPhysiology Part A, 146:565-575. \n\nMANSOUR, M.H.; ABDUL-SALAM, F. (2009) Characterization of fucose-binding lectins in rock-\n\nand mud-dwelling snails inhabiting Kuwait Bay. Immunobiology, 214(1): 77-85. \n\nMARTIM, S.J.; REUTELINGSPERGER, C.P.M.; MACGAHON, A.J.; RADER, J.A.; VAN \n\nSCHIE, R.C.A.A.; LAFACE, D.M.; GREEN, D.R. (1995) Early redistribution of plasma \n\nmembrane phosphatidylserine is a general feature of apoptosis regardless of the initiating \n\nstimulus: inhibition by overexpression of Bcl-2 and Abl. The Journal of Experimental \n\nMedicine, 182:1545-1556. \n\n\n\n34 \n\n \n\nMASTRO, A.M.; HURLEY, D.J.; WINNING, R.K.; FILIPOWSKI, R.; OLGIVIE, M.L.; \n\nGARTNER, T.K. (1986) Mitogenic activity of snake venom lectins. Cell &amp; Tissue Kinetics, \n\n19:557-566. \n\nMATLOW, A.G.; MORRIS, S.K. (2009) Control of antibiotic-resistant bacteria in the office and \n\nclinic. Canadian Medical Association Journal, 180(10): 1021-1024. \n\nMISE, Y.F.; LIRA-DA-SILVA, M.R.; CARVALHO, F.M. (2007) Envenomation by Bothrops in \n\nthe state of Bahia: epidemiological and clinical aspects. Revista da Sociedade Brasileira de \n\nMedicina Tropical, 40(5): 569-573. \n\nMONTEIRO, R.Q.; ZINGALI, R.B. (2002) Bothrojaracin, a proexosite I ligand, inhibits factor Va-\n\naccelerated prothrombin activation. Thrombosis and Haemostasis, 87:288-293. \n\nMOON, S.; SONG, K.B. (2001) Effect of ?-irradiation on the molecular properties of ovalbumin \n\nand ovomucoid and protection by ascorbic acid. Food Chemistry, 74:479-483.   \n\nMORITA, T. (2004) C-type lectin-related proteins from snake venoms. Current Drug Targets, \n\n4(4): 357-373.  \n\nMORITA, T. (2005) Structure-function relationships of C-type lectin-related proteins. \n\nPathophysiology of Haemostasis and Thrombosis, 35:156-159.   \n\nMOURA, M.R.; QUEIROZ, A.F.S.; FOOK, J.M.S.L.L.; DIAS, A.S.F.; MONTEIRO, N.K.V.; \n\nRIBEIRO, J.K.C.; MOURA, G.E.D.D.; MACEDO, L.L.P.; SANTOS, E.A.; SALES, M.P. \n\n(2006) CvL, a lectin from the marine sponge Cliona varians: isolation, characterization and its \n\neffects on pathogenic bacteria and Leishmania promastigotes. Comparative Biochemistry and \n\nPhysiology Part A, 145:517-523. \n\nNAIR, D.G.; FRY, B.G.; ALEWOOD, P.; KUMAR, P.P. (2007) Antimicrobial activity of \n\nomwaprin, a new member of the waprin family of snake venom proteins. Biochemical \n\nJournal, 402:93-104.  \n\nNAKAHARA, S.; OKA, N.; RAZ, A. (2005) On the role of galectin-3 in cancer apoptosis. \n\nApoptosis, 10:267-275. \n\nNIKAI, T.; KATO, S.; KOMORI, Y.; SUGIHARA, H. (2000) Amino acid sequence and biological \n\nproperties of the lectin from the venom of Trimeresurus okinavensis (himehabu). Toxicon, \n\n38:707-711. \n\n\n\n35 \n\n \n\nOGAWA, T.; CHIJIWA, T.; ODA-UEDA, N.; OHNO, M. (2005) Molecular diversity and \n\naccelerated evolution of a C-type lectin-like proteins from snake venom. Toxicon, 45:1-14. \n\nOHKURA, M.; MYASHITA, Y.; NIKAI, T.; SUZUKI, J.; KOMORI, Y.; SUGIHARA, H.; \n\nOHIZUMI, Y. (1996) Properties of Ca++ release induced by puff adder lectin, a novel lectin \n\nfrom the snake Bitis arietans, in sarcoplasmic reticulum. The Journal of Pharmacology and \n\nExperimental Therapeutics, 277(2): 1043-1048. \n\nOLIVEIRA, J.T.A.; MELO, V.M.M.; CAMARA, M.F.L.; VASCONCELOS, I.M.; BELTRAMINI, \n\nL.M.; MACHADO, O.L.T.; GOMES, V.M.; PEREIRA, S.P.; FERNANDES, C.F.; NUNES, \n\nE.P.; CAPISTRANO, G.G.G.; MONTEIRO-MOREIRA, A.C.O. (2002) Purification and \n\nphysicochemical characterization of a cotyledonary lectin from Luetzelburgia auriculata. \n\nPhytochemistry, 61:301-310. \n\nOTT, M.; GOGVADZE, V.; ORRENIUS, S.; ZHIVOTOVSKY, B. (2007) Mitochondria, oxidative \n\nstress and cell death. Apoptosis, 12(5): 913-922. \n\nOZEKI, Y.; MATSUI, T.; HAMAKO, J.; SUZUKI, M.; FUJIMURA, Y.; YOSHIDA, E.; \n\nNISHIDA, S.; TITANI, K. (1994) C-type galactoside-binding lectin from Bothrops jararaca \n\nvenom: comparison of its structure and function with those of botrocetin. Archives of \n\nBiochemstry and Biophysics, 308:306-310. \n\nOZGEN, U.; SAVASAN, S.; BUCK, S.; RAVINDRANATH, Y. (2000) Comparison of \n\nDiOC(6)(3) uptake and annexin V labeling for quantifications of apoptosis in leukemia cells \n\nand non-malignant T lymphocytes from children. Cytometry, 42: 74-78. \n\nPAHARI, S.; BICKFORD, D.; FRY, B.G.; KINI, R.M. (2007) Expression pattern of three-finger \n\ntoxin and phospholipase A2 genes in the venom glands of two sea snakes, Lapemis curtus and \n\nAcalyptophis peronii: comparison of evolution of these toxins in land snakes, sea kraits and sea \n\nsnakes. BMC Evolutionary Biology, 7:175. \n\nPAIVA, P.M.; OLIVA, M.L.; FRITZ, H.; COELHO, L.C.; SAMPAIO, C.A. (2006) Purification \n\nand primary structure determination of two Bowman-Birk type trypsin isoinhibitors from \n\nCratylia mollis seeds. Phytochemistry, 67(6): 545-552.   \n\nPANUNTO, P.C.; SILVA, M.A.; LINARDI, A.; BUZIN, M.P.; MELO, S.E.S.F.C.; MELLO, S.M.; \n\nPRADO-FRANCESCHI, J.; HYSLOP, S. (2006) Biological activities of a lectin from Bothrops \n\njararacussu snake venom. Toxicon, 47:21-31. \n\n\n\n36 \n\n \n\nPEREIRA-BITTENCOURT, M.; CARVALHO, D.D.; GAGLIARDI, A.R.; COLLINS, D.C. (1999) \n\nThe effect of a lectin from the venom of the snake, Bothrops jararacussu, on tumor cell \n\nproliferation. Anticancer Research, 19:4023-4026. \n\nPEUMANS, W.J.; VAN DAMME, E.J. (1995) Lectins as plant defense proteins. Plant Physiology, \n\n109(2): 347-352. \n\nPEUMANS, W.J.; VAN DAMME, E.J. (1998) Plant lectins: specific tools for the identification, \n\nisolation, and characterization of O-linked glycans. Critical Reviews in Biochemistry and \n\nMolecular Biology, 33(3): 209-258. \n\nPEUMANS, W.J.; VAN DAMME, E.J.; BARRE, A.; ROUGE, P. (2001) Classification of plant \n\nlectins in families of structurally and evolutionary related proteins. Advances in Experimental \n\nMedicine and Biology, 491:27-54. \n\nPOHLEVEN, J.; OBERMAJER, N.; SABOTIC, J.; ANZLOVAR, S.; SEPCIC, K.; KOS, J.; \n\nKRALJ, B.; STRUKELJ, B.; BRZIN, J. (2009) Purification, characterization and cloning of a \n\nricin B-like lectin from mushroom Clitocybe nebularis with antiproliferative activity against \n\nhuman leukemic T cells. Biochimica et Biophysical Acta, 1790(3): 173-181.  \n\nPORTER, A.G.; JANICKE, R.U. (1999) Emerging roles of caspase-3 in apoptosis. Cell Death &amp; \n\nDifferentiation, 6(2): 99-104. \n\nPRIANTI JR, A.C.G.; RIBEIRO, W.; LOPES-MARTINS, R.A.B.; LIRA-DA-SILVA, R.J.; \n\nPRADO-FRANCESCHI, J.; RODRIGUES-SIMIONI, L.; CRUZ-HOFLING, M.A.C.; LEITE, \n\nG.B.; HYSLOP, S.; COGO, J.C. (2003) Effect of Bothrops leucurus venom in chick biventer \n\ncervicis preparations. Toxicon, 41:595-603. \n\nR\u00c1DIS-BAPTISTA, G.; MORENO, F.B.M.B.; NOGUEIRA, L.L.; MARTINS, A.M.C.; \n\nTOYAMA, D.O.; CAVADA, B.S.; AZEVEDO, W.F.; YAMANE, T. (2006) Crotacetin, a \n\nnovel snake venom C-type lectin homolog of convulxin, exhibits na unpredictable \n\nantimicrobial activity. Cell Biochemistry and Biophysics, 44:412-423. \n\nRAGHUNATH, D. (2008) Emerging antibiotic resistance in bacteria with special reference to \n\nIndia. Journal Bioscience, 33(4): 593-603. \n\nREDDY, L.; ODHAV, B.; BHOOLA, K.D. (2003) Natural products for cancer prevention: a global \n\nperspective. Pharmacology &amp; Therapeutics, 99:1-13. \n\n\n\n37 \n\n \n\nREED, J.C. (2006) Proapoptotic multidomain Bcl-2/Bax family proteins: mechanisms physiological \n\nroles, and therapeutic opportunities. Cell Death &amp; Differentiation, 13(8): 1378-1386. \n\nREYES-ZURITA, F.J.; RUFINO-PALOMARES, E.E.; LIPI\u00c1\u00d1EZ, J.A.; CASCANTE, M. (2009) \n\nMaslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human \n\ncolon-cancer cells via the mitocondrial apoptotic pathway. Cancer Letters, 273:44-54. \n\nREYNOSO-CAMACHO, R.; DE MEJIA, G.E.; LOARCA-PINA, G. (2003) Purification and acute \n\ntoxicity of a lectin extracted from tepary bean (Phaseolus acutifolius). Food and Chemical \n\nToxicity, 41:21-27. \n\nRICCI, M.S.; ZONG, W.X. (2006) Chemotherapic approaches for targeting cell death pathway. \n\nOncology, 11:342-347. \n\nROJO, M.A.; CITORES, L.; JIMENEZ, P.; FERRERAS, J.M.; ARIAS, F.J.; MENDEZ, E.; \n\nGIRBES, T. (2003) Isolation and characterization of a new d-galactose-binding lectin from \n\nSambucus racemosa L. Protein Peptide Letters, 10:287-293. \n\nS\u00c1, R.A.; NAPOLE\u00c3O, T.H.; SANTOS, N.D.L.; GOMES, F.S.; ALBUQUERQUE, A.C.; \n\nXAVIER, H.S.; COELHO, L.C.B.B.; BIBIER, L.W.; PAIVA, P.M.G. (2008) Induction of \n\nmortality on Nasutitermes corniger (Isoptera, Termitidae) by Myracrodruon urundeuva \n\nheartwood lectin. International Biodeterioration Biodegradation, 62(4): 460-464. \n\nSAAD-HOSSNE, R.; SAAD-HOSSNE, W.; PRADO, R.G. (2004) Efeito de solu\u00e7\u00f5es aquosas de \n\nfenol, \u00e1cido ac\u00e9tico e glicerina sobre o tumor asc\u00edtico de Erlich. Estudo experimental in vitro. \n\nActa Cir\u00fargica Brasileira, 19(1): 56-58.  \n\nSAMPAIO, S.C.; HYSLOP, S.; FONTES, M.R.M.; PRADO-FRANCESCHI, J.; ZAMBELLI, \n\nV.O.; MAGRO, A.J.; BRIGATTE, P.; GUTIERREZ, V.P.; CURY, Y. (2010) Crotoxin: novel \n\nactivities for a classic ?-neurotoxin. Toxicon, 55:1045-1060. \n\nSANCHEZ, E.F.; FREITAS, T.V.; FERREIRA-ALVES, D.L.; VELARDE, D.T.; DINIZ, M.R.; \n\nCORDEITO, M.N.; AGOSTINI-COTTA, G.; DINIZ, C.R. (1992) Biological activities of \n\nvenoms from South American snakes. Toxicon, 30:95-103. \n\nSANCHEZ, E.F.; GABRIEL, L.M.; GONTIJO, S.; GREMSKI, L.H.; VEIGA, S.S.; \n\nEVANGELISTA, K.S.; EBLE, J.A.; RICHARDSON, M. (2007) Structural and functional \n\n\n\n38 \n\n \n\ncharacterization of a P-III metalloproteinase lecurolysin-B, from Bothrops leucurus venom. \n\nArchives of Biochemistry and Biophysics, 408:193-304. \n\nSANTANA, M.A.; SANTOS, A.M.C.; OLIVEIRA, M.E.; OLIVEIRA, J.S.; BABA, E.H.; \n\nSANTORO, M.M.; ANDRADE, M.H.G. (2008) A novel and efficient and low-cost \n\nmethodology for purification of Macrotyloma axillare (Leguminosae) seed lectin. \n\nInternational Journal of Biological Macromolecules, 43:352-358.  \n\nSANTOS, A.F.S.; LUZ, L.A.; ARGOLO, A.C.C.; TEIXEIRA, J.A.; PAIVA, P.M.G.; COELHO, \n\nL.C.B.B. (2009) Isolation of a seed coagulant Moringa oleifera lectin. Process Biochemistry, \n\n44:504-508. \n\nSARRAY, S; VIRGINIE, B.; CALVETE, J.J.; SECCHI, J.; MARVALDI, J.; EL AYEB, M.; \n\nMARRAKCHI, N.; LUIS, J. (2004) Lebectin, a novel C-type lectin from Macrovipera lebetina \n\nvenom, inhibits integrin-mediated adhesion, migration and invasion of human tumour cells. \n\nLaboratory Investigation, 84: 273-581.  \n\nSARRAY, S.; SRAIRI, N.; LUIS, J.; MARVALDI, J.; EL AYEB, M.; MARRAKCHI, N. (2001) \n\nLebecetin, a C-lectin protein from the venom of Macrovipera lebetina that inhibits platelet \n\naggregation and adhesion of cancerous cells. Haemostasis, 31:173-176. \n\nSARRAY, S.; DELAMARRE, E.; MARVALDI, J.; EL AYEB, M.; MARRAKCHI, N.; LUIS, J. \n\n(2007) Lebectin and lebecetin, two C-type lectins from snake venom, inhibit ?5?1 and ?v-\n\ncontaining integrins. Matrix Biology, 26(4): 306-313.  \n\nSARRAY, S.; SIRET, C.; LEHMANN, M.; MARRAKCHI, N.; LUIS, J.; EL AYEB, M.; ANDR\u00c9, \n\nF. (2009) Lebectin increases N-cadherin-mediated adhesion throught PI3K/AKT pathway. \n\nCancer Letters, 285(2): 174-181. \n\nSCHAFFER, C.; MESSNER, P. (2005) The structure of a secondary cell wall polymers: how gram-\n\npositive bacteria stick their cell walls together. Microbiology, 151:643-651. \n\nSEO, J.H.; KIM, J.H.; LEE, J.W.; YOO, Y.C.; KIM, M.R.; PARK, K.S.; BYUN, M.W. (2007) \n\nOvoalbumin modified by gamma irradiation alters its immunological functions and allergic \n\nresponses. International Immunopharmacology, 7:464-472. \n\nSHACTER, E. Q. (2000) Quantification and significance of protein oxidation in biological samples. \n\nDrug Metabolism Reviews, 32:307-326. \n\n\n\n39 \n\n \n\nSHARON, N.; LIS, H. (2002) How Proteins bind carbohydrates: lessons from legume lectins. \n\nJournal of Agricutural and Food Chemistry, 50:6586-6591. \n\nSHARON, N. (2007) Lectins: carbohydrate-specific reagents and biological recognition molecules. \n\nThe Journal of Biological Chemistry, 285(5): 2753-2764. \n\nSHARON, N.; LIS, H. (2004) History of lectins: from hemagglutinins to biological recognition \n\nmolecules. Glycobiology, 14:53-62. \n\nSHARON, E.; SHARON, N.; BEN-TAL, N. (2003) Evolutionary analysis reveals collective \n\nproperties and specificity in the C-type lectin and lectin-like domain superfamily. Structure, \n\nFunction and Genetics, 52:44-55.  \n\nSHAWRANG, P.; NIKKHAH, A.; ZARE-SHAHNEH, A.; SADEGHI, G.; RAISALI, A.A.; \n\nMORADI-SHAHREBABAK, M. (2008) Effects of gamma irradiation on chemical \n\ncomposition and ruminal protein degradation of canola meal. Radiation Physics and \n\nChemistry, 77: 918-922. \n\nSHIVIK, J.A. (2006) Are vultures birds and to snakes have venom, because of macro-and \n\nmicroscavenger conflict? Bioscience, 56:819-823. \n\nSILVA, E.F.; RICHARDSON, M.; GOMES, M.V.; SANCHEZ, E.F. (2007) Biochemical \n\nproperties of a L-amino acid oxidase from Bothrops leucurus (white-tailed-jararaca) snake \n\nvenom. Comparative Biochemistry and Physioloy Part A, 148:S103-S108. \n\nSILVA JR.; ALEXANDRE, G.M.C.; RAMOS, C.H.I.; DE-SIMONE, S.G. (2008) On the \n\nquaternary structure of a C-type lectin from Bothrops jararacussu venom \u2013 BJ-32 (BJcuL). \n\nToxicon, 52:944-953. \n\nSILVA, M.D.C.; S\u00c1, R.A.; NAPOLE\u00c3O, T.H.; GOMES, F.S.; SANTOS, N.D.L.; \n\nALBUQUERQUE, A.C.; XAVIER, H.S.; PAIVA, P.M.G.; CORREIA, M.T.S.; COELHO, \n\nL.C.B.B. (2009) Purified Cladonia verticillaris lichen lectin: insecticidal activity on \n\nNasutitermes corniger (Isoptera: Termitidae). International Biodeterioration &amp; \n\nBiodegradation, 63(3): 334-340. \n\nSINGH, R.S.; BHARI, R.; TIWARY, A.K. (2010) Optimization of culture conditions, partial \n\npurification and characterization of a new lectin from Aspergillus nidulans. Romanian \n\nBiotecnology Letters, 15(1): 4990-4999. \n\n\n\n40 \n\n \n\nSOBRAL, A.P.V.; REGO, M.J.B.M.; CAVALCANTI, C.L.B.; CARVALHO-JR, L.B.; BELTR\u00c3O, \n\nE.I.C. (2010) ConA and UEA-I lectin histochemistry of parotid gland mucoepidermoid \n\ncarcinoma. Journal of Oral Science, 52(1): 49-54, 2010. \n\nSOUZA, F.A.D.; SPENCER, P.J.; ROGERO, J.R.; NASCIMENTO, N.; DAL PAI-SILVA, M.; \n\nGALLACI, M. (2002) 60Co gamma irradiation prevents Bothrops jararacussu venom \n\nneurotoxicity and myotoxicity in isolated mouse neuromuscular junction. Toxicon, 40:1101-\n\n1106.     \n\nSPELLBERG, B.; GUIDOS, R.; GILBERT, D.; BRADLEY, J.; BOUCHER, H.W.; SCHELD, \n\nW.M.; BARTLETT, J.G.; JR, J.E. (2008) The epidemic of antibiotic-resitant infections: a call \n\nto action for the medical community form the infectious diseases society of America. Clinical \n\nInfectious Diseases, 46(2): 155-164.   \n\nSTRYER, LUBERT. Bioqu\u00edmica. 5a ed. Rio de Janeiro: Guanabara Koogan, 2004, 999p. \n\nSUN, J.; WANG, L.; GUO, Z.; LIU, M.; JIANG, K.; TAO, R.; ZHANG, G. (2008) Purification and \n\ncharacterization of a natural lectin from the plasma of the shrimp Fenneropenaeus chinensis. \n\nFish &amp; Shellfish Imunnology, 25:290-297. \n\nSUZUKI-INOUE, K.; FULLER, G.I.; GARCIA, A.; EBLE, J.A.; POHLMANN, S.; INOUE, O.; \n\nGARTNER, T.K.; HUGHAN, S.C.; PEARCE, A.C.; LAING, G.D.; THEAKSTON, R.D.; \n\nSCHWEIGHOFFER, E.; ZITZMANN, N.; MORITA, T.; TYBULEWICZ, V.I.; OZAKI, Y.; \n\nWATSON, S.P. (2006)  A novel Syk-dependent mechanism of platelet activation by the C-type \n\nlectin receptor CLEC-2. Blood, 107:542-549. \n\nTALAN, D.A.; CITRON, D.M.; OVERTURF, G.D.; SINGER, B.; FROMAN, P.; GOLDSTEIN, \n\nE.J. (1991) Antibacterial activity of crotalid venoms against oral snake flora and other clinical \n\nbacteria. Journal of Infections Diseases, 164:195-198. \n\nTATENO, H.; OGAWA, T.; MURAMOTO, K.; KAMIYA, H.; SANEYOSHI, M. (2002) \n\nRhamnose-binding lectins from Steelhead trout (Oncorhynchus mykiss) eggs recognize \n\nbacterial lipopolysaccarides and lipoteichoic acid. Bioscience Biotechnology and \n\nBiochemistry, 66(3): 604-612. \n\nTRABI, M.; SCHIRRA, H.J.; CRAIK, D.J. (2001) Three-dimensional structure of RTD-1, a cyclic \n\nantimicrobial defensin from Rhesus macaque leukocytes. Biochemistry, 40:4211-4221. \n\n\n\n41 \n\n \n\nTENOVER, F.C. (2006) Mechanisms of antimicrobial resistance in bacteria. The American \n\nJournal of Medicine, 119(6): 53-510. \n\nTINARI, A.; GIAMMARIOLI, A.M.; MANGANELLI, V.; CIARLO, L.; MARLONI, W. (2008) \n\nAnalyzing morphological and ultraestructural features in cell death. Methods Enzimology, \n\n442:1-26.   \n\nVAREJ\u00c3O, N.; ALMEIDA, S.M.; CICCO, N.N.T.; ATELLA, G.C.; COELHO, L.C.B.B.; \n\nCORREIA, M.T.S.; FOGUEL, D. (2010) Heterologous expression and purification of a \n\nbiologically active legume lectin from Cratylia mollis seeds (CRAMOLL 1). Biochimica et \n\nBiophysica Acta, 1804(9): 1971-1924. \n\nVAZ, A.F.M.; COSTA, R.M.P.B.; MELO, A.M.M.A.; OLIVA, M.L.V.; SANTANA, L.A.; \n\nSILVA-LUCCA, R.A.; COELHO, L.C.B.B.; CORREIA, M.T.S. (2010) Biocontrol of \n\nFusarium species by a novel lectin with low ecotoxicity isolated from Sebastiana jacobinenses. \n\nFood Chemistry, 119(4): 1507-1513. \n\nVERMES, I.; HAANEN, C.; STEFFENS-NAKKEN, H.; REUTELINGSPERGER, C. (1995) A \n\nnovel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early \n\napoptotic cells using fluorescein labeled annexin V. Journal Imunnology Methods, 184:39-\n\n51. \n\nWALKER, J.R.; NAGAR, B.; YOUNG, N.M.; HIRAMA, T.; RINI, J.M. (2004) X-ray crystal \n\nstructure of a galactose-specific C-type lectin possessing a novel decameric quaternary \n\nstructure. Biochemistry, 43:3783-3792. \n\nWANG, W.J. (2008) Agglucetin, a tetrameric C-type lectin-like venom protein regulates \n\nendhotelial cell survival and promotes angiogenesis by activating integrin ?v?3 signaling. \n\nBiochemical and Biophysical Research Communications, 369:753-760. \n\nWANG, Y.; HING, J.; LIU, X.; YANG, H.; LIU, R.; WU, J.; WANG, A.; LIN, D.; LAI, R. (2008) \n\nSnake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS ONE, \n\n3:e3217. \n\nWANG, N.; WHANG, I.; LEE, J. (2008) A novel C-type lectin from abalone, Haliotis discus \n\ndiscus, agglutinates Vibrio alginolyticus. Developmental and Comparative Immunology, \n\n32:1034-1040.  \n\n\n\n42 \n\n \n\nWEI, Q.; LU, Q.M.; JIN, Y.; LI, R.; WEI, J.F.; WANG, W.Y.; XIONG, Y.L. (2002) Purification \n\nand cloning of a novel C-type lectin-like protein with platelet aggregation activity from \n\nTrimeresurus mucrosquamatus venom. Toxicon, 40:1331-1338. \n\nWEIS, W.; DRICKAMER, K. (1996) Structural basis of lectin-carbohydrate recognition. Annual \n\nReview of Biochemistry, 65:441-473. \n\nWONG, J.H.; NG, T.B. (2003) Purification of a trypsin-stable with antiproliferative and HIV-1 \n\nreverse transcriptase inhibitory activity. Biochemical and Biophysical Research \n\nCommunications, 301:545-550. \n\nWORLD HEALTH ORGANIZATION. Policies and managerial guidelines for national cancer \n\ncontrol programs. Geneva: WHO, 2002, 366-370p. \n\nWORLD HEALTH ORGANIZATION. Global strategy for containment of antimicrobial resistance. \n\nGeneva: WHO, 2007, 105p. \n\nXU, Q.; WU, X.F.; XIA, Q.C.; WANG, K.Y. (1999) Cloning of a galactose-binding lectin from the \n\nvenom of Trimeresurus stejnegeri. Biochemical Journal, 341:733-737.  \n\nXU, G.; TENG, M.; NIU, L.; LIU, P.; DONG, Y.; LIU, Q.; HUANG, Q.; HAO, Q. (2004) \n\nPurification, characterization, crystallization and preliminary X-ray crystallographic analysis of \n\ntwo novel C-type lectin-like proteins: AaII and AaII-B from Deinagkistrodon acutus venom. \n\nBiological Crystallography, 60:2035-2037. \n\nXU, W.T.; WANG, X.W.; ZHANG, ZHAO, X.F.; YU, X.Q.; WANG, J.X. (2010) A new C-type \n\nlectin (FcLec5) from the Chinese white shrimp Fenneropenaeus chinensis. Amino Acids, \n\n39(5): 1227-1239. \n\nYAN, Q.; ZHU, L.; KUMAR, M.; JIANG, Z.; HUANG, L. (2010) Characterization of a novel \n\nmonomeric lectin (AML) from Astragalus membranaceus with anti-proliferative activity. Food \n\nChemistry, 122(3): 589-595. \n\nYAO, Q.; WU, C.F.; LUO, P.; XIANG, X.C.; LIU, J.J.; MOU, L.; BAO, J.K. (2010) A new chitin-\n\nbinding lectin from rizhome of Setcreasea purpurea with antifungal, antiviral and apoptosis-\n\ninducing activities. Process Biochemistry, 45(9): 1477-1485. \n\n\n\n43 \n\n \n\nYE, X.Y.; NG, T.B. (2002) Isolation of a new cyclophilin-like protein from chickpeas with \n\nmitogenic, antifungal and anti-HIV-1 reverse transcriptase activities. Life Science, 70:1129-\n\n1138. \n\nZANG, J.; TENG, M.; NIU, L. (2003) Purification, crystallization and preliminary crystallographic \n\nanalysis of AHP IX-bp, a zinc ion and pH-dependent coagulation factor IX binding protein \n\nfrom Agkistrodon halys pallas venom. Acta Crystallographic D, 59:730-733. \n\nZBIKOWSKA, H.M.; NOWAK, P.; WACHOWICZ, B. (2006) Protein modification caused by a \n\nhigh of gamma irradiation in cryo-sterilized plasma: protective effects of ascorbate. Free \n\nRadical Biology &amp; Medicine, 40:536-542. \n\nZELENSKY, A.N.; GREADY, J.E. (2005) The C-type lectin-like domain superfamily. FESB \n\nJournal, 272:6179-6217. \n\nZHANG, Z.T.; PENG, H.; LI, C.Y.; LIU, J.J.; ZHOU, T.T.; YAN, Y.F.; LI, Y.; BAO, J.K. (2010) \n\nPolygonatum cyrtonema lectin induces murine fibrosarcoma L929 cell apoptosis via caspase-\n\ndependent pathway as compared to Ophionpogon japonicus lectin. Phytomedicine, 18:25-31.  \n\nZHAO, Q.; CAO, X.;WANG, C.; YAN, L.; XU,C. (2010) Musca domestica larva lectin induces \n\napoptosis in BEL-740 through a mitochondria-mediated reactive oxygen species. Biological &amp; \n\nPharmaceutical Bulletin, 33(8): 1274-1278. \n\nZHENG, P.; WANG, H.; ZHAO, J.; SONG, L.; QIU, L.; DONG, C.; WANG, B.; GAI, Y.; MU, C.; \n\nLI, C.; NI, D.; XING, K. (2008) A lectin (CfLEC-2) aggregating Staphylococcus haemolyticus \n\nfrom scallop Chlamys farreri. Fish &amp; Shelfish Immunology, 24:286-293. \n\nZIEGLER, U.; GROSCRURTH, P. (2004) Morphological features of cell death. News Physiology \n\nScience, 12:124-128. \n\nZORNING, M.; HUEBER, A.; BAUM, W.; EVAN, G. (2001) Apoptosis regulators and their role \n\nin tumorigenesis. Biochimica et Biophysical Acta, 1551:1-37. \n\n \n\n \n\n \n\n \n\n\n\n44 \n\n \n\n5 ARTIGO CIENT\u00cdFICO I \n\n \n\n \n\n \n\n \n\n \n\n \n\nPurification of a lectin with antibacterial activity from Bothrops leucurus snake \nvenom \n\n \n\n \n\nArtigo submetido ao peri\u00f3dico Comparative Biochemistry and Physiology - Part B: \n\nBiochemistry &amp; Molecular Biology \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n45 \n\n \n\nErika dos Santos Nunesa,*, Mary Angela Aranda de Souzaa, Ant\u00f4nio Fernando de Melo Vaza, \n\nGiselly Maria de S\u00e1 Santanaa, Francis Soares Gomesa, Luana Cassandra Breitenbach Barroso \n\nCoelhoa, Patr\u00edcia Maria Guedes Paivaa, Rejane Maria Lira da Silvab, Rosemeire Aparecida Silva-\n\nLuccac,e, Maria Luiza Vilela Olivac, Miriam Camargo Guarnierid, Maria Tereza dos Santos Correiaa \n\n  \na\nDepartamento de Bioqu\u00edmica, Universidade Federal de Pernambuco, Avenida Professor Moraes \n\nR\u00eago, s/n, Cidade Universit\u00e1ria, 50670-420, Recife, Pernambuco, Brazil \n\nb\nDepartamento de Zoologia, Universidade Federal da Bahia, Rua Bar\u00e3o de Geremoabo, s/n, \n\nCampus de Ondina, 40170-210, Salvador, Bahia, Brazil.  \n\nc\nDepartamento de Bioqu\u00edmica, Universidade Federal de S\u00e3o Paulo, Rua Tr\u00eas de Maio, 100, Vila \n\nClementino, 04044-020, S\u00e3o Paulo, Brazil.\n \n\nd\nDepartamento de Zoologia, Universidade Federal de Pernambuco, Avenida Professor Moraes \n\nR\u00eago, s/n, Cidade Universit\u00e1ria, 50670-420, Recife, Pernambuco, Brazil. \n\ne\nCentro de Engenharias e Ci\u00eancias Exatas, Universidade Estadual do Oeste do Paran\u00e1, Rua da \n\nFaculdade, 645, Jardim La Salle, 85903-000, Toledo, Paran\u00e1, Brazil. \n\n \n\n*Corresponding author. Phone: +558121268540; Fax: +558121268576  \n\nE-mail address: erika.santosnunes@hotmail.com  \n\n \n\nABSTRACT  \n\nA novel lectin was isolated from Bothrops leucurus snake venom using a combination of affinity \n\nand gel filtration chromatographies. The lectin (BlL) agglutinated glutaraldehyde-treated rabbit and \n\nhuman erythrocytes with preference for rabbit erythrocytes. Galactose, raffinose, lactose, fetal \n\nbovine serum and casein inhibited lectin-induced rabbit erythrocyte agglutination. BlL, with a \n\nmolecular mass of 30 kDa and composed of two subunits of 15 kDa, showed dependence on \n\ncalcium. BlL is an acidic protein with highest activity over the pH range of 4.0-7.0 and stable under \n\nheating to 70 \u00b0C. Fluorescence emission spectra showed tryptophan residues partially buried within \n\nthe lectin structure. The percentages of secondary structure revealed by circular dichroism were 1% \n\n?-helix, 44% ?-sheet, 24% ?-turn and 31% unordered. BlL showed effective antibacterial activity \n\n\n\n46 \n\n \n\nagainst Gram-positive bacteria Staphylococcus aureus, Enterococcus faecalis and Bacillus subtilis \n\nwith minimal inhibitory concentrations of 31.25, 62.25 and 125 \u00b5 g/mL, respectively. In conclusion, \n\nB. leucurus snake venom contains a galactoside-binding lectin with antibacterial activity.  \n\n \n\nKeywords: antibacterial activity; fluorescence; circular dichroism; Bothrops leucurus; lectin; snake \n\nvenom. \n\n \n\n1. Introduction \n\n Lectins are proteins or glycoproteins that bind reversibly to carbohydrates and \n\nglycoconjugates (De-Simone et al., 2006). Lectins have been found in a wide range of organisms \n\nfrom microorganisms to plants and animals (Utarabhand et al., 2007). C-type lectins are a large \n\nfamily of Ca2+ dependent lectins. Animal C-type lectins can be classified into 17 groups according \n\nto structural and functional characteristics (Zelensky and Gready, 2005). Snake venoms contain C-\n\ntype lectins included in group VII, which are true sugar-binding lectins composed by homodimers \n\nor homooligomers and with Ca2+ and generally galactose binding properties (Clemetson, 2010). \n\nSnake venoms also contain C-type lectin-like proteins which are heterodimers or oligomeric \n\ncomplexes of heterodimers called snaclecs (snake venom C-type lectins); this group is more \n\nabundant and possesses a loop-swapping or higher order multimerization (Ogawa et al., 2005; \n\nClemetson et al., 2009; Clemetson, 2010).  Snake venom lectins are able to inhibit or activate \n\nspecific platelet membrane receptors and blood coagulation factors (Morita, 2004, 2005; Ogawa et \n\nal., 2005; Wang, 2008) and can promote a diversity of biological effects, such as lymphocyte \n\nproliferation (Mastro et al., 1986), induction of edema (Lomonte et al., 1990; Panunto et al., 2006), \n\ninduction of Ca2+ release from the sarcoplasmic reticulum (Ohkura et al., 1996), inhibition of cancer \n\ncell proliferation (Pereira-Bittencourt et al., 1999), erythrocyte agglutination in vitro (Kassab et al., \n\n2001), cytotoxicity to tumors and endothelial cell lines (Carvalho et al., 2001), renal effects (Havt et \n\nal., 2005) and induction of rolling of leukocytes (El\u00edfio-Esposito et al., 2007).  \n\nGlycoconjugates present on bacterial cell surfaces, such as peptidoglycans, \n\nlipopolysaccharides and teichoic acids, constitute potential lectin targets (Lee et al., 1998; Santi-\n\nGadelha et al., 2006). Recently, it was reported that snake venom lectins are able to inhibit growth \n\nof phytopathogenic bacteria (R\u00e1dis-Baptista et al., 2006; Barbosa et al., 2010); however, the \n\ninteractions between snake venom lectins and human pathogenic bacteria have not been studied. \n\nBothrops leucurus (white-tailed-jararaca) is an important venomous snake that inhabits \n\nnortheastern Brazil. B. leucurus was responsible for all cases of envenoming after snakebite \n\n\n\n47 \n\n \n\nrecorded in the metropolitan region of Salvador (State of Bahia, northeastern Brazil) from January \n\nto June 1990 (Lira-da-Silva and Nunes, 1993) and an epidemiological study in Bahia in 2001 \n\nrevealed that this species was responsible for all confirmed cases of envenoming by Bothrops \n\nspecies in this state (Mise et al., 2007). Recently, active components from B. leucurus venom were \n\nisolated, including a fibrinolytic proteinase (Bello et al., 2006), a thrombin-like enzyme (Magalh\u00e3es \n\net al., 2007), phospholipase A2 (Higuchi et al., 2007), a P-III metalloproteinase (Sanchez et al., \n\n2007), L-amino acid oxidases (Silva et al., 2007; Torres et al., 2010) as well as the \n\nmetalloproteinases leucurolysin-a (Gremski et al., 2007; Ferreira et al., 2009) and BleucMP (Gomes \n\net al., 2011). \n\nThis paper reports the purification, characterization and antibacterial activity of a novel \n\ngalactoside-binding lectin isolated from snake venom of B. leucurus, a species with great medical \n\nimportance in northeastern Brazil. \n\n \n\n2. Material and Methods \n\n \n\n2.1. Chemicals \n\nReference samples of 4.4'-Bis 1-anilinonaphthalene 8-sulfonate (bis-ANS) were purchased \n\nfrom Molecular Probes Inc., USA. Broad-range protein molecular mass markers, sugars and \n\nglycoproteins were purchased from Sigma-Aldrich (USA). All the solvents and other chemicals \n\nused were of analytical grade from Sigma-Aldrich (USA) or Merck (Germany). All solutions were \n\nprepared with water purified by the Milli-Q\u00ae system (Millipore). \n\n \n\n2.2. B. leucurus venom \n\nB. leucurus venom was kindly supplied by the N\u00facleo Regional de Ofiologia e Animais \n\nPe\u00e7onhentos da Bahia, Universidade Federal da Bahia, Salvador, Bahia, Brazil. \n\n \n\n \n\n \n\n\n\n48 \n\n \n\n2.3. Protein content  and  neutral carbohydrate analysis  \n\nProtein concentration was determined according to Bradford (1976) using bovine serum \n\nalbumin as a standard. Neutral carbohydrate content was determined by the phenol-sulphuric acid \n\nmethod (Dubois et al., 1956) using a mannose as a standard. \n\n \n\n2.4. Hemagglutinating activity and carbohydrate specificity \n\nHemagglutinating activity (HA) was assessed in microtiter plates according to Correia and \n\nCoelho (1995) using rabbit and human A, B, AB and O-type erythrocyte suspensions (2.5% v/v; 50 \n\n\u00b5 L) treated with glutaraldehyde (Bing et al., 1967). HA was defined as the lowest lectin \n\nconcentration able to promote erythrocyte agglutination. Specific hemagglutinating activity (SHA) \n\ncorresponded to the ratio between HA and protein concentration (mg). Carbohydrate binding \n\nspecificity was evaluated by determining HA in the presence of sugars (D-galactose, D-glucose, D-\n\nfructose, D-lactose, D-mannose, methyl-?-D-glucopyranoside, D-arabinose, L-rhamnose methyl-?-\n\nD-mannopyranoside, N-acetyl-D-glucosamine, D-xylose and L-raffinose) and glycoproteins \n\n(asialofetuin, casein, fetuin and fetal bovine serum). \n\n \n\n2.5. Purification of B. leucurus venom lectin \n\nLyophilized B. leucurus venom (30 mg) was dissolved in 1 mL of calcium-Tris-buffered \n\nsaline buffer (CTBS; 20 mM Tris-HCl, 150 mM NaCl and 5 mM CaCl2, pH 7.5) and centrifuged \n\n(2000 g, 5 min, 25\u00b0C) to remove insoluble material. The resulting supernatant was applied to a \n\ncolumn (10 x 1.0 cm) of guar gel previously equilibrated with CTBS at a flow rate of 10 mL/h. \n\nProtein elution was monitored by absorbance at 280 nm. After washing to remove unbound \n\nproteins, the adsorbed proteins were eluted from the column with 200 mM galactose in CTBS. \n\nAdsorbed fractions with HA were pooled, dialyzed, lyophilized and applied to a Superdex 75 HR \n\n10/300 GL column coupled to an \u00c4KTATM purifier system (GE Pharmacia). The column was \n\nequilibrated and eluted with 50 mM Tris\u2013HCl buffer (pH 8.0) containing 150 mM NaCl at a flow \n\nrate of 0.5 mL/min; fractions of 1 mL were collected and protein elution was monitored by \n\nabsorbance at 280 nm. Subsequently, active peak from Superdex 75 chromatography (B. leucurus \n\nlectin; BlL) was submitted to reverse-phase chromatography in a C-4 column (Vydac-Protein \n\nPeptide Ultrasphere) performed on an HPLC system (Shimadzu LC-10AD-Tokyo, Japan), with \n\nelution monitored at 280 nm. The column was equilibrated with 0.1% TFA (solvent A) and eluted \n\n\n\n49 \n\n \n\nusing 90% acetonitrile/10% H2O/0.1% TFA (solvent B) in a non-linear gradient, where B = 0% at t \n\n= 5 min, 45% at t = 10 min, 50% at t = 30 min and 100% at t = 35 min.  \n\n \n\n2.6. Effects of divalent ions, pH and temperature on HA \n\nTo evaluate the effect of divalent cations on BlL-induced HA, the lectin was previously \n\ndialyzed against 5 mM EDTA (16 h at 4\u00b0C) followed by 150 mM NaCl (6 h at 4\u00b0C) to eliminate \n\nEDTA. Subsequently, the HA of dialyzed BlL was evaluated in the presence of 50, 100 and 200 \n\nmM Ca2+, Mn2+ or Mg2+ in 150 mM NaCl. The effects of pH and temperature on HA were evaluated \n\nby incubating (45 min at 25\u00b0C) of BlL in selected buffers (10 mM citrate phosphate, pH 4.0-6.0; 10 \n\nmM sodium phosphate, pH 7.0; 10 mM Tris-HCl, pH 8.0-9.0) or after heating (30 min) at 30, 40, \n\n50, 60, 70, 80, 90 and 100\u00b0C. \n\n \n\n2.7. Polyacrylamide gel electrophoresis (PAGE) \n\nBlL was evaluated by native PAGE for basic [15% (w/v) gel] or acidic [15% (w/v) gel] \n\nproteins according to Reisfeld et al. (1962) and Davis (1964), respectively. Electrophoresis in the \n\npresence of SDS and ?-mercaptoethanol was performed on 15% (w/v) gel according to Laemmli \n\n(1970). Polypeptide bands were stained with Coomassie Brilliant Blue in 10% acetic acid (0.02%, \n\nv/v). Glycoprotein staining was performed using the periodic acid-Schiff method (Zacharius et al., \n\n1969). \n\n \n\n2.8. Analysis of polypeptide chains \n\nPolypeptide chain analyses were performed after reduction of disulfide bridges and \n\nalkylation. Lyophilized samples were reduced by the Friedman reaction  (Friedman et al., 1970) \n\nwith some modifications: BlL (0.5 mg) was dissolved in 250 \u00b5 L of a solution containing 50 mM \n\nTris\u2013HCl, pH 8.6, 6 M urea, 10 mM EDTA and 179 mM DTT; the mixture was incubated for 3 h at \n\n37\u00b0C in the dark before N2 purging. Free sulphydryl groups were then exposed to 100 \u00b5 L of \n\niodoacetate and the reaction continued for another 2 h under the same initial conditions. Iodoacetate \n\nderivative chains were desalted and separated by HPLC on a reverse-phase C4 column with the \n\nelution profile monitored at 280 nm.  \n\n\n\n50 \n\n \n\n2.9. Fluorescence spectroscopy  \n\nIntrinsic fluorescence emission of BlL in solution (0.07 mg/mL in 10 mM phosphate buffer \n\npH 7.0) was measured at 25\u00b0C using a spectrofluorimeter (JASCO FP-6300, Tokyo, Japan) and a \n\ncuvette (1-cm pathlength rectangular quartz). The excitation wavelengths were 280 and 295 nm; \n\nemission spectra were recorded at a range of 305 to 450 nm with band passes of 5 nm.  \n\n \n\n2.10. Circular dichroism (CD) measurements \n\nCD measurements were carried out on a J-810 JASCO spectropolarimeter. The instrument \n\nwas calibrated with D-10-camphorsulfonic acid. The measurement was carried out at 25\u00b0C with a \n\nprotein concentration of a 0.250 mg/mL (8 \u00b5 M) in a 1 mm pathlength cuvette. C spectrum was \n\nrecorded at the 191-250 nm range as an average of eight scans. The results were expressed as the \n\nmean residue ellipticity, [?], defined as [?]= ?obs/(10.C.l.n.), where ?obs is the CD in millidegrees, C \n\nis the protein concentration (M), l is the pathlength of the cuvette (cm) and n is the number of amino \n\nacid residues assuming a mean number of 272 residues. The CDPro software was used to estimate \n\nthe fractions of secondary structures (Sreerama and Woody, 2000) and the Cluster program was \n\nused to determine tertiary structure class of BlL (Sreerama et. al., 2001).  \n\n \n\n2.11. Antibacterial activity   \n\nGram-positive (Bacillus subtilis ATCC-6633, Staphylococcus aureus ATCC-6538 and \n\nEnterococcus faecalis ATCC-6057) and Gram-negative (Escherichia coli ATCC-25922 and \n\nKlebsiella pneumoniae ATCC-29665) bacterial strains were provided by the Departamento de \n\nAntibi\u00f3ticos, Universidade Federal de Pernambuco, Brazil. Stationary cultures were maintained in \n\nnutrient agar and stored at 4\u00b0C.  \n\nBacteria were cultured in nutrient broth and incubated under continuous shaking at 37\u00b0C \n\novernight. The culture concentrations were turbidimetrically adjusted at 600 nm to 105\u2013106 colony \n\nforming units (CFU)/mL. Purified lectin (BlL) was diluted (1:2048) in a microtiter plate containing \n\nnutrient broth (50 \u00b5 L per well). Subsequently, 20 \u00b5 L of bacterial suspension was applied in each \n\nwell and the plate was incubated at 37\u00b0C for 24 h. After incubation, the optical density at 490 nm \n\n(OD490) was measured using a spectrophotometer for microplates. The assays were performed in \n\ntriplicate. The minimal inhibitory concentration (MIC) corresponded to the lowest lectin \n\n\n\n51 \n\n \n\nconcentration able to inhibit the growth of 50% or more of microorganisms relative to the negative \n\ncontrol (Amsterdam, 1996). Thereafter, aliquots (20 \u00b5 L) of each well in which inhibitory activity \n\nwas observed were transferred to petri plates containing nutrient agar. The plates were incubated at \n\n37\u00b0C for 24 h. The minimal bactericide concentration (MBC) corresponded to the lowest \n\nconcentration of lectin able to reduce the number of CFU to 0.1% relative to the negative control. \n\nAntibacterial activity of BlL was also determined in presence of 200 mM galactose. \n\n \n\n3. Results and Discussion \n\nCrude extract of B. leucurus venom showed high lectin activity (SHA 136.5 units/mg) \n\ntowards rabbit erythrocytes. The inhibition of HA by galactose suggested the presence of a \n\ngalactoside-binding lectin; this result encouraged us to evaluate the use of affinity chromatography \n\non guar gel matrix to purify lectin.  \n\nLectin activity from crude venom adsorbed on guar gel column and only one active (SHA of \n\n29,257) peak was detected after elution with 200 mM galactose (Figure 1A). The use of guar gel \n\nwas an inexpensive and innovative protocol for isolation of a snake venom lectin. Guar gum \n\nconsists of straight chains of mannose substituted with ?(1-6) galactose residues and is a versatile \n\nand viable matrix for the isolation of D-galactopyranosyl- and N-acetyl-galactosaminyl-binding \n\nlectins (Lonngren and Goldstein, 1976; Gupta et al., 1979). Guar gum has been used as an efficient \n\nand inexpensive affinity support for the purification of lectins from Bauhinia monandra leaves \n\n(Coelho and Silva, 2000) and Moringa oleifera seeds (Santos et al., 2009) as well as from the alga \n\nVidalia obtusiloba (Melo et al., 2004).  \n\nThe adsorbed fractions from guar gel affinity chromatography were loaded onto gel \n\nfiltration column (Figure 1B); three peaks can be seen in the chromatographic profile. The lectin (B. \n\nleucurus lectin; BlL) was eluted at 18 mL, corresponding to an apparent molecular weight around 8 \n\nkDa; however, this major peak (SHA 10,240) showed a molecular mass of 30 kDa in SDS-PAGE. \n\nIn the presence of reducing agent ?-mercaptoethanol, BlL was revealed to be a dimeric protein \n\ncomposed of two subunits with a molecular mass of 15 kDa (Figure 1C). Because lectins may \n\ninteract in undesirable ways with Superdex beads, a possible interaction of BlL with the stationary \n\nphase may have affected the retention time and apparent molecular weight of BlL in gel filtration \n\nchromatography as well as may be responsible for the reduction of SHA observed (Table 1).  \n\n\n\n52 \n\n \n\nEvaluation of BlL by native electrophoresis showed a single polypeptide band in PAGE for \n\nacidic proteins (Figure 1C). No polypeptide band was detected in native PAGE for basic proteins. \n\nAs showed by Lomonte et al. (1990) using isoelectric focusing, other snake venom lectins are \n\ncharacterized as acidic proteins. BlL was eluted from C-4 column with about 50% of acetonitrile \n\n(Figure 1D). The reduction and alkylation reactions of BlL were performed using DTT. After \n\ndesalting on the C-4 column, only one peak was obtained (Figure 1E), suggesting the presence of \n\nhomodimeric chains covalently linked by disulfide bridges; this result agrees with that observed in \n\nelectrophoresis. Several lectins from snake venoms are constituted by disulfide-linked homodimers, \n\nsuch as the lectins from Agkistrodon piscivorus piscivorus and Crotalus ruber (Komori et al., 1999; \n\nHamako et al., 2007). However, the crystal structure of a galactoside-binding lectin from Crotalus \n\natrox revealed a decameric structure composed of two 5-fold symmetric pentamers (Walker et al., \n\n2004). \n\nTable 1 summarizes the BlL purification. The amount of protein recovered after gel \n\nfiltration chromatography was less than 1%. The content of BlL in snake venom (&lt;1%) was similar \n\nto those found for other lectins isolated from snake venoms (Ogilvie et al., 1986; Lomonte et al., \n\n1990; Carvalho et al., 1998; Nikai et al., 2000; Guimar\u00e3es-Gomes et al., 2004). \n\nTable 1 \n\nSummary of B. leucurus lectin (BlL) purification   \n\n \n\nSample \n\n \n\nProtein (mg) \n\n \n\nTotal HAa \n\n \n\nSHA (HA/mg) \n\n \n\nPurification (fold)b \n\n \n\nCrude venom \n\n \n\n30 \n\n \n\n4,096 \n\n \n\n136.5 \n\n \n\n1 \n\nAffinity chromatography 0.21 6,144 29,257 214.3 \n\nGel filtration 0.1 1,024 10,240 75 \naHemagglutinating activity (HA) with rabbit erythrocytes. SHA: specific HA (ratio between HA and \n\nprotein content). bPurification fold corresponds to the ratio between SHA of BlL and SHA of crude \n\nvenom. The data corresponds to one purification process. \n\n \n\nThe HA of BlL was abolished after treatment with the chelating agent EDTA (5 mM); Mn2+ \n\nand Mg2+  did not restore BlL HA but the activity was gradually increase by addition of Ca2+ and \n\ncompletely restored when this ion was added at 200 mM (Figure 1F); this result indicates that Ca2+ \n\nis essential for the carbohydrate-recognizing property of BlL. The homodimeric structure and \n\n\n\n53 \n\n \n\ncalcium dependence indicate that BlL may be included in the group of true galactoside-binding \n\nlectins from snake venoms and did not belong to the group of snaclecs described by Clemetson et \n\nal. (2009). Several other lectins isolated from snake venoms are dependent on calcium (Ozeki et al., \n\n1994; Kassab et al., 2001; Guimar\u00e3es-Gomes et al., 2004; Clemetson, 2010). However, this \n\nstatement can only be confirmed after N-terminal sequencing and homology studies. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 1. (A) Purification of BlL by affinity chromatography of B. leucurus venom (30 mg of protein) \n\non a guar gel column. Elution with CTBS buffer (-?-) followed by 200 mM D-galactose (-?-; \n\narrow). Specific hemagglutinating activity (SHA, -?-). (B) Purification of BlL by chromatography \n\nin Superdex 75 column coupled to an \u00c4KTA purifier system. (C) SDS-PAGE of BlL. (MW) \n\nmolecular weight markers; BlL under non-reducing (lane 1) or reducing conditions (lane 2); \n\n\n\n54 \n\n \n\nelectrophoresis under native conditions for acidic proteins (lane 3). (D) Reverse phase HPLC on a \n\nC4 column. (E) BlL chain separation after desalting on a C4 column. The column was equilibrated \n\nwith 0.1% TFA (solvent A) and eluted using 90% acetonitrile/10% H2O/0.1% TFA (solvent B) in a \n\nnon-linear gradient, where B = 0% at t = 5 min, 45% at t = 10 min, 50% at t = 30 min and 100% at t \n\n= 35 min. (F) Hemagglutinating activity (HA) of EDTA-treated BlL after addition of Ca2+ in \n\ndifferent concentrations. \n\n \n\nBlL was not detected by glycoprotein staining using periodic acid-Schiff\u00b4s reagent and no \n\ncarbohydrate was detected using the phenol-sulphuric acid method. The absence of carbohydrate \n\nmoiety was also reported for lectins from the snakes Bothrops atrox, Lachesis muta, Dendroaspis \n\njamesonii, and Bothrops jararacussu (Gartner et al., 1980; Gartner and Ogilvie, 1984; Ogilvie et al. \n\n1986; Carvalho et al., 2002). BlL recognized the structure of saccharides comprising the surface of \n\nerythrocyte membranes since it agglutinated glutaraldehyde-treated erythrocytes from rabbits (SHA \n\n10,240) and human types A, B and O (SHA of 320, 320 and 160, respectively). The difference in \n\nerythrocyte agglutination, depending on cell type (A, B, AB and O) and species of origin, may be \n\ndue to the presence of different glycoproteins on the erythrocyte surface. Similar to other lectins \n\nfrom snakes, HA of BlL was abolished in the presence of galactose, lactose and raffinose (Table 2), \n\nindicating that that BlL is a galactoside-binding protein. Inhibition assays revealed that BlL was \n\npartially inhibited by fetal bovine serum and casein, but not by fetuin and asialofetuin (Table 2). \n\nCasein is a protein with a small carbohydrate fraction and contains phosphorus in its structure \n\n(Roman and Sgarbieri, 2005). Two N-glycosidic carbohydrate complex-type rich in galactose are \n\npresent in the structure of ?-fetoprotein, a protein found in fetal bovine serum (Krusius and \n\nRuoslahti, 1982); the presence of galactose may be responsible for inhibition of BlL in presence of \n\nfetal bovine serum. The results indicate that BlL recognizes complex glycoproteins. \n\n   \n\n \n\n \n\n \n\n \n\n \n\n\n\n55 \n\n \n\nTable 2 \n\nInhibition of hemagglutinating activity of BlL by carbohydrates and glycoproteins \n\nInhibitor Minimal inhibitory concentrationa \n\nD-galactose 0.78 \n\nD-lactose 1.56 \n\nL-raffinose 1.56 \n\nD-glucose 12.5 \n\nN-acetyl-D-glucosamine NI \n\nD-arabinose NI \n\nD-mannose NI \n\nD-fructose NI \n\nD-xylose NI \n\nL-rhamnose NI \n\nMethyl-?-D-mannopyranoside NI \n\nMethyl-?-D-glucopyranoside NI \n\nAsialofetuin NI \n\nFetuin NI \n\nCasein 0.25 \n\nFetal bovine serum 0.25 \n\nAssays were performed with rabbit erythrocytes and in triplicate. aMinimal inhibitory concentration \n\ncorresponds to lowest carbohydrate and glycoproteins concentrations able to inhibit HA of BlL. \n\nHighest carbohydrates and glycoproteins concentrations used were 200 mM and 0.5 mg/mL, \n\nrespectively. NI indicates that no inhibition was detected. SHA of BlL in absence of sugars or \n\nglycoproteins: 10,240.  \n\n\n\n56 \n\n \n\nBlL HA was heat-stable up to 70\u00b0C, with total loss of activity after heating to 80\u00b0C \n\nindicating that HA depends on BlL native conformation. The HA of BlL was not affected at a pH \n\nrange of 4.0 to 7.0, unlike Bothrops jararacussu lectin, which was more active in neutral pH (El\u00edfio-\n\nEsposito et al., 2007). The intrinsic protein fluorescence spectra of BlL (Figure 2A) revealed a \n\nsingle major peak at 344 nm. Tryptophan residues exposed to water show a maximal fluorescence \n\nemission at wavelengths around 340-350 nm whereas completely buried residues fluoresce at about \n\n330 nm. The displacement of the mass center of the aromatic residues indicates partially buried \n\nhydrophobic domains within the lectin structure. C-type lectins are usually a dimer of two identical \n\npolypeptides, each containing two tryptophan residues and one tyrosine residue (Morita, 2005). The \n\nindividual subunits are able to bind carbohydrates but for the lectin-like function they need at least \n\nbivalency, which is achieved through a simple interchain disulfide linkage. Although dimerization \n\nis essential, the two tryptophan residues and the tyrosin are essential to stabilize intra-subunit \n\ncontacts and for biological activities in C-type lectins (Doyle and Kini, 2009). \n\nThe CD spectrum of BIL (Figure 2B) indicated that BlL possessed a large amount of ?-sheet \n\nstructure, characterized by a maximum at approximately 195 nm and a minimum at the range 216-\n\n220 nm (Venyaminov and Yang, 1996). Analysis of the secondary structure content using CDPro \n\nsoftware yielded following results: 1.0% ?-helix, 44% ?-sheet, 24% ?-turn, 31% unordered \n\nstructures and an RMS (root-mean-square) of 2.0%. Cluster analysis classified BlL as a ?-class \n\nprotein (proteins containing mainly ? structure), corroborated by results of CDPro analysis (68% ? \n\nstructures). The secondary structure content of BlL was similar to that determined for Lachesis \n\nmuta snake venom lectin (Arag\u00f3n-Ort\u00edz et al., 1989); however, the majority of lectins from snake \n\nvenoms belong to the ?+? class, such as the C-type lectin from B. jararacussu venom which \n\npossesses 18.8% ?-helix and 32.2% ?-sheet (Silva Jr. et al., 2008). \n\n \n\n\n\n57 \n\n \n\n \n\nFig.2. (A) Intrinsic fluorescence emission of BlL excited at 280 nm (---) and 295 nm (\u2014). (B) CD \n\nspectrum of BIL in 50 mM phosphate buffer, pH 7.2, at 25\u00b0C. Measurements are the average of \n\neight scans using a solution containing 0.25 mg of protein/mL. CD spectrum deconvolution using \n\nCDPro software calculated 1% ?-helix, 44% ?-sheet, 24% ?-turn, 31% unordered structures and an \n\nRMS of 2%. \n\n \n\nIn the present study, antibacterial assays demonstrated that BlL exhibited antibacterial \n\neffects against the human pathogenic Gram-positive bacteria S. aureus, E. faecalis and B. subtilis. \n\nMinimal inhibitory (MIC) and minimum bactericidal (MBC) concentrations were determined for \n\nBlL (Table 3). The lectin was not effective against Gram-negative bacteria E. coli and K. \n\npneumoniae. A possible reason for the difference in susceptibility is the difficulty that BlL \n\nencounters in crossing the outer cell wall of Gram-negative bacteria to reach the periplasmic space. \n\nBlL may interact with the peptidoglycan present in Gram-positive bacteria cell wall while the lectin \n\nmay not be able to bind peptidoglycans of Gram-negative bacteria whether it does not enter in the \n\nperiplasmic space. BlL showed absence of antimicrobial activity in presence of 200 mM galactose \n\nassuring that the antibacterial effect involves the carbohydrate-binding property of lectin. MIC \n\nvalues of BlL against S. aureus and E. faecalis show the clinical relevance of lectin since these \n\nconcentrations are below the range of 64-100 \u00b5 g/mL (Gibbons, 2004). The MBC of BlL against B. \n\nsubtilis (250 \u00b5 g/mL) was lower than that (500 \u00b5g/mL) described for Phthirusa pyrifolia leaf lectin \n\n(Costa et al., 2010). \n\n\n\n58 \n\n \n\nThe MBC for bactericidal drugs is generally the same or not more than four-fold higher than \n\nthe MIC. In contrast, the MBC of bacteriostatic drugs are many-fold higher than their MIC \n\n(Levison, 2004). The term tolerant is applied to bacterial strains which growth stops in the presence \n\nan antimicrobial concentration but do not rapidly die leading to high values of MBC (Charpentier \n\nand Tuomanen, 2000). On the basis of MBC/MIC ratio, S. aureus showed to be tolerant to BlL \n\nsince the MBC was 15.8-fold greater than MIC (Ishida et al., 1982). On the other hand, Canillac and \n\nMourey (2001) reported that if the MBC/MIC ratio was found to be less than or equal to 4, the \n\nbacteria were considered to be susceptible. Therefore, B. subtilis was susceptible to BlL. Recently, \n\nTorres et al. (2010) showed that Bothrops leucurus total venom (BleuTV) inhibited the growth of S. \n\naureus. Therefore, according to our results we can suggest that BlL is involved in the antibacterial \n\nactivity of the venom.  \n\n \n\nTable 3 \n\nMinimum inhibitory (MIC) and minimum bactericidal concentrations (MBC) of BlL \n\nBacteria MICa MBCa \n\nStaphylococcus aureus (+) 31.5 500 \n\nEnterococcus faecalis (+) 62.5 330 \n\nBacillus subtilis (+) 125 250 \n\nEscherichia coli (-) ND ND \n\nKlebsiella pneumoniae (-) ND ND \n\naMIC and MBC expressed as \u00b5 g/mL of lectin. ND: antibacterial activity not detected at 1000 \n\n\u00b5 g/mL of BlL. Gram-positive (+) and Gram-negative (-) bacteria.  \n\n \n\nIn conclusion, a new galactoside-binding lectin was isolated from B. leucurus venom. BlL \n\nshowed antibacterial activity against human pathogenic Gram-positive bacteria. Further studies are \n\nrequired to determine the mechanisms involved in this bactericidal activity.   \n\n \n\n\n\n59 \n\n \n\nAcknowledgements \n\nThe authors express their gratitude to the Conselho Nacional de Desenvolvimento Cient\u00edfico \n\ne Tecnol\u00f3gico (CNPq) and to the Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior \n\n(CAPES) for research grants. The authors thank Maria Barbosa Reis da Silva and Jo\u00e3o Ant\u00f4nio \n\nVirg\u00ednio for technical assistance, and Scott V. Heald for reviewing the English of the manuscript.  \n\n \n\nReferences \n\nAmsterdam, D., 1996. Susceptibility testing of antimicrobials in liquid media. In: Loman, V. (Ed.), \n\nAntibiotics in Laboratory Medicine. Williams and Wilkins, Baltimore, pp. 52-111. \n\nArag\u00f3n-Ort\u00edz, F., Brenes-Brenes, J.R., Gubensek, F., 1989. Characterization of a lectin-like protein \n\nisolated from Lachesis muta snake venom. Rev. Biol. Trop. 37, 70-83. \n\nBarbosa, P.S.F., Martins, A.M.C., Toyama, M.H., Joazeiro, P.P., Beriam, L.O.S., Fonteles, M.C., \n\nMonteiro, H.S.A., 2010.  Purification and biological effects of a C-type lectin isolated from \n\nBothrops moojeni. J. Venom. Anim. Toxins incl. Trop. Dis. 16, 493-504. \n\nBello, C.A., Herm\u00f3genes, A.L., Magalh\u00e3es, A., Veiga, S.S., Gremski, L.H., Richardson, M., \n\nSanchez, E.F., 2006. Isolation and biochemical characterization of a fibrinolytic proteinase \n\nfrom Bothrops leucurus (white-tailed-jararaca) snake venom. Biochimie 88, 189-200. \n\nBing, D.H., Weyand, J.G., Stavitsky, A.B., 1967. Hemagglutination with aldehyde-fixed \n\nerythrocytes for assay of antigens and antibodies. Proc. Soc. Exp. Biol. Med. 124, 1166-\n\n1170. \n\nBradford, M.M., 1976. A rapid and sensitive method for the quantification of microgram quantities \n\nof protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. \n\nCanillac, N., Mourey, A., 2001. Antibacterial activity of the essential oil of Picea excelsa on \n\nListeria, Staphylococcus aureus and coliform bacteria. Food Microbiol. 18, 261-268. \n\nCarvalho, D.D., Marangoni, S., Oliveira, B., Novello, J.C., 1998. Isolation and characterization of a \n\nnew lectin from the venom of the snake Bothrops jararacussu. Biochem. Mol. Biol. Inter. \n\n44, 933-938. \n\n\n\n60 \n\n \n\nCarvalho, D.D., Schmitmeier, S., Novello, J.C., Markland, F.S., 2001. Effect of BJcuL (a lectin \n\nfrom the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and \n\nendothelial cells. Toxicon 39, 1471-1476.  \n\nCarvalho, D.D., Marangoni, S., Novello, J.C., 2002. Primary structure characterization of Bothrops \n\njararacussu snake venom lectin. J. Protein Chem. 21, 43-50. \n\nCharpentier, E., Tuomanen, E., 2000. Mechanisms of antibiotic resistance and tolerance in \n\nStreptococcus pneumoniae. Microbes Infect. 2, 1855-1864. \n\nClemetson, K.J., Morita, T., Kini, R.M., 2009. Scientific and standardization committee \n\ncommunications: classification and nomenclature of snake venom C-type lectins and related \n\nproteins. J. Thromb. Haemost. 7, 360.  \n\nClemetson, K.J., 2010. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to \n\nreceptors. Toxicon 56, 1236-1246. \n\nCoelho, L.C.B.B., Silva, M.B.R., 2000. Simple method to purify milligram quantities of the \n\ngalactose-specific lectin from leaves of Bauhinia monandra. Phytochem. Anal. 11, 295-300. \n\nCorreia, M.T.S., Coelho, L.C.B.B., 1995.  Purification of a glucose/manose specific lectin, isoform \n\n1, from seeds of Cratylia mollis Mart. (Camaratu bean). Applied Biochem. Biotechnol.  55,  \n\n261-273. \n\nCosta, R.M.P.B., Vaz, A.F.M., Oliva, M.L.V., Coelho, L.C.B.B., Correia, M.T.S., Carneiro-da-\n\nCunha, M.G., 2010. A new mistletoe Phthirusa pyrifolia leaf lectin with antimicrobial \n\nproperties. Process Biochem. 45, 526-533. \n\nDavis, B.J.,1964. Disc electrophoresis. II. Method and application to human serum proteins. Ann. \n\nN. Y. Acad. Sci. 121, 404-427. \n\nDe-Simone, S.G., Netto, C.C., Silva Jr., F.P., 2006. Simple affinity chromatographic procedure to \n\npurify ?-galactoside binding lectins. J. Chromatogr. B 838, 135-138. \n\nDoyle, R., Kini, R.M., 2009. Protein complexes in snake venom. Cell. Mol. Life Sci. 66, 2851-\n\n2871. \n\nDubois, M., Gilles, K.A., Hamilton, J.K., Rebers, P.A., Smith, F., 1956. Colorimetric  method for \n\ndetermination of sugar and related substances. Anal. Chem. 28, 350-356. \n\n\n\n61 \n\n \n\nEl\u00edfio-Esposito, S.L., Hess, P.L., Moreno, A.N., Lopes-Ferreira, M., Ricart, C.A.O., Souza, M.V., \n\nHasselman-Zielinski, F., Becker, J.A., Pereira, L.F., 2007. A C-type lectin from Bothrops \n\njararacussu venom can adhere to extracellular matrix proteins and induce the rolling of \n\nleukocytes. J. Venom. Anim. Toxins incl. Trop. Dis. 13, 782-799. \n\nFerreira, R.N., Rates, B., Richardson, M., Guimar\u00e3es, B.G., Sanches, E.O., Pimenta, A.M., Nagem, \n\nR.A., 2009. Complete amino-acid sequence, crystallization and preliminary X-ray \n\ndiffraction studies of leucurolysin-a, a nonhaemorrhagic metalloproteinase from Bothrops \n\nleucurus snake venom. Acta Crystallogr. Sect. F - Struct. Biol. Cryst. Commun. 65, 798-\n\n801. \n\nFriedman, M., Krull, L.H., Cavins, J.F., 1970. The chromatographic determination of cystine and \n\ncysteine residues in proteins as S-?-(4-pyridylethyl) cysteine.  J. Biol. Chem. 245, 3868-\n\n3871. \n\nGartner, T.K., Ogilvie, M.L., 1984. Isolation and characterization of three Ca2+-dependent beta-\n\ngalactoside-specific lectins from snake venoms. Biochem. J. 224, 301-307. \n\nGartner, T.K., Stocker, K., Williams, D.C., 1980. Thrombolectin: a lectin isolated from Bothrops \n\natrox venom. FEBS Lett. 117, 13-16. \n\nGibbons, S., 2004. Anti-staphylococcal plant natural products. Nat. Prod. Rep. 21, 263-277. \n\nGomes, M.S., de Queiroz, M.R., Mamede, C.C., Mendes, M.M., Hamaguchi, A., Homsi-\n\nBrandeburgo, M.I., Sousa, M.V., Aquino, E.N., Castro, M.S., de Oliveira, F., Rodrigues, \n\nV.M., 2011. Purification and functional characterization of a new metalloproteinase \n\n(BleucMP) from Bothrops leucurus snake venom. Comp. Biochem. Physiol. C, \n\ndoi:10.1016/j.cbpc.2010.11.008 \n\nGuimar\u00e3es-Gomes, V., Oliveira-Carvalho, A.L., Junqueira-de-Azevedo, I.L., Dutra, D.L.S., Pujol-\n\nLuz, M., Castro, H.C., Ho, P.L., Zingali, R.B., 2004. Cloning, characterization and structural \n\nanalysis of a C-type lectin from Bothrops insularis (BiL) venom. Arch. Biochem. Biophys. \n\n432, 1-11. \n\nGupta, K.C., Sahni, M.K., Rathaur, B.S., Narang, C.K., Mathur, N.K., 1979. Gel filtration medium \n\nderived from guar gum. J. Chromatogr. 169, 183-190. \n\n\n\n62 \n\n \n\nHamako, J., Suzuki, Y., Hayashi, N., Kimura, M., Ozeki, Y., Hashimoto, K., Matsui, T., 2007. \n\nAmino acid sequence and characterization of a C-type lectin purified from the snake venom \n\nof Crotalus ruber. Comp. Biochem. Physiol. B 146, 299-306. \n\nHavt, A., Toyama, M.H., do Nascimento, N.R., Toyama, D.O., Nobre, A.C., Martins, A.M., \n\nBarbosa, P.S., Novello, J.C., Boschero, A.C., Carneiro, E.M., Fonteles, M.C., Monteiro, \n\nH.S., 2005. A new C-type animal lectin isolated from Bothrops pirajai is responsible for the \n\nsnake venom major effects in the isolated kidney. Int. J. Biochem. Cell Biol. 37, 130-141. \n\nHiguchi, D.A., Barbosa, C.M.V., Bincoletto, C., Chagas, J.R., Magalh\u00e3es, A., Richardson, M., \n\nSanchez, E.F., Pesquero, J.B., Araujo, R.C., Pesquero, J.L., 2007. Purification and partial \n\ncharacterization of two phospholipases A2 from Bothrops leucurus (white-tailed-jararaca) \n\nsnake venom. Biochimie 89, 319-328. \n\nIshida, K., Guze, P.A., Kalmanson, G.M., Albrandt, K., Guze, L.B., 1982. Variables in \n\ndemonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrob. Agents \n\nChemother. 21, 688-690. \n\nKassab, B.H., Carvalho, D.D., Marangoni, S., Novello, J.C., 2001. Characterization of a \n\nhemagglutinating glycoprotein isolated Bothrops moojeni snake venom. Protein Pept. Lett. \n\n8, 13-20.    \n\nKomori, Y., Nikai, T., Tohkai, T., Sugihara, H., 1999. Primary structure and biological activity of \n\nsnake venom lectin (APL) from Agkistrodon p. piscivorus (Eastern cottonmouth). Toxicon \n\n37, 1053-1064. \n\nKrusius, T., Ruoslahti, E., 1982. Carbohydrate structure of the concanavalin A molecular variants of \n\n?-fetoprotein. J. Biol. Chem. 257, 3453-3457. \n\nLaemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of \n\nbacteriophage T4. Nature 227, 680-685.  \n\nLee, W., La Barca, A.M.C., Drake, D., Doyle, R.J., 1998. Lectin-oral streptococci interactions. J. \n\nMed. Microbiol. 47, 29-37. \n\nLevison, M.E., 2004. Pharmacodynamics of antimicrobial drugs. Infec. Dis. Clin. N. Am. 18, 451-\n\n465. \n\n\n\n63 \n\n \n\nLira-da-Silva, R.M., Nunes, T.B., 1993. Ophidic accidents by Bothrops leucurus Wagler, 1824 in \n\nBahia, Brazil. Toxicon 31, 143-144. \n\nLomonte, B., Rojas, G., Guti\u00e9rrez, J.M., Ram\u00edrez, G., 1990. Isolation of a galactose-binding lectin \n\nfrom the venom of the snake Bothrops godmani (Godmann\u00b4s pit viper). Toxicon 28, 75-81. \n\nLonngren, J., Goldstein, I.J., 1976. Cross-linked guaran: a versatile immunosorbent for D-\n\ngalactopyranosyl binding lectins. FEBS Lett. 68, 31-34. \n\nMagalh\u00e3es, A., Magalh\u00e3es, H.P.B., Richardson, M., Gontijo, S., Ferreira, R.N., Almeida, A.P., \n\nSanchez, E.F., 2007. Purification and properties of a coagulant thrombin-like enzyme from \n\nthe venom of Bothrops leucurus. Comp. Biochem. Physiol. A 146, 565-575. \n\nMastro, A.M., Hurley, D.J., Winning, R.K., Filipowski, R., Ogilvie, M.L., Gartner, T.K., 1986. \n\nMitogenic activity of snake venom lectins. Cell. Tissue Kinet. 19, 557-566. \n\nMelo, F.R., Benevides, N.M.B., Pereira, M.G., Holanda, M.L., Mendes, F.N.P., Oliveira, S.R.M., \n\nFreitas, A.L.P., Silva, L.M.C.M., 2004. Purification and partial characterisation of a lectin \n\nfrom the red marine alga Vidalia obtusiloba C. Agardh. Rev. Bras. Bot. 27, 263-269. \n\nMise, Y.F., Lira-da-Silva, R.M., Carvalho, F.M., 2007. Envenomation by Bothrops in the State of \n\nBahia: epidemiological and clinical aspects. Rev. Soc. Bras. Med. Trop. 40, 569-573.   \n\nMorita, T., 2004. C-type lectin-related proteins from snake venoms. Curr. Drug Targets Cardiovasc. \n\nHaematol. Disord. 4, 357-373. \n\nMorita, T., 2005. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with \n\nanticoagulant-, procoagulant-, and platelet-modulating activities. Toxicon 45, 1099-1114. \n\nNikai, T., Kato, S., Komori, Y., Sugihara, H., 2000. Amino acid sequence and biological properties \n\nof the lectin from the venom of Trimeresurus okinavensis (himehabu). Toxicon 38, 707-711. \n\nOgawa, T., Chijiwa, T., Oda-Ueda, N., Ohno, M., 2005. Molecular diversity and accelerated \n\nevolution of C-type lectin-like proteins from snake venom. Toxicon 45, 1-14. \n\nOgilvie, M.L., Dockter, M.E., Wenz, L., Gartner, T.K., 1986. Isolation and characterization of \n\nlactose-binding lectins from the venoms of the snakes Lachesis muta and Dendroaspis \n\njamesonii. J. Biochem. 100, 1425-1431. \n\n\n\n64 \n\n \n\nOhkura, M., Miyashita, Y., Nikai, T., Suzuki, J., Komori, Y., Sugihara, H., Ohizumi, Y., 1996. \n\nProperties of Ca++ release induced by puff adder lectin, a novel lectin from the snake Bitis \n\narietans, in sarcoplasmic reticulum. J. Pharmacol. Exp. Ther. 277, 1043-1048. \n\nOzeki, Y., Matsui, T., Hamako, J., Suzuki, M., Fujimura, Y., Yoshida, E., Nishida, S., Titani, K., \n\n1994. C-type galactoside-binding lectin from Bothrops jararaca venom: comparison of its \n\nstructure and function with those of botrocetin. Arch. Biochem. Biophys. 308, 306-310. \n\nPanunto, P.C., Silva, M.A., Linardi, A., Buzin, M.P., Melo, S.E., Mello, S.M., Prado-Franceschi, J., \n\nHyslop, S., 2006. Biological activities of a lectin from Bothrops jararacussu snake venom. \n\nToxicon 47, 21-31. \n\nPereira-Bittencourt, M., Carvalho, D.D., Gagliard, A.R., Collins, D.C., 1999. The effect of a lectin \n\nfrom the venom of the snake, Bothrops jararacussu, on tumor cell proliferation. Anticancer \n\nRes. 19, 4023-4025. \n\nR\u00e1dis-Baptista, G., Moreno, F.B., de Lima Nogueira, L., Martins, A.M., Toyama, D.O., Toyama, \n\nM.H., Cavada, B.S., Azevedo, W.F., Yamane, T., 2006. Crotacetin, a novel snake venom C-\n\ntype lectin homolog of convulxin, exhibits an unpredictable antimicrobial activity. Cell. \n\nBiochem. Biophys. 44, 412-423.  \n\nReisfeld, R.A., Lewis, U.J., Williams, D.E., 1962. Disk electrophoresis of basic protein and \n\npeptides on polyacrylamide gels. Nature 195, 281-283. \n\nRoman, J.A., Sgarbieri, V.C., 2005. Obten\u00e7\u00e3o e caracteriza\u00e7\u00e3o qu\u00edmica e nutricional de diferentes \n\nconcentrados de case\u00edna. Rev. Nutr. 18, 75-83. \n\nSanchez, E.F., Gabriel, L.M., Gontijo, S., Gremski, L.H., Veiga, S.S., Evangelista, K.S., Eble, J.A., \n\nRichardson, M., 2007. Structural and functional characterization of a P-III \n\nmetalloproteinase, leucurolysin-B, from Bothrops leucurus venom. Arch. Biochem. \n\nBiophys. 468, 193-204. \n\nSanti-Gadelha, T., de Almeida Gadelha, C.A., Arag\u00e3o, K.S., Oliveira, C.C., Mota, M.R.L., Gomes, \n\nR.C., Pires, A.F., Toyama, M.H., Toyama, D.O., Alencar, N.M.N., Criddle, D.N., Assreuy, \n\nA.M.S., Cavada, B.S., 2006. Purification and biological effects of Araucaria angustifolia \n\n(Araucariaceae) seed lectin. Biochem. Biophys. Res. Commun. 350, 1050-1055. \n\n\n\n65 \n\n \n\nSantos, A.F.S., Luz, L.A., Argolo, A.C.C., Teixeira, J.A., Paiva, P.M.G., Coelho, L.C.B.B., 2009. \n\nIsolation of a seed coagulant Moringa oleifera lectin. Process Biochem. 44, 504-508. \n\nSilva, E.F., Richardson, M., Gomes, M.V., Sanchez, E.F., 2007. Biochemical properties of a L-\n\namino acid oxidase from Bothrops leucurus (white-tailed jararaca). Comp. Biochem. \n\nPhysiol. A 148, S105.  \n\nSilva Jr., F.P., Alexandre, G.M.C., Ramos, C.H.I., De-Simone, S.G., 2008. On the quaternary \n\nstructure of a C-type lectin from Bothrops jararacussu venom \u2013 BJ-32 (BJcuL). Toxicon 52, \n\n944-953. \n\nSreerama, N., Woody, R.W., 2000. Estimation of protein secondary structure from circular \n\ndichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an \n\nexpanded reference set. Anal. Biochem. 287, 252-260. \n\nSreerama, N., Venyaminov, S.Y., Woody, R.W., 2001. Analysis of protein CD spectra with a \n\nreference protein set based on tertiary structure class. Anal. Biochem. 299, 271-274.  \n\nTorres, A.F.C., Dantas, R.T., Menezes, R.R.P.P.B., Toyama, M.H., Filho, E.D., Oliveira, M.F., \n\nNogueira, N.A.P., Oliveira, M.R., Monteiro, H.S.A., Martins, A.M.C., 2010. Antimicrobial \n\nactivity of an L-amino acid oxidase isolated from Bothrops leucurus snake venom. J. \n\nVenom. Anim. Toxins incl. Trop. Dis. 16, 614-622.  \n\nUtarabhand, P., Riitidach, W., Paijit, N., 2007. Bacterial agglutination by sialic acid-specific lectin \n\nin the hemolymph of the banana shrimp, Penaeus (Fenneropenaeus) merguiensis. Sci. Asia \n\n33, 41-46. \n\nVenyaminov, S.Y., Yang, J.T., 1996. Determination of protein secondary conformation. In: \n\nFasman, G.D. (Ed.), Circular dichroism and the conformational analysis of biomolecules. \n\nPlenum. New York, pp. 69-105 \n\nWalker, J.R., Nagar, B., Young, N.M., Hirama, T., Rini, J.M., 2004. X-ray crystal structure of a \n\ngalactose-specific C-type lectin possessing a novel decameric quaternary structure. \n\nBiochem. 43, 3783-3792. \n\nWang, W.J., 2008. Agglucetin, a tetrameric C-type lectin-like venom protein, regulates endothelial \n\ncell survival and promotes angiogenesis by activating integrin ?v?3 sinaling. Biochem. \n\nBiophys. Res. Commun. 369, 753-760. \n\n\n\n66 \n\n \n\nZacharius, R.M., Zell, T.E., Morrison, J.H., Woodlock, J.J., 1969. Glycoprotein staining following \n\nelectrophoresis on acrylamide gels. Anal. Biochem. 30, 148-152. \n\nZelesnky, A.N., Gready, J.E., 2005. The C-type lectin-like domain superfamily. FESB J. 272, 6179-\n\n6217.   \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n67 \n\n \n\n6 ARTIGO CIENT\u00cdFICO II \n\n \n\n \n\n \n\n \n\n \n\nCytotoxic effect and apoptosis induction by Bothrops leucurus venom lectin on \n\ntumor cell lines \n\n \n\nArtigo a ser submetido ao peri\u00f3dico Toxicology in vitro \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n68 \n\n \n\nErika S. Nunesa,*; Mary A.A. Souzaa; Ant\u00f4nio F.M. Vaza; Teresinha G. Silvab; Jaciana S. Aguiarb; \n\nAndr\u00e9 M. Batistac; Maria M.P. Guerrac; Miriam C. Guarnierid; Luana C.B.B. Coelhoa; Maria T.S. \n\nCorreiaa \n\n \na\nDepartamento de Bioqu\u00edmica, CCB, Universidade Federal de Pernambuco, Avenida Professor \n\nMoraes R\u00eago, s/n, Cidade Universit\u00e1ria, 50670-420, Recife, Pernambuco, Brazil \n\nb\nDepartamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Avenida Prof. Arthur de S\u00e1, \n\ns/n, Cidade Universit\u00e1ria, 50670-901, Recife, Pernambuco, Brazil.\n \n\nc\nDepartamento de Medicina Veterin\u00e1ria, Rua Dom Manoel Medeiros, s/n, Dois Irm\u00e3os, 52171-900, \n\nUniversidade Federal Rural de Pernambuco, Recife, Pernambuco, Brazil.\n \n\nd\nDepartamento de Zoologia, CCB, Universidade Federal de Pernambuco, Avenida Professor \n\nMoraes R\u00eago, s/n, Cidade Universit\u00e1ria, 50670-420, Recife, Pernambuco, Brazil. \n\n \n\n*Corresponding author. Phone: +558121268540; Fax: +558121268576.  \n\nE-mail address: erika.santosnunes@hotmail.com  \n\n \n\n \n\nABSTRACT  \n\nNeoplastic transformation results from cell changes that escaped of control mechanisms leading to \n\nan increased growth potential as well as alterations in cell surface and other attributes that give to \n\nthe tumor cells the ability to invade and metastasize. These transformations are often related to \n\nchanges in cell surface glycoconjugates which can be detected by lectins. In this study we evaluated \n\nthe anti-tumor potential of BlL, a galactoside-binding lectin isolated from Bothrops leucurus \n\nvenom. BlL was evaluated for its cytotoxicity using MTT assay against tumor cell lines (K562, \n\nNCI-292 and Hep-2) and hemolysis assay on mice erythrocytes. The annexin-V and JC-1 assays \n\nwere used to determine the phosphatidylserine externalization and mitochondrial membrane \n\npotential in K562 cells, respectively. BlL exhibited cytotoxic activity against all tumor cell lines \n\ntested with IC50 values of 6.63, 11.75 and 15.42 \u00b5 g/mL for Hep-2, NCI-H292 and K562, \n\nrespectively, but was not able to induce hemolysis in mice erythrocytes. BlL treatment induced \n\nphosphatidylserine externalization and mitochondrial depolarization, indicating cell death by \n\n\n\n69 \n\n \n\napoptosis.Our results suggest that BlL has a promising potential for application in cancer therapy \n\nand/or diagnosis. \n\n \n\nKeywords: antitumor activity; apoptosis; Bothrops leucurus; lectin; cytotoxicity; mitochondria.  \n\n \n\n1. Introduction \n\n \n\n Cancer is the second cause of mortality worldwide (Hemalswarya and Doble, 2006) and in \n\nBrazil the estimate for the year 2010 (also valid for 2011) is the occurrence of 489,270 new cases of \n\ncancer (Instituto Nacional do C\u00e2ncer, 2009). Etiologic factors associated with cancer include \n\nimproper diet, genetic predisposition and environment conditions; the majority of human cancers \n\nresult from exposure to environmental carcinogens (Reddy et al., 2003).    \n\nGlycosylation is the most frequent form of post-translational modifications of proteins \n\n(Chen et al., 2007; Rek et al., 2009) and alterations in  the pattern of cell surface glycoconjugates \n\nare remarkable characteristic of malignant cells associated with induction of tissue invasion and \n\nmetastasis (Hakomori, 2002; Kobata and Amano, 2005; Reis et al., 2010). Due to their peripheral \n\nlocation, oligosaccaride epitopes of glycoproteins and glycolipids are recognized by membrane-\n\nanchored carbohydrate-recognition domains of different molecules, including lectins (Jim\u00e9nez-\n\nCastells et al., 2008).  \n\nLectins comprise proteins or glycoproteins which bind specifically to mono or \n\noligosaccharides and glyconconjugates (Wu et al., 2009). Carbohydrate-specificity of lectins has \n\nbeen shown to be a versatile and useful molecular tool for study of glycoconjugates on cell surface, \n\nin particular the changes that cells suffer in malignancy (Sharon and Lis, 2004). Thus, lectins are \n\nexcellent candidates to be explored in cancer research as therapeutics agents.  \n\nLectins from snake venoms exhibit several biological activities like ability to inhibit \n\nintegrin-dependent proliferation, migration and invasion of tumor cells (Sarray et al., 2004; Sarray \n\net al., 2007) as well as to reduce the growth of tumor and endothelial cells (Carvalho et al., 2001). \n\nHowever, the induction of tumor cell apoptosis by snake venom lectins has not been studied.  \n\nThe BlL is a lectin isolated from the venom of Bothrops leucurus (white-tailed-jararaca). \n\nBlL is a Ca2+-dependent and galactoside-binding protein of 30 kDa composed by dissulfide-linked \n\ndimers of 15 kDa and exhibits antibacterial activity against human pathogenic Gram-positive \n\nbacteria (Nunes et al., 2011).  \n\n\n\n70 \n\n \n\nApoptosis (programmed cell death) is an essential cellular homeostasis mechanism that \n\nensures the correct development and function of multi-cellular organisms. However, cancer cells \n\nshow a reduced sensitivity towards apoptosis and tumors are dependent on the mechanisms of this \n\nresistance to continue alive. Therefore, it is of enormous therapeutic interest the discovery of drugs \n\nthat selectively affect the balance of tumor cellular functions towards apoptosis. According \n\nTaraphdar et al. (2001), induction of apoptosis is an important strategy for cancer therapy and \n\nprevention.  \n\nThe aims of this study were to evaluate the in vitro cytotoxicity of BlL on different human \n\ntumor cell lines (K562, NCI-292 and Hep-2), its lytic property on mouse erythrocytes and its ability \n\nto induce apoptosis in human tumor cells.     \n\n  \n\n2. Material and Methods \n\n \n\n2.1. Chemicals \n\nPhosphate buffered saline (PBS), penicillin, streptomycin and DMEM (Dulbecco\u2019s Modified \n\nEagle\u2019s Medium) were purchased from GibcoTM. MTT (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-\n\n2H-tetrazolium bromide) was purchased from InvitrogenTM. Eposide (Etoposide) was purchased \n\nfrom Blausiegel. Fetal bovine serum, glutamine, Triton X-100 and JC-1 (5,5?,6,6?-Tetrachloro-\n\n1,1?,3,3? tetraethylbenzimidazolocarbocyanine iodide) were  purchased from Sigma-Aldrich\u00ae. \n\nAnnexin V FITC Apoptosis Kit was purchased from Calbiochem. DMSO (Dimethil sulfoxide) was \n\npurchased from Vetec. \n\n \n\n2.2. BlL purification \n\nBlL was purified according to the protocol previously described by Nunes et al. (2011). \n\nLyophilized crude venom of B. leucurus (30 mg) was dissolved in 1 mL of CTBS buffer (20 mM \n\nTris-HCl, 150 mM NaCl and 5 mM CaCl2, pH 7.5) and centrifuged (2000 g, 5 min, 25 \u00b0C) to \n\nremove insoluble material. The resulting supernatant was applied to a column (10 x 1.0 cm) of guar \n\ngel previously equilibrated with CTBS at a flow rate of 10 mL/h. BlL was eluted from the column \n\nwith 200 mM galactose in CTBS. \n\n \n\n\n\n71 \n\n \n\n2.3. Cell lines and cell culture \n\nThe cell lines used in cytotoxicity assays were K562 (chronic myelocytic leukemia), NCI-\n\nH292 (human lung mucoepidermoid carcinoma cells) and Hep-2 (human larynx epidermoid \n\ncarcinoma cells) obtained from Instituto Adolfo Lutz (S\u00e3o Paulo, Brazil). The cells were maintained \n\nin DMEM supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/mL penicillin and \n\n100 \u00b5 g/mL streptomycin and maintained at 37 \u00b0C with 5 % CO2.  \n\n \n\n2.4. MTT assay \n\nCytotoxicity of BlL was tested on K562, NCI-H292 and Hep-2 tumor cell lines. The cells \n\n(105 cells/mL for adherent cells or 0.3x106 cells/mL for suspended cells) were plated in 96-well \n\nmicrotiter plates and after 24 h, BlL (0.07\u201350 \u00b5 g/mL) dissolved in DMSO was added to each well \n\nand incubated for 72 h  at 37 \u00b0C.  Then, MTT (5.0 mg/mL) was added to the plate and growth of \n\ntumor cells was estimated by the ability of living cells to reduce the yellow tetrazolium to a blue \n\nformazan product (Mosmann, 1983; Alley et al., 1988). Negative control groups received only \n\nDMSO; etoposide (1.25\u201320 \u00b5 g/mL) was used as positive control. After 3 h (for suspend cells) or 2 \n\nh (for adherent cells), the formazan product was dissolved in DMSO and absorbance was measured \n\nusing a multi-plate reader (Multiplate Reader Thermoplate). The BlL effect was quantified by \n\nmeasuring the absorbance at 450 nm resulting from MTT reduction. The results were compared \n\nwith negative control absorbance and the values of 50% inhibition of cell proliferation (IC50) were \n\ncalculated. \n\n \n\n2.5. Hemolytic assay \n\nAssay was performed in 96-well microtiter plates according to the method described by \n\nCosta-Lotufo et al. (2002). Each well received 100 \u00b5 L of 0.85% NaCl solution containing 10 mM \n\nCaCl2. The first well was the negative control and contained only the vehicle (10 % DMSO). To the \n\nsecond well, 100 \u00b5 L of BlL (10\u20132000 \u00b5 g/mL) were added and serial dilution was performed until \n\n1:1024. Positive control used 20 \u00b5 L of 0.1% Triton X-100 (in 0.85% NaCl) to obtain 100% \n\nhemolysis. Then, each well received 100 \u00b5 L of a 2 % suspension of mice (Mus musculus) \n\nerythrocytes in 0.85 % NaCl containing 10 mM CaCl2. After incubation at 28 \u00baC for 30 min and \n\ncentrifugation, the supernatant was removed and the haemoglobin released by hemolysis was \n\ndetermined by measurement of absorbance at 450 nm.  \n\n\n\n72 \n\n \n\n2.6. Annexin/PI cell death assay   \n\nThe K562 suspension (0.3 x 106 cells/mL) was seeded in 96-well microtiter plates and \n\nincubated at 37 \u00b0C at 5 % CO2 for 24 h; after this period, BlL at IC50 was added. After 48 h the cells \n\nwere stained with annexin V and propidium iodide using Annexin V\u2013FITC Kit (Calbiochem\u00ae) \n\nfollowing the protocol provided by the manufacturer and analysed by epifluorescence  microscope \n\n(Carl Zeiss, Gottingen, Germany) with increase of 1000x under oil immersion with filters for LP \n\n515 nm emission and BP 450-490 nm for excitement. A minimum of 200 cells was counted in \n\nevery sample. \n\n \n\n2.7. Measurement of mitochondrial membrane potential \n\nMitochondria depolarization was evaluated by incorporation of JC-1 (5,5\u00b4,6,6\u00b4-tetrachloro-\n\n1,1\u00b4,3,3\u00b4-tetraethilbenzimidazolcarbocyanine iodide), a fluorescent lipophilic cationic probe (Kang \n\net al., 2002; Guthrie and Welch, 2006). The probe JC-1 is freely permeable to cells and undergoes \n\nreversible transformation from a monomer to an aggregate form (Jagg). K562 suspension (0.3 x 10\n6 \n\ncells/mL) was seeded into 96-well microtiter plates and incubated at 37 \u00b0C and 5 % CO2; after 24 h, \n\nBlL at IC50 was added and plates incubated for 48 h. Then, 50 \u00b5 L of treated cell suspension were \n\ncollected and incubated with JC-1 (10 \u00b5 L/mL) for 30 min in the dark followed by washing two \n\ntimes with PBS. The cells were fixed with paraformaldehyde 4% (10 \u00b5 L), mounted on glass slides \n\nand observed using an epifluorescence microscope (Carl Zeiss, Gottingen, Germany), with increase \n\nof 1000x under oil immersion with filter for LP 515 nm emission and BP 450-490 nm excitement. \n\nA minimum of 200 cells was counted in every sample. Cells with high potential of mitochondrial \n\nmembrane were stained in red while cells with low membrane potential were stained in green. \n\n    \n\n2.8. Statistical analysis \n\nAll data are presented as mean \u00b1 S.D. The IC50 and EC50 values were obtained by nonlinear \n\nregression with 95% confidence interval using the SigmaPlot software (Systal Software Inc., San \n\nJose, USA). The differences between experimental groups were determined using one-way analysis \n\nof variance (ANOVA) followed by Newman-Keuls test at significance level of 1%.  \n\n \n\n\n\n73 \n\n \n\n3. Results     \n\n \n\nCytotoxicity of BlL on tumor cell lines was evaluated after 72 h using MTT assay and the \n\nresults are presented in Table 1. BlL exhibited cytotoxic activity against all cell lines with IC50 \n\nvalues of 6.63, 11.75 and 15.42 \u00b5 g/mL for Hep-2, NCI-H292 and K562, respectively. \n\n \n\nTable 1 \n\nCytotoxic activity of BlL against tumor cell lines. \n\nIC50 (\u00b5 g/mL) Sample \n\nHep-2 NCI-H292 K562 \n\nBlL 11.75\u00b10.035 6.63\u00b10.052 15.42\u00b10.060 \n\nEtoposide 6.10\u00b10.19 2.75\u00b10.10 4.48\u00b10.23 \n\nThe IC50 values at 95% confidence interval were obtained by non linear regression. Etoposide was \n\nused as positive control. \n\n \n\nIn order to verify whether the cytotoxicity was related to injury of cell plasma membrane, \n\nBlL was tested for lytic activity on mice erythrocytes. The results showed that it does not cause \n\nmembrane damage even at the upper concentration (2000 \u00b5 g/mL).   \n\nThe involvement of apoptosis induction on K562 death was verified by evaluation of \n\nphosphatidylserine externalization using the Annexin V-FITC kit and fluorescence microscope. We \n\nobserved that after treatment with BlL (15.42 \u00b5 g/mL), the number of cells in early apoptosis (Ann \n\nVpos/PIneg) corresponded to 70.5% (Figure 1). Treatment with BlL exhibited values less than 1% of \n\nlate apoptotic cells (AnnVpos/PIpos) and values less than 2% of cell necrosis (AnnVneg/PIpos). \n\n \n\n \n\n \n\n \n\n\n\n74 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 1. Effect of BlL in K562 cell population determined by fluorescence microscopy using \n\nAnnexin V\u2013FITC Kit, after 48 h incubation. The negative control (NC) was the vehicle used \n\n(DMSO). Etoposide was used as positive control (E). *p &lt;0.01 in comparison to control by \n\nANOVA followed by Newman Keulls test. Data are presented as mean \u00b1 S.D. from three \n\nindependent experiments. \n\n \n\nFigure 2 shows that the treatment of K562 cells with BlL caused mitochondrial membrane \n\npotential loss, as fluorescence microscopy analysis determined that BlL treatment induced \n\nsignificant increase in cells with depolarized mitochondria (63.8%) as compared to control cells, as \n\nmeasured by JC-1 incorporation.     \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 2. Effect of BlL in K562 cell population determined by fluorescence microscopy using JC-1, \n\nafter 48 h incubation. The negative control (NC) was the vehicle used (DMSO). Etoposide was used \n\nas positive control (E). *p &lt;0.01 in comparison to control by ANOVA followed by Newman \n\nKeulls test. Data are presented as mean \u00b1 S.D. from three independent experiments. \n\n0\n\n10\n\n20\n\n30\n\n40\n\n50\n\n60\n\n70\n\nNC E BlL\n\nM\nit\n\no\nc\nh\n\no\nn\n\nd\nr\nia\n\nl \nD\n\ne\np\n\no\nla\n\nri\nza\n\nti\no\n\nn\n (\n\n%\n)\n\n*\n*\n\n0\n\n10\n\n20\n\n30\n\n40\n\n50\n\n60\n\n70\n\nNC E BlL\n\nM\nit\n\no\nc\nh\n\no\nn\n\nd\nr\nia\n\nl \nD\n\ne\np\n\no\nla\n\nri\nza\n\nti\no\n\nn\n (\n\n%\n)\n\n*\n*\n\n0\n\n10\n\n20\n\n30\n\n40\n\n50\n\n60\n\n70\n\n80\n\n90\n\nNC E BlL\n\nC\ne\n\nll\n n\n\nu\nm\n\nb\ne\n\nr \n(%\n\n)\n\nVi a bl e Apoptos i s Ne cros i s\n\n*\n\n*\n\n*\n\n*\n\n0\n\n10\n\n20\n\n30\n\n40\n\n50\n\n60\n\n70\n\n80\n\n90\n\nNC E BlL\n\nC\ne\n\nll\n n\n\nu\nm\n\nb\ne\n\nr \n(%\n\n)\n\nVi a bl e Apoptos i s Ne cros i s\n\n*\n\n*\n\n*\n\n*\n\n\n\n75 \n\n \n\n4. Discussion \n\nUncontrolled proliferation and decreased apoptotic signals are attributes of oncogenic \n\ntransformation (Hill et al., 2003), and activation of apoptosis constitutes a fundamental mechanism \n\nby which drugs may kill tumor cells (Debatin, 2004). Therefore, compounds with the ability to \n\ninduce apoptosis in tumor have potential for anticancer agents (Reed, 2003).  \n\nMTT assay demonstrated that BlL showed significant cytotoxic effect against human tumor \n\ncell lines Hep-2, NCI-H292 and K562 indicating that the activity of this lectin was not specific to a \n\nparticular tumor cell type. However, different IC50 values were determined for the lectin revealing a \n\ndifferent cytotoxic activity on the different cell lines. Glycoconjugates or saccharides present on the \n\nsurface of tumor cells are binding sites for lectins (Luo et al., 2007) and differences in sugar pattern \n\nbetween different tumor cells may be a reason for the differential effect of BlL. Differences in the \n\neffect snake venom lectins towards human tumor cell lines have been reported (Pereira-Bittencourt \n\net al., 1999; Carvalho et al., 2001). In addition, cells that not express specific carbohydrates may be \n\ninsensitive to cytotoxic lectins (Gorelik et al., 2001).  \n\nThe presence of 10% fetal bovine serum in culture medium did not exert any effect in \n\ncytotoxicity induced by BlL on tumor cell lines. Pereira Bittencourt et al. (1999), studying the \n\naction of C-type lectin from Bothrops jararacussu (BJcuL) on the proliferation of human cancer \n\ncell lines, observed marked toxicity in presence of 5% fetal bovine serum, however incubation with \n\n10% fetal bovine serum decreased the inhibitory activity of BJcuL lectin by approximately 50%. \n\nThe lectin BJcul was highly cytotoxic to OVCAR-5 cells in the presence of 5% fetal bovine serum \n\nand has no inhibitory effect on cell growth when 10% fetal bovine serum was used (Carvalho et al., \n\n2001). One possible explanation for this is that fetal bovine serum contains specific sugars that \n\ninhibit the cytotoxic action of BJcuL. Our results suggest that fetal bovine serum contains a low \n\namount of glycoligands specific for BlL in comparison with BJcuL.  \n\nDespite their cytotoxic action, BlL was inactive against erythrocytes of mice, suggesting that \n\nthe cytotoxic mechanism is not related to lytic property or induction of membrane instability by \n\nBlL. \n\nMorphological and biochemical characteristics of apoptosis are nuclear chromatin \n\ncondensation, DNA fragmentation, membrane blebbing (Okada and Mak, 2004; Vermeulen et al., \n\n2005), externalization of phosphatidylserine (Hengartner, 2000) and depolarization of the \n\nmembrane potential (Ly et al. 2003). In this study, apoptosis induction in BlL-treated K562- cells \n\n\n\n76 \n\n \n\nwas assessed by fluorescence microscopy analysis of phosphatidylserine externalization on cell \n\nsurface and mitochondrial membrane potential.        \n\nThe loss of plasma membrane asymmetry represents and early event of apoptosis resulting \n\nin translocation of phosphatidylserine from the inner to the outer surface while membrane integrity \n\nremains unchanged (Van Engeland et al., 1998, Fadok et al., 2000; Kagan et al., 2000); this \n\nexternalization provides the recognition and removal of apoptotic cells by phagocytes \n\n(Zimmermann et al., 2001; Taylor et al., 2008). The phospholipid-binding protein annexin V has a \n\nhigh affinity for phosphatidylserine and binds to cells fluorescently labeled with FITC (Reyes-\n\nZurita et al., 2009). However, translocation de phosphatidylserine also occurs during necrosis, so \n\npropidium iodide is often used to bind to nucleic acids (Gong et al., 2007). We observed by staining \n\nwith annexin V-FITC simultaneously with dye propidium iodide that BlL was able to increase \n\nsignificantly the number of apoptotic cells. The results suggest that the cytotoxic effect is due to \n\ninduction of apoptosis in K562 cells.  \n\nThe mitochondrial apoptotic pathway is one of the major routes to initiate apoptosis (Kuo et \n\nal., 2010). Different stimuli cause changes in the inner mitochondrial membrane leading to the \n\nopening of the mitochondrial permeability transition pore, loss of the mitochondrial transmembrane \n\npotential (Ly et al., 2003; Saelens et al., 2004) and pro-apoptotic proteins release from the \n\nintermembrane space into the cytosol (Mayer and Oberbauer, 2003; Borutaite, 2010). One of these \n\nproteins is the cytochrome C which triggers the formation of the apoptosome complex culminating \n\nwith the activation of caspases (Gogvadze et al., 2009). \n\nThe loss of mitochondrial membrane potential is the early change in the mitochondria-\n\nmediated apoptosis (Zhao et al., 2010). Our studies demonstrated that treatment with BlL increased \n\nmitochondrial membrane potential loss, which may indicate cell death by apoptosis in K562 cells. \n\nSome lectins such as Con A, POL, PCL and MLL may cause disruption of the mitochondrial \n\nmembrane potential as an event associated with apoptosis (Liu et al., 2009a; Liu et al., 2009b; Liu \n\net al., 2009c; Zhao et al., 2010). \n\nIn conclusion, the galactoside-binding lectin from B. leucurus snake venom (BlL) exhibited \n\ncytotoxic activity on tumor cells and induced apoptosis in K562 cells, as verified by \n\nphosphatidylserine externalization analysis and mitochondrial membrane potential determination. \n\nThese results suggest that BlL has a promising potential for application in therapy and / or diagnosis \n\nof cancer. Future studies are needed to elucidate the details of BlL induced-apoptosis mechanism in \n\nseveral tumor cell lines.  \n\n \n\n\n\n77 \n\n \n\nConflict of interest statement \n\nThe authors declare that there are no conflicts of interest. \n\n \n\nAcknowledgements \n\nThe authors express their gratitude to the Conselho Nacional de Desenvolvimento Cient\u00edfico e \n\nTecnol\u00f3gico (CNPq) for research grants and fellowship (LCBBC and MTSC) and to the \n\nCoordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES) for research grants. \n\nAuthors are deeply grateful to Maria Barbosa Reis da Silva, Maria D. Rodrigues and Jo\u00e3o Ant\u00f4nio \n\nVirg\u00ednio for the technical assistance.  \n\n \n\nReferences \n\nAlley, M.C., Scudiere, D.A., Monks, A., Hursey, M.L., Czerwinski, M.J., Fine, D.L., Abbott, B.J., \n\nMayo, J.G., Shoemaker, R.H., Boyd, M.R., 1988. Feasibility of drug screening with panels \n\nof human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601. \n\nBorutaite, V., 2010. Mitochondria as decision-makers in cell death. Environ. Mol. Mutagen. 51, \n\n406-416.   \n\nCarvalho, D.D., Schmitmeier, S., Novello, J.C., Markland, F.S., 2001. Effect of BJcuL (a lectin \n\nfrom the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and \n\nendothelial cells. Toxicon 39, 1471-1476.  \n\nChen, S., LaRoche, T., Hamelinck, D., Bergsma, D., Brenner, D., Simeone, D., Brand, R.E., Haab, \n\nB.B., 2007. Multiplexed analysis of glycan variation on native proteins captured by antibody \n\nmicroarrays. Nature Methods 4, 437-444. \n\nCosta-Lotufo, L.V., Cunha, G.M.A., Farias, P.A.M., Viana, G.S.B., Cunha, K.M.A., Pessoa, C., \n\nMoraes, M.O., Silveira, E.R., Gramosa, N.V., Rao, V.S.N., 2002. The cytotoxic and \n\nembryotoxic effects of kaurenoic acid, a diterpene isolated from Copaifera langsdorffii oleo-\n\nresin. Toxicon 40, 1231-1234. \n\nDebatin, K.M., 2004. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol. \n\nImmunother. 53, 153-159. \n\n\n\n78 \n\n \n\nFadok, V.A., Bratton, D.L., Rose, D.M., Pearson, A., Ezekewitz, R.A., Henson, P.M., 2000. A \n\nreceptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85-90. \n\nGong, F., Ma, Y., Ma, A., Q., Zhang, J., Nie, H., Chen, X., Shen, B., Li, N., Zhang, D., 2007. A \n\nlectin from Chinese Mistletoe increases ?? T cell-mediated cytotoxicity through induction of \n\ncaspase-dependent apoptosis. Acta Biochim. Biophys. Sin. 39, 445-452. \n\nGogvadze, V., Orrenius, S., Zhivotovsky, B., 2009. Mitochondria as targets for cancer \n\nchemotherapy. Semin. Cancer Biol. 19, 57-66. \n\nGorelik, E., Galili, U., Raz, A., 2001. On the role of cell surface carbohydrates and their binding \n\nproteins (lectins) in tumor metastasis. Cancer Metastasis Rev. 20, 245-277. \n\nGuthrie, H.D., Welch, G.R., 2006. Determination of intracellular reactive oxygen species and high \n\nmitochondrial membrane potential in Percoll-treated viable boar sperm using fluorescence-\n\nactivated flow cytometry. J. Anim. Sci. 84, 2089-2100. \n\nHakomori, S., 2002. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. \n\nNatl. Acad. Sci. 99, 10231-10233. \n\nHemalswarya, S., Doble, M., 2006. Potential synergism of natural products in the treatment of \n\ncancer. Phytother. Res. 20, 239-249. \n\nHengartner, M.O., 2000. The biochemistry of apoptosis. Nature 407, 770-776. \n\nHill, M.M., Adrain, C., Martin, S.J., 2003. Portrait of a killer: The mitochondrial apoptosome \n\nemerges from the shadows. Mol. Interv. 3, 19-26. \n\nInstituto Nacional de C\u00e2ncer, 2009. Estimativa 2010: Incid\u00eancia de C\u00e2ncer no Brasil, INCA, Rio de \n\nJaneiro. http//www.inca.gov.br/estimativa/2010/estimativa20091201.pdf. \n\nJim\u00e9nez-Castells, C., de la Torre, B.G., Andreu, D., Guti\u00e9rrez-Gallego, R., 2008. Neo-\n\nglycopeptides: the importance of sugar core conformation in oxime-linked glycoprobes for \n\ninteraction studies. Glycoconj. J. 25, 879-887. \n\nKagan, V.E., Fabisiak, J.P., Shedova, A.A., Tyurina, Y.Y., Tyurin, V.A., Schor, N.F., Kawai, K., \n\n2000. Oxidative signaling pathway for externalization of plasma membrane \n\nphosphatidylserine during apoptosis. FEBS Lett. 477, 1-7. \n\n\n\n79 \n\n \n\nKang, K.S., Yun, J.W., Lee, Y.S., 2002. Protective effect of l-carnosine against 12-\n\nOtetradecanoylphorbol-13-acetate- or hydrogen peroxide-induced apoptosis on v-myc \n\ntransformed rat liver epithelial cells. Cancer Lett. 178, 53-62. \n\nKobata, A., Amano, J., 2005. Altered glycosylation of proteins produced by malignant cells, and \n\napplication for the diagnosis and immunotherapy of tumors. Immunol. Cell Biol. 83, 429-\n\n439. \n\nKuo, W.T., Ho, Y.J., Kuo, S.M., Lin, F.H., Tsai, F.J., Chen, Y.S., Dong, G.C., Yao, C.H., 2010. \n\nInduction of the mitochondria apoptosis pathway by phytohemagglutinin \n\nerythroagglutinating in human lung cancer cells. Ann. Surg. Oncol., doi:10.1245/s10434-\n\n010-1351-2 \n\nLiu, B., Cheng,Y., Bian, H.J., Bao, J.K., 2009c. Molecular mechanisms of Polygonatum cyrtonema \n\nlectin-induced apoptosis and autophagy in cancer cells. Autophagy 5, 253-255. \n\nLiu, B., Li, C.Y., Bian, H.J., Min, M.W., Chen, L.F., Bao, J.K., 2009a. Antiproliferative activity \n\nand apoptosis-inducing mechanism of Concanavalin A on human melanoma A375 cells. \n\nArch. Biochem. Biophys. 482, 1-6. \n\nLiu, B., Zhang, B., Min, M.W., Bian, H.J., Chen, L.F., Liu, Q., Bao, J.K., 2009b. Induction of \n\napoptosis by Polygonatum odoratum lectin and its molecular mechanisms in murine \n\nfibrosarcoma L929 cells. Biochim. Biophys. Acta 1790, 840-844.  \n\nLuo, Y., Xu, X., Liu, J., Li, J., Sun, Y., Liu, Z., Liu, J., Van Damme, E., Balzarini, J., Bao, J., 2007. \n\nA novel mannose-binding tuber lectin from Typhonium divaricatum (L.) Decne (family \n\nAraceae) with antiviral activity against HSV-II and anti-proliferative effect on human \n\ncancer cell lines. J. Biochem. Mol. Biol. 40, 358-367.  \n\nLy, J.D., Grubb, D.R., Lawen, A., 2003. The mitochondrial membrane potential (deltapsi(m)) in \n\napoptosis; an update. Apoptosis 8, 115-128.  \n\nMayer, B., Oberbauer, R., 2003. Mitochondrial regulation of apoptosis. News Physiol. Sci. 18, 89-\n\n94. \n\nMosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to \n\nproliferation and cytotoxicity assays. J. Immunol. Methods 16, 55-63.  \n\nOkada, H., Mak, T.W., 2004. Pathways of apoptotic and non-apoptotic death in tumor cells. Nat. \n\nRev. Cancer 4, 592-603. \n\n\n\n80 \n\n \n\nPereira-Bittencourt, M., Carvalho, D.D., Gagliard, A.R., Collins, D.C., 1999. The effect of a lectin \n\nfrom the venom of the snake, Bothrops jararacussu, on tumor cell proliferation. Anticancer \n\nRes. 19, 4023-4026. \n\nReddy, L., Odhav, B., Bhoola, K.D., 2003. Natural products for cancer prevention: a global \n\nperspective. Pharmacol. Ther. 99, 1-13. \n\nReed, J.C., 2003. Apoptosis-targeted therapies for cancer. Cancer Cell 3, 17-22. \n\nReis, C.A., Osorio, H., Silva, L., Gomes, C., David, L., 2010. Alterations in glycosylation as \n\nbiomarkers for cancer detection. J. Clin. Pathol. 63, 322-329. \n\nRek, A., Krenn, E., Kungl, A.J., 2009. Therapeutically targeting protein-glycan. J. Pharmacol. 157, \n\n686-694. \n\nReyes-Zurita, F.J., Rufino-Palomares, E.E., Lupi\u00e1\u00f1ez, J.A., Cascante, M., 2009. Maslinic acid, a \n\nnatural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer \n\ncells via the mitochondrial apoptotic pathway. Cancer Lett. 273, 44-54.  \n\nSaelens, X., Festjens, N., Walle, L.V., Van Gurp, M., Van Loo, G., Vandenabeele, P., 2004. Toxic \n\nproteins released from mitochondria in cell death. Oncogene 23, 2861-2874. \n\nSarray, S., Berthet, V., Calvete, J.J., Secchi, J., Marvaldi, J., El-Ayeb, M., Marrakchi, N., Luis, J., \n\n2004. Lebectin, a novel C-type lectin from Macrovipera lebetina venom, inhibits integrin-\n\nmediated adhesion, migration and invasion of human tumour cells. Lab. Invest. 84, 573-581. \n\nSarray, S., Delamarre, E., Marvaldi, J., El Ayeb, M., Marrakchi, N., Luis, J., 2007. Lebectin and \n\nlebecetin, two C-type lectins from snake venom, inhibit ?5?1 and ?v-containing integrins. \n\nMatrix Biol. 26, 306-313. \n\nSharon N., Lis, H., 2004. History of lectins: from hemagglutinins to biological recognition \n\nmolecules. Glycobiology 14, 53-62. \n\nTaraphdar, A.K., Roy, M., Bhattacharya, R.K., 2001. Natural products as inducers of apoptosis: \n\nimplication for cancer therapy and prevention. Curr. Sci. 80, 1387-1396. \n\nTaylor, R.C., Cullen, S.P., Martin, S.J., 2008. Apoptosis: controlled demolition at the cellular level. \n\nNature Reviews Mol. Cell Biol. 9, 231-241. \n\n\n\n81 \n\n \n\nVan Engeland, M., Nieland, L.J.W., Ramaekers, F.C.S., Schutte, B., Reutelingsperger, C.P.M., \n\n1998. Annexin V-afinnity assay: A review on an apoptosis detection system based on \n\nphosphatidylserine exposure. Cytometry 31, 1-9. \n\nVermeulen, K., Bockstaele, V., Berneman, Z.N., 2005. Apoptosis: mechanisms and relevance in \n\ncancer. Ann. Hematol. 84, 627-639. \n\nWu, A.M., Lisowska, E., Duk, M., Yang, Z., 2009. Lectins as tools in glycoconjugate research. \n\nGlycoconj. J. 26, 899-913. \n\nZhao, Q., Cao, X., Zheg, B., Wang, C., Yan, L., Xu, C., 2010. Musca domestica larva lectin induces \n\napoptosis in BEL-7402 cells through a mitochondria-mediated reactive oxygen species way. \n\nBiol. Pharm. Bull. 33, 1274-1278. \n\nZimmermann, K.C., Bonzon, C., Green, D.R., 2001. The machinery of programmed cell death. \n\nPharmacol. Ther. 92, 57-70. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n82 \n\n \n\n7 ARTIGO CIENT\u00cdFICO III \n\n \n\n \n\n \n\n \n\n \n\nGamma irradiation abolish in vitro cytotoxicity of lectin of Bothrops leucurus \n\nsnake venom \n\n \n\nArtigo a ser submetido ao peri\u00f3dico Toxicon \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n83 \n\n \n\nErika dos Santos Nunesa*, Mary Angela Aranda de Souzaa, Ant\u00f4nio Fernando Melo Vaza, Maria \n\nLuiza Vilela Olivab, Jaciana Santos Aguiarc, Teresinha Gon\u00e7alves da Silvac, Miriam Camargo \n\nGuarnierid, Luana Cassandra Breitenbach Barroso Coelhoa, Ana Maria M. de Albuquerque Meloe, \n\nMaria Tereza dos Santos Correia.a \n\n  \na\nDepartamento de Bioqu\u00edmica, Universidade Federal de Pernambuco, Avenida Professor  Moraes \n\nR\u00eago, s/n, Cidade Universit\u00e1ria, 50670-420, Recife, Pernambuco, Brazil \n\nb\nDepartamento de Bioqu\u00edmica, Universidade Federal de S\u00e3o Paulo, Rua Tr\u00eas de Maio, 100,  Vila \n\nClementina, 04044-020, S\u00e3o Paulo, Brazil.\n \n\nc\nDepartamento de Antibi\u00f3ticos, Universidade Federal de Pernambuco, Avenida Arthur de S\u00e1, s/n, \n\nCidade Universit\u00e1ria, 50670-901, Recife, Pernambuco, Brazil.\n \n\nd\nDepartamento de Zoologia, Universidade Federal de Pernambuco, Avenida Professor Moraes \n\nR\u00eago, s/n, Cidade Universit\u00e1ria, 50670-420, Recife, Pernambuco, Brazil. \n\ne\nDepartamento de Biofisica e Radiobiologia,  Universidade Federal de Pernambuco, Avenida \n\nProfessor Moraes R\u00eago, s/n, Cidade Universit\u00e1ria, 50670-420, Recife, Pernambuco, Brazil. \n\n \n\n*Corresponding author. Phone: +558121268540; Fax: +558121268576  \n\nE-mail address: erika.santosnunes@hotmail.com  \n\n \n\nABSTRACT  \n\nGamma radiation alters the molecular structure of biomolecules and has been able to mitigate snake \n\nvenoms and its isolated toxins. The aims of this work was to evaluate the effects of ionizing \n\nradiation in Bothrops lecurus venom lectin (BlL) by fluorescence spectroscopy and in vitro \n\ncytotoxicity. BlL has been structurally altered and hemagglutinating assay shows significant change \n\nafter gamma irradiation. SDS-PAGE analyses indicated that irradiation caused fragmentation and \n\naggregation of lectin. The reverse phase chromatography analysis revealed a loss of the peak area \n\nwith structural fragmentation. The effect of ?-radiation on the folding of the lectin was measured by \n\nintrinsic and bis-ANS fluorescence. Cytotoxic activity of BlL on Hep-2, K562 and NCI-H292 \n\ntumor cell lines was abolished after irradiation. To improve antivenom and extend the useful life of \n\n\n\n84 \n\n \n\nimmunized horses effort has been devoted to decrease chronic venom toxicity, the irradiation may \n\nacts as a detoxification strategy in snake venoms avoiding its cytotoxicity. \n\n \n\nKeywords: Bothrops leucurus; lectin; fluorescence; Bis-ANS; gamma rays. \n\n \n\n1. Introduction \n\n Snake venoms are complex mixtures of bioactive proteins and polypeptides (Koh et al., \n\n2006). These toxins are enzymatic and non enzymatic proteins and synergistic interactions between \n\nvenom proteins enhanced the lethal potency of the snake venom. Complexes of proteins families, \n\nsuch as metalloproteases, serine proteases, C-type lectins (CTLs), C-type lectin-related proteins \n\n(CLRPs) and three-finger toxins (3FTxs), have also been reported in venoms (Doley and Kini, \n\n2009). CTLs are true sugar-binding lectin composed by homodimers or homooligomers and with \n\nCa2+ and generally galactose binding properties (Clemetson, 2010). C-type lectin-like proteins are \n\nheterodimers or oligomeric complexes of heterodimers called Snaclecs (Snake venom C-type \n\nlectins) (Ogawa et al., 2005; Clemetson et al., 2009; Clemetson, 2010). Lectins are proteins or \n\nglycoproteins that are ubiquitous in nature and bind reversibly to carbohydrates (Sharon and Lis, \n\n2004).  \n\nIonizing radiation causes changes in the function and integrity of biomolecules, including \n\nproteins, by two different effects. First, interacting directly on target proteins (Kempner, 2001); and \n\nsecond, the formation of major products from radyolisis water and its subsequent interaction with \n\nproteins are described as indirect mechanism, which are responsible for most of the radiation effects \n\non proteins (Riley, 1994; Wang and Wang, 2007). The exposure of proteins at low dose radiation \n\nproduces chemical and physical damage that may result in changes in its primary structure, \n\nsecondary or tertiary, keeping intact their immunological properties (Nascimento et al., 1996).  \n\nThe intimate relationship existing structure-activity proteins may be affected by the use of \n\nionizing radiation, which functions to an important tool in the study of attenuation of snake venoms. \n\nThis aspect has received attention from researchers, on many occasions show the effects of gamma \n\nradiation the molecular level, with the involvement of biological activity de snake venom, which \n\nresult in a decrease or loss of enzymatic and toxic actions (Gallaci et al., 2000; Souza et al., 2002; \n\nCasare et al., 2006). This phenomenom has led scientists to the formulation of concepts and ideas \n\nextremely relevant, increasing interest in experiments such as the detoxification from snake venoms \n\nby radiation, without affecting its immunogenic properties in order to optimize the production of \n\nantiserum (Moreira et al., 1997; Netto et al., 2002; Ferreira Junior et al., 2005; Ferreira Junior et al., \n\n\n\n85 \n\n \n\n2006; Ferreira et al., 2009). Traditional methods to reduce unwanted or intolerant immunological \n\neffects of lectins have been ineffective (Sathe et al., 2005). However, an alternative treatment was \n\nrecently reviewed to abolish allergenicity of lectins in food using gamma irradiation (Vaz et al., \n\n2011). \n\nA valuable feature of intrinsic protein fluorescence is the high sensitivity of tryptophan to its \n\nlocal environment. Changes in the emission spectra of tryptophan often occur in response to \n\nconformational transitions, subunit association, substrate binding, or denaturation (Lakowicz, \n\n2006). Bis-ANS have proved to be sensitive probes for partially folded intermediates in protein-\n\nfolding pathways. The basis of these applications is the strong fluorescence enhancement exhibited \n\nby these amphiphilic dyes when their exposure to water is lowered (Semisotnov et al., 1991). The \n\nmajority of misfolding states are involving the self-aggregation of specific proteins (or protein \n\nfragments) into filamentous deposits known as amyloid fibrils, which adopt a characteristic cross-?-\n\nsheet structure. Thioflavin T (ThT) dye fluorescence is used regularly to quantify the formation of \n\namyloid fibrils in the presence of stress physics or oxidative (Hawe et al., 2008). \n\nBothrops leucurus venom lectin (BlL) has been purified by affinity chromatography of \n\nvenoms snake. The galactoside-binding, a protein of 30 kDa composed of 15 kDa subunits, presents \n\ninhibitory activity against antibacterial, citotoxicity on human tumor cell lines as well as induction \n\nof apoptosis (Nunes et al., 2011). Here, the interest lies in studying the effects of ionizing radiation \n\nin the lectin isolated from venom of Bothrops leucurus and evaluated if gamma radiation attenuates \n\nits citotoxicity in tumor cell.  \n\n \n\n2. Material and Methods \n\n \n\n2.1. Chemicals \n\nReference samples of 4.4'-Bis 1-anilinonaphthalene 8-sulfonate (bis-ANS) were purchased \n\nfrom Molecular Probes Inc., USA. The broad-range standard marker proteins were purchased from \n\nSigma Chemical Co. USA. Phosphate buffered saline (PBS), penicillin \u2013 streptomycin liquid and \n\nDMEM (Dulbecco\u2019s Modified Eagle\u2019s Medium) were purchased from GibcoTM. MTT (3-(4,5-\n\nDimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) were  purchased from InvitrogenTM. \n\nEposide (Etoposide) was purchased from Blausiegel. Fetal bovine serum (FBS) and glutamine were \n\n\n\n86 \n\n \n\npurchased from Sigma-Aldrich\u00ae. All the solvents and other chemicals used were of analytical grade \n\nfrom Merck, Germany. All solutions were made with water purified by the Milli-Q system.   \n\n2.2. Cell line and Cell culture \n\nThe cell lines used in vitro cytotoxicity were K562 (chronic myelocytic leukemia), NCI-\n\nH292 (human lung mucoepidermoid carcinoma cells) and Hep-2 (human larynx epidermoid \n\ncarcinoma cells) all obtained from Adolph Lutz Institute (S\u00e3o Paulo, Brazil). The cells were \n\nmaintained in DMEM supplemented with 10% fetal bovine serum, 2mM glutamine, 100 U/mL \n\npenicillin, 100 \u00b5 g/mL streptomycin at 37 \u00b0C with 5% CO2.  \n\n \n\n2.3. Purification of Bothrops leucurus lectin (BlL) \n\nB. leucurus venom was kindly supplied by the N\u00facleo Regional de Ofiologia e Animais \n\nPe\u00e7onhentos da Bahia, Universidade Federal da Bahia, Salvador, Bahia, Brazil. BlL was purified \n\naccording to the protocol previously described by Nunes et al. (2011). Lyophilized crude venom of \n\nB. leucurus (30 mg) was dissolved in 1 mL of CTBS buffer (20 mM Tris-HCl, 150 mM NaCl and 5 \n\nmM CaCl2, pH 7.5) and centrifuged (2000 g, 5 min, 25 \u00b0C) to remove insoluble material. The \n\nresulting supernatant was applied to a column (10 x 1.0 cm) of guar gel previously equilibrated with \n\nCTBS at a flow rate of 10 mL/h. BlL was eluted from the column with 200 mM galactose in CTBS. \n\n \n\n2.4. Lectin irradiation \n\nThe lectin aliquots (0.07 mg/mL) in phosphate buffer (pH 7.0) in borosilicate glass vials \n\n(16-125 mm) were frozen and irradiated under atmospheric O2 using a Gammacell 220 Excel \n60Co \n\ngamma ray irradiator (Ontario, Canada) with doses of 1 and 2 kGy at a rate of 7.2 kGy/h. Each \n\nsample was analyzed after irradiation by the following methods. \n\n \n\n2.5. Hemagglutination activity and protein concentration  \n\nHemagglutination activity (HA), which was defined as the lowest sample dilution that \n\nshowed hemagglutination, was evaluated as described by Correia and Coelho (1995). Specific HA \n\n(SHA) corresponded to the relationship between the HA and protein concentration measured \n\naccording to Bradford (1976) using bovine serum albumin (BSA) as a standard. The percentage of \n\n\n\n87 \n\n \n\nthe remaining SHA (%SHAREM) was calculated according to the equation: %SHAREM = (SHA)GM / \n\n(SHA)GO x 100, where GM is the lectin SHA of each radiation dose (1 and 2 kGy) and G0 is the of \n\nnon-irradiated lectin (control). \n\n \n\n2.6. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) \n\nSDS-PAGE was performed according to Laemmli (1970). Protein samples were mixed with \n\nloading buffer (60 mM Tris-HCl, pH 6.8, with 2% SDS, 25% glycerol, and 0.1% bromophenol \n\nblue), resolved on a 15% separating gel and stained using Coomassie Brilliant Blue (Sigma). The \n\nfollowing standard molecular weight markers were used: rabbit muscle myosin (205 kDa), E. coli \n\n?-galactosidase (116 kDa), rabbit muscle phosphorylase b (97.4 kDa), rabbit muscle fructose-6-\n\nphosphate kinase (84 kDa), bovine serum albumin (66 kDa), bovine liver glutamic dehydrogenase \n\n(55 kDa), egg albumin (45 kDa), rabbit muscle glyceraldehyde-3-phosphate dehydrogenase (36 \n\nkDa), bovine erythrocyte carbonic anhydrase (29 kDa), bovine pancreas trypsinogen (24 kDa), \n\nsoybean trypsin inhibitor (20 kDa), bovine milk ?-lactalbumin (14.2 kDa) and bovine lung aprotinin \n\n(6.5 kDa).  \n\n \n\n2.7. Reverse phase chromatography analysis    \n\nBlL (0.07 mg/mL) was irradiated (1 and 2 kGy) and submitted to reverse phase \n\nchromatography on a C-4 column (Vydac-protein peptide ultrasphere), performed on a HPLC \n\nsystem (Shimadzu LC-10AD, Kyto, Japan) and monitored at 280 nm. The column was equilibrated \n\nwith solvent A (0.1% TFA in H2O) at a flow rate of 0.7 mL/min,\n and a non-linear gradient elution \n\nwas used with solvent B (90% acetonitrile, 10% H2O, 0.1% TFA) in A, with 0% B at t = 5 min; \n\n45% B at t = 10 min; 50% B at t = 30 min; and 100% B at t = 35 min. \n\n \n\n2.8. Fluorescence spectroscopy \n\nThe fluorescence emission intensity of the irradiated 0.07 mg/mL BlL solution in phosphate \n\nbuffer at pH 7.0 was measured at 25\u00b0C using a spectrofluorometer (JASCO FP-6300, Tokyo, Japan) \n\nin a rectangular quartz cuvette with a 1-cm path length. The excitation wavelengths were 295 and \n\n280 nm; emission spectra were recorded in the range of 305 to 450 nm, and band passes were 5 nm. \n\nLight scattering was measured at 90\u00b0 for the aggregation assays; light scattering values at 320 nm \n\n\n\n88 \n\n \n\nwere monitored (300 to 340 nm). The spectra displayed in the figures are the average of three scans \n\nthat were corrected for the solution signal by subtracting the solution spectrum. \n\n \n\n2.9. Hydrophobic surface analysis \n\nThe lectin hydrophobic surface was measured using the same conditions employed for the \n\nintrinsic fluorescence experiment. Samples were transferred to a quartz cuvette and then mixed with \n\n5 \u00b5 M bis-ANS; fluorescence was measured in the JASCO spectrofluorometer. The fluorescence \n\nemission was obtained at 400 to 600 nm with an excitation at 360 nm (Bhattacharyya et al., 2000). \n\n \n\n2.10. Thioflavin T (ThT) fluorescence assay \n\nThe amyloid fibrils detection was measured using the same conditions employed for the \n\nintrinsic fluorescence experiment. Samples were transferred to a quartz cuvette and then mixed with \n\n13 \u00b5 M ThT; fluorescence intensity of each sample was recorded every 5 min in the JASCO \n\nspectrofluorometer. The fluorescence emission was obtained at 465 to 550 nm with an excitation at \n\n450 nm (LeVine, 1999). \n\n \n\n2.11. MTT assay \n\nThe cytotoxicity of the BlL irradiated in dose of 1 and 2 kGy was tested against K562, NCI-\n\nH292 and Hep-2 tumor cell lines. The cells (105 cells/mL for adherent cells or 0.3x106 cells/mL for \n\nsuspended cells) were plated in 96-well microtiter plates and after 24 h, irradiated BlL (0.07 \n\nmg/mL) dissolved in DMSO was added to each well and incubated for 72 h  at 37 \u00b0C.  Then, MTT \n\n(5.0 mg/mL) was added to the plate and growth of tumor cells was estimated by the ability of living \n\ncells to reduce the yellow tetrazolium to a blue formazan product (Mosmann, 1983; Alley et al., \n\n1988). Negative control groups received only DMSO; etoposide (1.25\u201320 \u00b5 g/mL) was used as \n\npositive control. After 3 h (for suspend cells) or 2 h (for adherent cells), the formazan product was \n\ndissolved in DMSO and absorbance was measured using a multi-plate reader (Multiplate Reader \n\nThermoplate). The BlL effect was quantified by measuring the absorbance at 450 nm resulting from \n\nMTT reduction. The results were compared with negative control absorbance and the values of 50% \n\ninhibition of cell proliferation (IC50) were calculated. \n\n\n\n89 \n\n \n\n2.12. Statistical analysis \n\nData are presented as mean \u00b1 S.D. The IC50 values and their 95% confidence intervals were \n\nobtained by nonlinear regression using the SigmaPlot graphing software Inc. San Jose, USA. The \n\ndifferences between experimental groups were compared by one-way of variance (ANOVA) \n\nfollowed by Newman-Keuls test and the significance level was also set at 1%.  \n\n \n\n3. Results and Discussion    \n\nIonizing radiation has been widely employed to attenuate venoms and isolated toxins, \n\npreserving and even enhancing their immunogenic properties. However, little is know about the \n\nmolecular changes that irradiated proteins undergo. Thus, we compared native and irradiated \n\nBothrops leucurus snake venom lectin (BlL) aiming to characterize the structural modifications that \n\nradiation induces. BlL SHA was determined after irradiation. In dose of 1 kGy, no significant \n\nchange was observed. However, in dose of 2 kGy shows significantly loss of SHA (Figure 1a). C-\n\ntype lectins exhibit biological activities like adhesion, via CRDs (carbohydrate recognition domain), \n\nfor recognition of oligosaccharides in cell surface. The CRD can function independently of the rest \n\nof the protein and thus may be employed to assess whether agglutination or clumping is maintained \n\nor disrupted after irradiation (Taylor and Drickamer, 1991). Thus, the loss of HA after irradiation \n\nsuggests modification of the dimmers interact which can result in dissociation pentamer and loss of \n\ninteraction sites on surface cells (Walker et al., 2004).    \n\nThe precipitate was run on SDS-PAGE after centrifugation to detect any insoluble \n\naggregates that formed, and the supernatant was separated by RP-HPLC. In dose of 1 kGy, initial \n\ndegradation of the BlL (MW 30.0 kDa) was observed. Degradation of the main band was detected \n\nin dose of 2 kGy, indicating that the aggregate formed was composed of fragmented polypeptides \n\n(Figure 1b). The reverse phase chromatography analysis showed the loss of the peak area with the \n\nstructural fragmentation (Figure 1c) and aggregation can be evaluated by light scattering (Figure \n\n1d). According Puchala and Schuessler (1995), in fragile bonds in the polypeptide chain break \n\npoints occurring protein caused by radiation. Because of the generation of inter-protein cross-\n\nlinking reactions, formation of disulfide bonds, as well as hydrophobic and electrostatic \n\ninteractions, proteins can be converted to higher molecular weight aggregates (Moon and Song, \n\n2001; Xu and Chance, 2005). The analysis of molecular weight pattern and RP-HPLC shows \n\nconditions that induce denaturation, with subsequent precipitation into insoluble amorphous \n\naggregates.  \n\n\n\n90 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 1. Effect of ?-radiation on lectin activity and molecular weight. (a) The percentage of \n\nremaining specific hemagglutination activity, %SHAREM is represented after irradiation. Error in the \n\ndetermination of %SHAREM for the different doses was approximately \u00b1 1%, which is less than the \n\nsize of the symbols. * Significant difference (p &lt;0.05) compared to non-irradiated lectin. (b) SDS-\n\nPAGE from irradiated BlL. SDS-PAGE was performed in a discontinuous system with 15% \n\nseparating and 5% stacking gels. (MW) Molecular weight; (C) non-irradiated control; (1) 1 kGy and \n\n(2) 2 kGy. (c) Reverse phase chromatography on an HPLC system: (?) control and irradiated \n\nlectins at (?) 1 kGy and (?) 2 kGy. (d) Light scattering was measured at 90\u00b0 for the aggregation \n\nassays. \n\nNascimento et al. (1996) observed that crotoxin, the main neurotoxin isolated from snake \n\nvenom Crotalus durissus terrificus, when irradiated with 2 kGy dose of gamma rays produced \n\nprotein aggregation and generation of lower molecular weight breakdown products. Such clusters \n\napplaud less myotoxic, devoid of phospholipase activity and are virtually non-toxic in mice when \n\ncompared with native crotoxin. The bothropstoxin-1, the main myotoxic component of Bothrops \n\njararacussu snake venom, after irradiation com 60Co gamma rays, promoted structural \n\nmodifications in the toxin characterized aggregates and oligomers (Caproni et al., 2009).  \n\n0\n\n20\n\n40\n\n60\n\n80\n\n100\n\nControl 1 2\n\nDose (kGy)\n\nS\nH\n\nA\n R\n\nem\n (\n\n%\n)\n\n205\n116\n\n66\n55\n\n45\n36\n\n24\n20\n\n14.2\n\n6.5\n\n29\n\n84\n\n97.4\n\nMW 1 2C\n\n*\n\na\nb\n\n0\n\n50\n\n100\n\n150\n\n200\n\n250\n\n300\n\n300 310 320 330 340\n\nWave le ngth (nm)\n\nF\nlu\n\no\nre\n\ns\nc\n\ne\nn\n\nc\ne\n\n i\nn\n\nte\nn\n\ns\nit\n\ny\n (\n\nA\n.U\n\n.)\n\nc\n\n-50\n\n150\n\n350\n\n550\n\n750\n\n950\n\n0 10 20 30 40\n\nTime (min)\n\nA\nb\n\ns\no\n\nrb\na\nn\n\nc\ne\n a\n\nt \n2\n8\n0\n n\n\nm\n (\n\nm\nA\n\nU\n)\n\nd\n\nnon-irradiated\n\n1 kGy\n\n2 kGy\n\n0\n\n20\n\n40\n\n60\n\n80\n\n100\n\nControl 1 2\n\nDose (kGy)\n\nS\nH\n\nA\n R\n\nem\n (\n\n%\n)\n\n205\n116\n\n66\n55\n\n45\n36\n\n24\n20\n\n14.2\n\n6.5\n\n29\n\n84\n\n97.4\n\nMW 1 2C\n\n*\n\na\nb\n\n0\n\n50\n\n100\n\n150\n\n200\n\n250\n\n300\n\n300 310 320 330 340\n\nWave le ngth (nm)\n\nF\nlu\n\no\nre\n\ns\nc\n\ne\nn\n\nc\ne\n\n i\nn\n\nte\nn\n\ns\nit\n\ny\n (\n\nA\n.U\n\n.)\n\nc\n\n-50\n\n150\n\n350\n\n550\n\n750\n\n950\n\n0 10 20 30 40\n\nTime (min)\n\nA\nb\n\ns\no\n\nrb\na\nn\n\nc\ne\n a\n\nt \n2\n8\n0\n n\n\nm\n (\n\nm\nA\n\nU\n)\n\nd\n\nnon-irradiated\n\n1 kGy\n\n2 kGy\n\n\n\n91 \n\n \n\nCTLs display anticoagulant and hemagglutinating activity. Its activity depends on the extent \n\nof association to dimmers. The intrinsic fluorescence of BlL was used to study its association into \n\ndimmers. CTLs is usually a dimer of two identical polypeptides, each containing two tryptophan \n\nresidue and one tyrosine residues (Morita, 2005). The emission spectrum of the BlL dimer displays \n\nemission from both tyrosine and tryptophan when excited at 280 nm. Only tryptophan emission is \n\nseen for 295 nm excitation. The intrinsic fluorescence emission decreased (1 and 2 kGy) with \n\nchanging the ?max at approximately 347 and 345 nm for hydrophobic and thryptophan residues, \n\nrespectively, after irradiation (Figure 2 a-b). To tryptophan residues that are exposed to water have \n\na maximal fluorescence at wavelengths around 340-350 nm, whereas completely buried residues \n\nfluoresce at about 330 nm. In CTLs individual subunits are able to bind to carbohydrates, but for the \n\nlectin-like function they need at least bivalency, which is achieved through a simple interchain \n\ndisulfide linkage. Although dimerization is essential, two Trp residues (one at each end) and a Tyr \n\nresidue in the middle of the interaction interface are essential to stabilize intra-subunit contacts and \n\nfor the expression of their biological activities (Doyle and Kini, 2009). The displacement of the \n\nmass center of the aromatic residues indicates a possible protein denaturation and exposure of \n\nhydrophobic domains to the solvent. Thus, the subtle differences in the positioning of interactive \n\nsegment may lead to distinct quaternary structures of these proteins after irradiation.  \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 2. BlL intrinsic fluorescence. (a) Mass center; Lectin excitation (280 nm) and emission (295\u2013\n\n450 nm). (b) Mass center tryptophan; Lectin excitation (295 nm) and emission (305-450 nm).    \n\nThe aromatic amino acid residues of proteins are major targets of reactive oxygen species by \n\noxidation (ROS) (Stadtman and Levine, 2003), which are produced after water radiolysis. Partial \n\naromatic amino acid substituition caused by hydrogen abstraction promote a decrease in the \n\nintensity fluorescence emission being the magnitude of the intensity very informative in itself. \n\n338\n\n339\n\n340\n\n341\n\n342\n\n343\n\n344\n\n345\n\n346\n\ncontrol 1 kGy 2 kGy\n\nDose (kGy)\n\nC\nen\n\nte\nr \n\nof\n m\n\nas\ns \n\n(n\nm\n\n)\n\n0\n\n100\n\n200\n\n300\n\n400\n\n500\n\n300 320 340 360 380\n\nWavelength (nm)\n\nF\nlu\n\no\nre\n\nsc\nen\n\nce\n i\n\nnt\nen\n\nsi\nty\n\n (\nA\n\n.U\n.)\n\n342\n\n342.5\n\n343\n\n343.5\n\n344\n\n344.5\n\n345\n\n345.5\n\n346\n\n346.5\n\n347\n\n347.5\n\nControl 1 kGy 2 kGy\n\nDose (kGy)\n\nC\nen\n\nte\nr \n\nof\n m\n\nas\ns \n\n(n\nm\n\n)\n\n0\n\n150\n\n300\n\n450\n\n600\n\n750\n\n900\n\n300 320 340 360 380 400\n\nWavelength (nm)\n\nF\nlu\n\no\nre\n\nsc\nen\n\nce\n in\n\nte\nn\n\nsi\nty\n\n (\nA\n\n.U\n.)\n\na b\n\n338\n\n339\n\n340\n\n341\n\n342\n\n343\n\n344\n\n345\n\n346\n\ncontrol 1 kGy 2 kGy\n\nDose (kGy)\n\nC\nen\n\nte\nr \n\nof\n m\n\nas\ns \n\n(n\nm\n\n)\n\n0\n\n100\n\n200\n\n300\n\n400\n\n500\n\n300 320 340 360 380\n\nWavelength (nm)\n\nF\nlu\n\no\nre\n\nsc\nen\n\nce\n i\n\nn\nte\n\nn\nsi\n\nty\n (\n\nA\n.U\n\n.)\n\n342\n\n342.5\n\n343\n\n343.5\n\n344\n\n344.5\n\n345\n\n345.5\n\n346\n\n346.5\n\n347\n\n347.5\n\nControl 1 kGy 2 kGy\n\nDose (kGy)\n\nC\nen\n\nte\nr \n\nof\n m\n\nas\ns \n\n(n\nm\n\n)\n\n0\n\n150\n\n300\n\n450\n\n600\n\n750\n\n900\n\n300 320 340 360 380 400\n\nWavelength (nm)\n\nF\nlu\n\no\nre\n\nsc\nen\n\nce\n in\n\nte\nn\n\nsi\nty\n\n (\nA\n\n.U\n.)\n\na b\n\n\n\n92 \n\n \n\nOxidative damage distorts the intra-subunit contacts and the hydrophobic core of proteins, allowing \n\ndissociation of chains and denaturation. \n\nCompared with the buffer, bis-ANS was weakly detected in the non-irradiated control BlL. \n\nBis-ANS fluorescence, after irradiation, increased in two doses used in this study, with a maximum \n\nto 500 nm to above 1 kGy (Figure 3). Hydroxyl radicals may attack hydrophobic surfaces in \n\nproteins, causing changes in the protein hydrophobicity, which are considered the determining \n\nfactor for structural collapse. Molten globule intermediates and insoluble amorphous aggregates are \n\ncharacterized by particularly high bis-ANS fluorescence intensities due to the exposure of \n\nhydrophobic core regions that are inaccessible to the dye in the native structure (Semisotnov et al., \n\n1991). Despite of misfold states involve the self-aggregation of specific proteins (or protein \n\nfragments) into filamentous deposits know as amyloi fibrils, was not observed fluorescence \n\nThioflavin T after irradiation. For a lectin isolated from Sebastiana jacobinensis, a variety of \n\nconditions was observed that induce denaturation, with subsequent precipitation into insoluble \n\namorphous aggregates or structured intermediates after irradiation (Vaz et al., 2011). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFig. 3. BlL bis-ANS fluorescence. Mass center; Lectin excitation (360 nm) and emission (400\u2013600 \n\nnm).   \n\nIn previous reports, was observed by MTT assay showed that BlL significant cytotoxic \n\neffect against human tumor cell lines Hep-2, NCI-H292 and K562 (Nunes et al., 2011). In this \n\nwork, we found that in contrast to native BlL, BlL irradiated (1 and 2 kGy) did not show cytotoxic \n\nactivity on tumor cell lines used in the study cited above. Baptista et al. (2010) showed that the \n\n465\n\n470\n\n475\n\n480\n\n485\n\n490\n\n495\n\n500\n\n505\n\n510\n\nC ontrol 1 kGy 2 kGy\n\nD os e  (k Gy)\n\nC\nen\n\nte\nr \n\nof\n m\n\nas\ns \n\n(n\nm\n\n)\n\n0\n\n50\n\n100\n\n150\n\n200\n\n250\n\n400 435 470 505 540 575\n\nWave le ngth (nm)\n\nF\nlu\n\no\nre\n\nsc\nen\n\nce\n in\n\nte\nn\n\nsi\nty\n\n (\nA\n\n.U\n.)\n\n465\n\n470\n\n475\n\n480\n\n485\n\n490\n\n495\n\n500\n\n505\n\n510\n\nC ontrol 1 kGy 2 kGy\n\nD os e  (k Gy)\n\nC\nen\n\nte\nr \n\nof\n m\n\nas\ns \n\n(n\nm\n\n)\n\n0\n\n50\n\n100\n\n150\n\n200\n\n250\n\n400 435 470 505 540 575\n\nWave le ngth (nm)\n\nF\nlu\n\no\nre\n\nsc\nen\n\nce\n in\n\nte\nn\n\nsi\nty\n\n (\nA\n\n.U\n.)\n\n\n\n93 \n\n \n\nirradiated bothropstoxin-I was 5 folds less toxic than its native counterpart, but still immunogenic. \n\nSouza-Filho et al. (1992), in a study on detoxification of the crotoxin complex by gamma radiation \n\nfound structural changes that occurred in this neurotoxin venom of the rattlesnake, were due to the \n\nformation of intermolecular covalent bonds and to the rupture of disulfide bonds. Gallaci et al. \n\n(1998), suggest that the breaking of the disulfide bonds of crotoxin by gamma radiation may be an \n\nimportant role in the loss of its neuromuscular blocking action. The homodimer BJcuL, a lectin \n\nisolated from Bothrops jararacussu snake proved to be active only as a dimeric configuration \n\n(Carvalho et al., 2002). According to Kassab et al (2004), the presence of the monomers without the \n\nformation of a correct inter-chain disulfide bond, as well as structural instability of dimer \n\nconfiguration avoiding may be favorable activity. \n\nBased on these considerations, we suggest that the loss in cytotoxicity ascribed to \n\nirreversible may be structural changes in BlL, induced by gamma radiation, which may have \n\naffected the interaction of lectin with glicoconjugates exposed on the surface of tumor cells. In \n\nconclusion, our results indicates that gamma irradiation of BlL can induce significant modifications \n\nin their structure, as well as promote its effective detoxification.   \n\n \n\nConflict of interest statement \n\nThe authors declare that there are no conflicts of interest. \n\n \n\nAcknowledgements \n\nThe authors express their gratitude to the Conselho Nacional de Desenvolvimento Cient\u00edfico e \n\nTecnol\u00f3gico (CNPq) and to the Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior \n\n(CAPES) for research grants. We are grateful to the Departamento de Energia Nuclear from the \n\nuniversidade Federal de Pernambuco (UFPE). The authors thank Maria D. Rodrigues and Jo\u00e3o \n\nAnt\u00f4nio Virg\u00ednio for technical assistance.  \n\n\n\n94 \n\n \n\nReferences \n\nAlley, M.C., Scudiero, D.A., Monks, A., Hursey, M.L., Czrwinski, M.J., Fine, D.L., Abbott, B.J., \n\nMayo, J.G., Shoemaker, R.H., Boyd, M.R., 1988. Feasibility of drug screening with panels \n\nof human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601. \n\nBaptista, J.A., Vieira, D.P., Galisteo J\u00fanior, A.J., Higa, O.Z., Casare, M., Yonamine, C.M., \n\nCaproni, P., Campos, L.A., Andrade J\u00fanior, H.F., Spencer, P.J., Nascimento, N., 2010. \n\nStructure alteration and immunological properties of 60C0-gamma-rays irradiated \n\nbothropstoxin-I. J. Radioanal. Nucl. Chem. DOI 10.1007/s10967-009-0399-6. \n\nBhattachryya, A., Mandal, A.K., Banerjee, R., Roy, S., 2000. Dynamics of compact denatured \n\nstates of glutaminyl-tRNA synthetase probed by bis-ANS binding kinetics. Biophys. Chem. \n\n87, 201-212. \n\nBradford, M.M., 1976. A rapid and sensitive method for the quantification of microgram quantities \n\nof protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254. \n\nCaproni, P., Baptista, J.A., Almeida, T.L., Passos, L.A.C., Nascimento, N., 2009. Study of \n\nirradiated bothropstoxin-1 with 60Co gamma rays: immune system behavior. J. Venom. \n\nAnim. Toxins Incl. Trop. Dis. 15(2), 216-225. \n\nCarvalho, D.D., Marangoni, S., Novello, J.C., 2002. Primary structure characterization of Bothrops \n\njararacussu snake venom lectin. J. Protein Chem. 21, 43-50.  \n\nCasare, M.S., Spencer, P., Campos, L.A., Nascimento, N., 2006. Study of gamma-radiation effects \n\non crotamine and crotoxin. J. Radioanalytical Nucl. Chem. 269(3), 571-577. \n\nClemetson, K.J., Morita, T., Kini, R.M., 2009. Scientific and standardization committee \n\ncommunications: classification and nomenclature of snake venom C-type lectins and related \n\nproteins. J. Thromb. Haemost. 7, 360. \n\nClemetson, K.J., 2010. Snaclecs (snake C-type lectins) that inhibit or activate platelets by binding to \n\nreceptors. Toxicon 56, 1236-1246. \n\nCorreia, M.T.S., Coelho, L.C.B.B., 1995.  Purification of a glucose/manose specific Lectin, isoform \n\n1, from seeds of Cratylia mollis Mart. (Camaratu bean). Appl. Biochem. Biotechnol.  55,  \n\n261-273. \n\nDoyle, R., Kini, R.M., 2009. Protein complexes in snake venom. Cell. Mol. Life Sci. 66, 2851-\n\n2871. \n\n\n\n95 \n\n \n\nFerreira Junior, R.S., Nascimento, N., Martinez, J.C., Alves, J.B., Meira, D.A., Barraviera, B., \n\n2005. Immunization with native and cobalt 60-irradiated Crotalus durissus terrificus venom \n\nin swiss mice: assessment of the neutralizing potency of antisera. J. Venom. Anim. Toxins \n\nIncl. Trop. Dis. 11(3), 299-314. \n\nFerreira Junior, R.S., Nascimento, N., Couto, R., Alves, J.B., Meira, D.A., Barraviera, B., 2006. \n\nLaboratory evaluation of young ovines inoculated with natural or 60Co-irradiated Crotalus \n\ndurissus terrificus venom during hyperimmunization process. J. Venom. Anim. Toxins Incl. \n\nTrop. Dis. 12(4), 620-631. \n\nFerreira, R.S., Nascimento, N., Couto, R., Alves, J.B., Meira, D.A., Barraviera, B., 2009. Immune \n\nresponse and neutralization capacity of antibodies produced in young sheep immunized with \n\nCrotalus durissus terrificus native or cobalt-60 irradiated venom. Braz. J. Vet. Res. Anim. \n\nSci. 46(3), 207-214. \n\nGallaci, M., Nunes, E.C., Moreira, E.G., Nascimento, N., Rogero, J.R., Vassilieff, V.S., 1998. \n\nReduction of crotoxin-induced neuromuscular blockade by gamma radiation. Toxicon, \n\n36(6), 941-945.  \n\nGallaci, M., Nascimento, N., Rogero, J.R., Vassilieff, V.S., 2000. Influence of temperature upon \n\neffects of crotoxin and gamma-irradiated crotoxin at rat neuromuscular transmission. \n\nToxicol. Lett.114, 77-80. \n\nHawe, A., Sutter, M., Jiskoot, W., 2008. Extrinsic fluorescent dyes as tools for protein \n\ncharacterization. Pharm. Res. 25, 1487-1499. \n\nKassab, B.H., Carvalho, D.D., Oliveira, M.A., Baptista, G.R., Pereira, G.A.G., Novello, J.C., 2004. \n\nCloning, expression, and structural analysis of recombinant BJcuL a C-type lectin from the \n\nBothrops jararacussu snake venom. Protein Expr. Purif. 35, 344-352.  \n\nKempner, E.S., 2001. Effects of high-energy electrons and gamma rays directly on protein \n\nmolecules. J. Pharm. Sci. 90, 1637-1646. \n\nKoh, D.C.I., Armugan, A., Jeyaseelan, K., 2006. Snake venom components and their applications in \n\nbiomedicine. Cell. Mol. Life sci. 63, 3030-3041. \n\nLakowicz, J.R., 2006. Principles of fluorescence spectroscopy. Springer Science Business Media, \n\nLLC, 233 Spring Street, New York, NY, USA.  \n\n\n\n96 \n\n \n\nLaemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of \n\nbacteriophage T4. Nature 227, 680-685.  \n\nLe Vine, H., 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods \n\nEnzymol. 309, 274-284. \n\nMoon, S., Song, K.B., 2001. Effect of ?-irradiation on the molecular properties of ovalbumin and \n\novomucoid and protection by ascorbic acid. Food Chem. 74(4), 479-83. \n\nMoreira, E.G., Nascimento, N., Rosa, G.J.M., Rogero, J.R., Vassilieff, V.S., 1997. Effect of gamma \n\nirradiation on the behavioral properties of crotoxin. Braz. J. Med. Biol. Res. 30(2), 245-249. \n\nMorita, T., 2005. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with \n\nanticoagulant-, procoagulant-, and platelet-modulating activities. Toxicon 45, 1099-1114. \n\nMosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to \n\nproliferation and cytotoxicity assays. J. Immunol. Methods 16, 55-63.  \n\nNascimento, N., Seebart, C.S., Francis, B., Rogero, J.R., Kaiser, I.I., 1996. Influence of ionizing \n\nradiation on crotoxin: biochemical and imunological aspects. Toxicon 34(1), 123-131. \n\nNetto, D.P., Chiacchio, S.B., Bicudo, P.L., Alfieri, A.A., Nascimento, N., 2002. Humoral response \n\nand neutralization capacity of sheep serum inoculated with natural and cobalt 60-irradiated \n\nCrotalus durissus terrificus venom (Laurenti, 1768). J. Venom. Anim. Toxins 8(2), 297-\n\n314. \n\nOgawa, T., Chijiwa, T., Oda-Ueda, N., Ohno, M., 2005. Molecular diversity and accelerated \n\nevolution of C-type lectin-like proteins from snake venom. Toxicon 45, 1-14. \n\nPuchala, M., Schuessler, H., 1995. Oxygen effect in the radiolysis of proteins. IV. Myoglobin. \n\nIntern. J. Pept. Protein Res. 46, 326-332. \n\nRiley, P.A., 1994. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int. \n\nJ. Radiat. Biol. 65, 27-33. \n\nSathe, S.K., Teuber, S.S., Roux, K.H., 2005. Effects of food processing on the stability of food \n\nallergens. Biotechnol. Adv. 23, 423-429. \n\n\n\n97 \n\n \n\nSemisotnov, G.V., Rodionova, N.A., Razgulyaev, O.I., Uversky, V.N., Gripas\u00b4, A.F., Gilmanshin, \n\nR.I., 1991. Study of the \u201cmolten globule\u201d intermediate state in protein folding by a \n\nhydrophobic fluorescent probe. Biopolymers 31, 119-128. \n\nSharon, N., Lis, H., 2004. History of lectins: from hemagglutinins to biological recognition \n\nmolecules. Glycobiology 14, 53-62.  \n\nSouza, F.A.D., Spencer, P. J., Rogero, J.R., Nascimento, N., Dal Pai-Silva, M., Gallaci, M., 2002. \n\n60Co gamma irradiation prevents Bothrops jararacussu venom neurotoxicity and \n\nmyotoxicity in isolated mouse neuromuscular junction. Toxicon 40, 1101-1106. \n\nSouza-Filho, J.N., Guarnieri-Cruz, M.C., Murata, Y., Rogero, J.R., 1992. Detoxification of the \n\ncrotoxin complex by gamma radiation. Braz. J. Med. Biol. Res. 25, 103-113. \n\nStadtman, E.R., Levine, R.L., 2003. Free radical-mediated oxidation of free amino acids and amino \n\nacid residues in proteins. Amino Acids 25, 207-218. \n\nTaylor, M.E., Drickamer, K., 1991. Carbohydrate-recognition domains as tools for rapid \n\npurification of recombinant eukaryotic proteins. Biochem. J. 274, 575-580. \n\nVaz, A.F.M., Costa, R.M.P.B., Coelho, L.C.B.B., Oliva, M.L.V., Santana, L.A., Melo, A.M.M.A., \n\nCorreia, M.T.S., 2011. Gamma irradiation as an alternative treatment to abolish allergenicity \n\nof lectins in food. Food Chem. 124, 1289-1295. \n\nWalker, J.R., Nagar, B., Young, N.M., Hirama, T., Rini, J.M., 2004. X-ray crystal structure of a \n\ngalactose-specific C-type lectin possessing a novel decameric quaternary structure. \n\nBiochem. 43, 3783-3792. \n\nWang, J., Wang, J., 2007. Application of radiation technology to sewage sludge processing: a \n\nreview. J. Hazard. Mater. 143, 2-7.  \n\nXu, G., Chance, M.R., 2005. Radiolytic modification of sulfur-containing amino acid residues in \n\nmodel peptides: fundamental studies for protein footprinting. Anal. Chem. 77, 2437-2499. \n\n \n\n \n\n \n\n \n\n\n\n98 \n\n \n\n8 CONCLUS\u00d5ES \n\n \n\n- Num protocolo eficiente, cromatografias de gel de Guar e Superdex, purificaram uma lectina tipo-\n\nC (BlL) do veneno da serpente Bothrops leucurus. \n\n- BlL \u00e9 dependente de c\u00e1lcio e inibida por a\u00e7\u00facares contendo galactos\u00eddeos. Estruturalmente BlL \u00e9 \n\num d\u00edmero composto de subunidades de 15 kDa unidas por liga\u00e7\u00f5es dissulfeto; \n\n- O Dicro\u00edsmo Circular revelou que BlL pode ser classificada como uma prote\u00edna toda ? (contendo \n\nprincipalmente estrutura ?); \n\n- BlL possui atividade antibacteriana contra bact\u00e9rias gram-positivas (Staphylococcus aureus, \n\nEnterococcus faecalis e Bacillus subtilis);  \n\n- BlL apresentou significante atividade citot\u00f3xica em c\u00e9lulas tumorais (K562, Hep-2 e NCI-H292) e \n\ninduziu morte celular por apoptose em c\u00e9lulas tumorais K562; \n\n- A radia\u00e7\u00e3o gamma de 60Co causou altera\u00e7\u00f5es funcionais e estruturais em BlL, al\u00e9m de abolir a sua \n\natividade citot\u00f3xica em linhagens tumorais."}]}}}